{
  "name" : "twin.sci-hub.se_6692_b82ce13412ddfd7a288a1072918fa48e_roy2017.pdf",
  "metadata" : {
    "source" : "META",
    "title" : "Graphene-Based Nanomaterials for Theranostic Applications",
    "authors" : [ "Shounak Roy", "Amit Jaiswal" ],
    "emails" : [ "*j.amit@iitmandi.ac.in" ],
    "sections" : [ {
      "heading" : null,
      "text" : "Graphene-Based Nanomaterials for Theranostic\nApplications\nShounak Roy and Amit Jaiswal*\nSchool of Basic Sciences, Indian Institute of Technology Mandi\nKamand, Mandi 175005, Himachal Pradesh, India\nBioX Centre, Indian Institute of Technology Mandi Kamand, Mandi 175005, Himachal Pradesh, India *j.amit@iitmandi.ac.in\nPublished 15 January 2018\nGraphene and graphene-based nanomaterials such as graphene oxide (GO), reduced graphene oxide (rGO) and graphene quantum dots (GQDs) have gained a lot of attention from diverse scienti¯c ¯elds for applications in sensing, catalysis, nanoelectronics, material engineering, energy storage and biomedicine due to its unique structural, optical, electrical and mechanical properties. Graphene-based nanomaterials emerge as a novel class of nanomedicine for cancer therapy for several reasons. Firstly, its structural properties like high surface area and aromaticity enables easy loading of hydrophobic drugs. Secondly, presence of oxygen containing functional groups improve its physiological stability and also act as site for biofunctionalization. Thirdly, its optical absorption in the NIR region enable them to act as photoagents for photothermal and photodynamic therapies of cancer, both in vitro and in vivo. Finally, its intrinsic °uorescence property helps in bioimaging of cancer cells. Overall, graphene-based nanomaterials can act as agents for developing multifunctional theranostic platforms for carrying out more e±cient detection and treatment of cancers. This review provides a detailed summary of the di®erent applications of graphene-based nanomaterials in drug delivery, nucleic acid delivery, phototherapy, bioimaging and theranostics.\nKeywords: Graphene; graphene oxide; reduced graphene oxide, drug delivery; nucleic acid delivery; phototherapy; bioimaging; theranostics."
    }, {
      "heading" : "1. Introduction",
      "text" : "With its discovery in the year 2002 followed by a Nobel prize in Physics in 2010, graphene has attracted a lot of attention from diverse scienti¯c ¯elds for applications in sensing, catalysis, nanoelectronics, material engineering, energy storage and biomedicine. The reason behind this diverse set of applications is its unique structural,\n*Corresponding author.\nThis is an Open Access article published by World Scienti¯c Publishing Company. It is distributed under the terms of the Creative Commons Attribution 4.0 (CC-BY) License. Further distribution of this work is permitted, provided the original work is properly cited.\nVol. 1, No. 4 (2017) 1750011 (53 pages) #.c The Author(s) DOI: 10.1142/S2424942417500116\n1750011-1\nR ep\n. A dv\n. P hy\ns. S\nci . 2\n01 7.\n01 . D\now nl\noa de\nd fr\nom w\nw w\n.w or\nld sc\nie nt\nif ic\n.c om\nby 1\n79 .2\n18 .7\n6. 13\n4 on\n0 3/\n01 /1\n8. F\nor p\ner so\nna l u\nse o\nnl y.\noptical, electrical, and mechanical properties that have been found to be superior than other widely explored carbon and plasmonic nanomaterials.1–4 Graphene is a two-dimensional (2D) nanomaterial having a monoatomic layer of sp2 hybridized carbon atoms organized in the form of a honeycomb lattice.5 Synthesis of graphene oxide (GO) and reduced graphene oxide (rGO) have been made possible with the development of new synthesis methods that have further enhanced interest in this material speci¯cally in the biomedical ¯eld due to the incorporation of new features and novel properties in these derivatives (Fig. 1).5–7 The ultra-thin nanosheets of graphene and its derivatives like GO and rGO provide very high surface area for e±cient loading of therapeutic cargoes like drugs, nucleic acids, °uorescent probes, biomolecules and cells. Additionally, these materials also provide a distribution of delocalized electrons on the surface giving it an aromatic character, that help in increasing the loading and binding e±ciency of graphene-based nanomaterials with other molecules of therapeutic interest through hydrophobic interactions and – stacking.5 The synthesis procedures of GO introduce wide variety of oxygen containing functional groups like carboxyl, hydroxyl, carbonyl, ethoxy, epoxy, etc., on both planes of GO sheets, thereby increasing its stability in aqueous solutions. This also provides easy functionalization and derivatization of these materials through both covalent and non-covalent modi¯cations with di®erent biocompatible polymers like PEG, chitosan and conjugation with targeting moieties like peptides and antibodies, to develop biofunctionalized nanocomposite systems with improved biological properties.5,8,9 Apart from these surface properties, GO and rGO also possess exciting intrinsic optical properties like photoluminescence and increased absorbance in the near-infrared region (NIR) of electromagnetic spectrum, that make them excellent photo-responsive agents for cancer therapies like photothermal therapy (PTT) and photodynamic therapy (PDT).5 Similar to plasmonic nanomaterials, GO and rGO show photothermal conversion properties in response to NIR irradiation that has been widely explored as a therapeutic strategy for treating cancers. In this context, rGO has been found to be much more e±cient than GO because of the\nFig. 1. Structures of graphene-based materials show (a) the pristine graphene (pure-arranged carbon atoms) with sp2-hybridized carbon atoms, and the chemically modi¯ed graphene, including (b) GO; (c) rGO and (d) graphene quantum dot (GQD). Reproduced with permission from Ref. 7.\n1750011-2\nR ep\n. A dv\n. P hy\ns. S\nci . 2\n01 7.\n01 . D\now nl\noa de\nd fr\nom w\nw w\n.w or\nld sc\nie nt\nif ic\n.c om\nby 1\n79 .2\n18 .7\n6. 13\n4 on\n0 3/\n01 /1\n8. F\nor p\ner so\nna l u\nse o\nnl y.\npresence of more defects and greater aromaticity in its structure that are introduced into it during reduction of GO.5 Owing to these excellent physicochemical and biocompatible properties, graphene-based nanomaterials have found a wide variety of applications in the ¯eld of biomedicine, mostly in cancer research, ranging from serving as nanocarriers and photoagents for drug/gene delivery to cancer cells and for photothermal and photodynamic therapies of cancer, both in vitro and in vivo, till its use as bioimaging agents for developing multifunctional theranostic platforms for carrying out more e±cient detection and treatment of cancers.10\nIn this review, we provide a detailed and systematic description of the journey that graphene-based nanomaterials have undertaken in the ¯eld of biomedical sciences in the last decade by discussing the di®erent applications in drug delivery, gene delivery, phototherapy, bioimaging and theranostics. The main objective of this review is to make the readers understand the evolution of graphene as a nanomedicine over the years and appreciate the immense potential that this nanomaterial holds for the future."
    }, {
      "heading" : "2. Graphene-Based Nanomaterials for Drug Delivery",
      "text" : "In the recent years, graphene-based nanomaterials such as GO and rGO have emerged as excellent nanocarriers for drug delivery owing to their structural and surface properties that make them very suitable for biomedical applications.10,11 The monolayer 2D structure of GO and rGO provide ultrahigh speci¯c surface area and delocalized electrons on the surface that allow highly e±cient loading of hydrophobic anti-cancer drugs through hydrophobic interactions and – stacking, and also provide di®erent oxygen containing functional groups for easy biofunctionalization.12–15 In this section, we discuss the di®erent drug delivery applications of graphene-based nanomaterials under two broad categories (A) Direct drug delivery systems and (B) Stimulus responsive drug delivery systems, to understand the di®erent strategies by which graphene and its derivatives have been exploited for improving cancer chemotherapy. Direct drug delivery systems involve delivery of drugs to a cell or tissue either in a targeted or non-targeted manner without any control on the delivery mechanism. On the other hand, stimulus responsive drug delivery systems provide a controlled and systematic release of drugs from the nanocarrier in response to a speci¯c stimulus, which can be both internal such as pH, redox, etc., as well as external such as temperature, light, magnetic and electrical ¯eld, etc. Table 1 summarizes the di®erent graphene-based drug delivery systems developed so far.\n2.1. Direct drug delivery systems\n2.1.1. Non-targeted drug delivery\nDelivery of anti-cancer drugs using GO as a nanocarrier was reported for the ¯rst time by Liu et al. in 2008.16 They used PEGylated GO to load a hydrophobic\n1750011-3\nR ep\n. A dv\n. P hy\ns. S\nci . 2\n01 7.\n01 . D\now nl\noa de\nd fr\nom w\nw w\n.w or\nld sc\nie nt\nif ic\n.c om\nby 1\n79 .2\n18 .7\n6. 13\n4 on\n0 3/\n01 /1\n8. F\nor p\ner so\nna l u\nse o\nnl y.\nanti-cancer drug SN38 onto the surfaces of GO through – stacking and hydrophobic interactions. This SN38 loaded GO-PEG nanocarrier was then used to deliver the drug to HCT-116 colon cancer cells in vitro. It was observed that the nanocarriers could e±ciently deliver the drug into the cancer cells and demonstrated 2–3 fold improvement in the therapeutic e±ciency as compared to the water soluble prodrug of SN38, irinotecan. In the same year, Yang et al. also showed highly e±cient loading and delivery of another very commonly used hydrophobic cancer drug, doxorubicin using GO as a nanocarrier.17 To further improve the therapeutic e±ciency, Zhang et al. loaded both doxorubicin and camptothecin onto GO sheets and demonstrated e±cient killing of MCF-7 breast cancer cells by combining the e±cacies of both drugs into a single platform.18 Moore et al. demonstrated drug delivery to glioblastomas\nTable 1. Summary of graphene-based nanomaterials for drug delivery.\nNanocomposite Drug Target Reference\nPEG-GO SN38 HCT-116 cells 16\nDOX 17 DOX & CPT MCF-7 cells 18\nnGr-PLA-PEG PTX U-138 glioblastoma cells 19 PEG-GO PTX A549 & MCF-7 cells 20 PLA-PEG-GO PTX A549 cells 21 PDA-GO-FA DOX 22 HA-GO DOX KB epidermal carcinoma\ncells and tumors\n23\nHA-GO DOX HeLa tumors 24 Tf-PEG-GO DOX Glioma 25 CTX-GO DOX Glioma 26 GONR-PEG-DSPE Lucanthone EGFR positive glioblasto-\nma multiforme cells\n29\nGO/PVA hydrogel Vitamin B12 30 GO-CS-FA DOX 31 Pluronic F38, Tween80\nand maltodextrin functionalized GO\nEllagic acid MCF-7 & HT29 cells 32\nGO ADR MCF-7/ADR 33 Lipid monolayer membrane\nfunctionalized graphene sheets\nDOX 34\nGN-CNT-Fe3O4 5-FU HepG2 cells 35 HA-GO DOX H22 hepatic carcinoma\ntumors\n36\nAlbumin-GO PTX 37 rGO-C6H4-CO-NH-PEI-NH-\nCO-CD-Biotin\nDOX HepG2 cells 38\nGO-Abs/PEI/PAH-Cit DOX U87 MG & MCF-7 cells 39 NGO-SS-mPEG DOX HeLa cells 40 PEG-GO DOX A549 cells 41 PEG-BPEI-rGO DOX PC-3 cells 42 Graphene/Fe3O4 composites DOX 43 Fe3O4/GNS Rhodamine B 44 rGO/PVA hydrogel Lidocaine hydrochloride 45\n1750011-4\nR ep\n. A dv\n. P hy\ns. S\nci . 2\n01 7.\n01 . D\now nl\noa de\nd fr\nom w\nw w\n.w or\nld sc\nie nt\nif ic\n.c om\nby 1\n79 .2\n18 .7\n6. 13\n4 on\n0 3/\n01 /1\n8. F\nor p\ner so\nna l u\nse o\nnl y.\nusing biodegradable polylactic acid (PLA) coated nanographene (nGr) functionalized with PEG (nGr-PLA-PEG) as a biocompatible drug delivery system.19 nGr-PLA-PEGs could encapsulate the anticancer drug Paclitaxel (PTX) at a high loading e±ciency and showed controlled release of the drug over a period of 19 days. PTX loaded nGr-PLA-PEGs exhibited 20% killing of U-138 glioblastoma cells in vitro and in vivo biodistribution studies revealed accumulation of nGr in intracranial U-138 glioblastoma xenografts and organs of the reticuloendothelial system. In a recent study, PEGylated GO was used as a nanocarrier for the delivery of PTX to A549 human lung cancer cells and MCF-7 breast cancer cells in vitro.20 PTX was ¯rst attached to a 6-armed PEG which was then covalently conjugated to GO sheets. The GO-PEG-PTX nanocomposites showed e±cient cellular uptake and greater cytotoxicity against the cancer cells as compared to free PTX (Fig. 2(i)). PLA-PEG stabilized GO nanocomposites were developed and used as a drug delivery vehicle by Angelopoulou et al. for delivering PTX to A549 human lung cancer cells in culture.21 The nanocomposites showed e±cient loading and sustained drug release properties alongwith signi¯cant cellular uptake and cytotoxicity against the cancer cells.\n2.1.2. Targeted drug delivery\nCancer cell speci¯c targeted drug delivery systems have also been developed using graphene-based nanomaterials for further increasing the therapeutic e±ciency by selectively delivering the drugs into cancer cells, thereby minimizing the dose of the therapeutic load and also avoiding unnecessary side-e®ects to normal cells. Lin et al. reported the synthesis of folic acid decorated, polydopamine capped GO nanocomposites by a one-pot method and demonstrated targeted delivery of doxorubicin to cancer cells in vitro with high therapeutic e±ciency.22 Cholesteryl hyaluronic acid (HA) conjugated GO loaded with doxorubicin was developed by Miao et al. for targeted delivery of doxorubicin to KB epidermal carcinoma cells both in in vitro and in vivo.23 In vitro studies showed that the targeted nanocomposite induced 40.3% increase in cell death as compared to the non-targeted one. Similarly, subcutaneous injection of the targeted nanocomposites in tumor bearing athymic mice resulted in 14.1% decrease in the tumor volume within 24 days. In another study, HA was linked to GO via an adipic acid dihydrazide (ADH) linkage to form HA tagged GO-based targeted drug delivery system that was used for delivering doxorubicin to mice with subcutaneous HeLa tumors.24 Within 16 days, the targeted nanocomposites showed 12% and 17% greater tumor inhibition rates as compared to free doxorubicin and non-targeted nanocomposites, respectively. In addition to FA and HA, transferrin (Tf) protein is also used as a targeting agent. Liu et al. synthesized Tf conjugated PEGylated nanographene oxide composites loaded with doxorubicin (Tf-PEG-GODox) for targeted delivery of drug to glioma cells.25 The nanocomposites showed a drug loading ratio of up to 115.4% and demonstrated signi¯cantly higher cytotoxicity against gliomas as compared to free drug and PEG-GO-Dox, both in in vitro\n1750011-5\nR ep\n. A dv\n. P hy\ns. S\nci . 2\n01 7.\n01 . D\now nl\noa de\nd fr\nom w\nw w\n.w or\nld sc\nie nt\nif ic\n.c om\nby 1\n79 .2\n18 .7\n6. 13\n4 on\n0 3/\n01 /1\n8. F\nor p\ner so\nna l u\nse o\nnl y.\n(i) Non-Targeted DDS\n(ii) Targeted DDS\nFig. 2. Graphene-based nanomaterials for drug delivery. (i) Non-targeted drug delivery system (a) Preparation of GO-PEG-PTX Nanoscale Drug Delivery System. Di®erential interference contrast (DIC), FITC, DAPI, and merge (FITCþDAPI) images of A549, (b) and MCF-7, (c) cells incubated with GO-PEG-FITC for 3 h; scale bar 25 m, (d) Relative cell viability of MCF-7 cells after treatment with di®erent concentrations of PTX and GO-PEG-PTX for 72 h. Reproduced with permission from Ref. 20. Copyright 2014 American Chemical Society. (ii) Targeted drug delivery system (a) Schematic representation of targeted delivery of Tf-PEG-GO-Dox to cells in vitro and in vivo. (b) C6 viability–concentration curves for Dox, PEG-GO-Dox, and Tf-PEG-GO-Dox. (c) Glioma volume in di®erent therapeutic groups on the 14th day. Reproduced with permission from Ref. 25. Copyright 2013 American Chemical Society. (iii) Internal-stimulus responsive drug delivery system. Schematic diagram showing antitumor activity of redox-sensitive DXR-loaded NGO-SS-mPEG Reproduced with permission from Ref. 40. Copyright 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. (iv) External-stimulus responsive drug delivery system. Schematic representation of photothermally triggered cytosolic drug delivery via endosomal disruption using PEG-BPEI-rGO. Reproduced with permission from Ref. 42. Copyright 2013 American Chemical Society.\n1750011-6\nR ep\n. A dv\n. P hy\ns. S\nci . 2\n01 7.\n01 . D\now nl\noa de\nd fr\nom w\nw w\n.w or\nld sc\nie nt\nif ic\n.c om\nby 1\n79 .2\n18 .7\n6. 13\n4 on\n0 3/\n01 /1\n8. F\nor p\ner so\nna l u\nse o\nnl y.\nand in vivo (Fig. 2(ii)). Another glioma targeted drug delivery system was developed by Wang et al., where they conjugated GO with chlorotoxin (CTX-GO) as the targeting agent for selective delivery of doxorubicin to glioma cells.26 Chlorotoxin is a toxin derived from Leiurus quinquestriatus having high a±nity for matrix-metalloprotease-2 proteins that are known to be overexpressed in gliomas. CTX-GO loaded with doxorubicin showed higher accumulation of drug inside gliomas and caused greater cytotoxicity against glioma cells as compared to free drug and GO-Dox. A new type of graphene derivative referred to as graphene oxide nanoribbons (GONR) was synthesized by Chowdhury et al. by using carbon nanotubes (CNT) as the precursor material.27 These GONRs upon functionalization with PEG-DSPE (1, 2-distearoyl-sn-glycero-3 phosphoethanolamine) (GONR-PEG-DSPE) showed cancer cell targeted cytotoxicity without the use of a targeting agent. The targeting speci¯city was found towards cells overexpressing EGFR and this property of GONRs was exploited by the group to selectively deliver lucanthone\n(iii) Internal Stimuli Responsive DDS\n(iv) External Stimuli Responsive DDS\nFig. 2. (Continued)\n1750011-7\nR ep\n. A dv\n. P hy\ns. S\nci . 2\n01 7.\n01 . D\now nl\noa de\nd fr\nom w\nw w\n.w or\nld sc\nie nt\nif ic\n.c om\nby 1\n79 .2\n18 .7\n6. 13\n4 on\n0 3/\n01 /1\n8. F\nor p\ner so\nna l u\nse o\nnl y.\n(apurinic endonuclease-1 (APE-1) inhibitor) to EGFR over-expressing glioblastoma multiforme cells in culture.28,29 Lucathone-GONR nanocomposites showed signi¯cant cytotoxicity against glioblastoma multiforme cells but demonstrated no toxicity to EGFR negative glial precursor cells, thereby showing the speci¯city of GONRs as a novel drug delivery system.\n2.2. Stimuli-responsive drug delivery systems\nStimulus-responsive drug delivery systems allow for a controlled release of drugs at a particular site only in the presence of a speci¯c stimulus, that directs the nanocarrier system to release its therapeutic payload. Controlled release of drugs improves the therapeutic e±ciency of the system by minimizing the chances of premature and burst release of drugs in the circulation. Stimulus can be either internal or external. Internal stimulus refers to the changes in the intracellular environment such as pH, redox, etc., that can trigger release of drugs from nanocarriers speci¯cally designed to respond to such stimuli, or it can respond to external stimuli such as light, temperature, magnetic and electrical ¯eld.\n2.2.1. Internal stimuli responsive systems\nSeveral graphene-based drug delivery systems have been developed in the recent years that are responsive to internal stimulus like pH and redox. Cancer cells and tumor microenvironments are known to have an acidic pH and high concentrations of redox enzymes like GSH as compared to surrounding healthy cells and tissues. So, these two intracellular stimuli have been exploited to e±ciently modulate and control the release of drugs from nanocarriers speci¯cally inside the tumor cells and tissues. Bai et al. reported a pH-sensitive composite hydrogel consisting of GO and poly (vinyl alcohol) (GO/PVA) that showed pH-responsive gel–sol transition properties, thereby allowing e±cient loading and release of drugs at di®erent pH conditions.30 Depan et al. developed a doxorubicin loaded GO-chitosan-FA nanocomposite (DOX-GO-CH-FA) and studied its drug release properties in response to di®erent pH values.31 It was observed that the nanocomposites showed higher and faster release of DOX at an acidic pH than physiological pH, and also showed morphological transition from non-porous to porous structure after drug release. Similarly, a biocompatible polymer pluronic F38, Tween80 and maltodextrin functionalized GO nanocomposite was prepared by Kakran et al. which showed good loading of a poorly water soluble anti-cancer drug ellagic acid and increased release pro¯les at acidic pH.32 In an interesting study by Wu et al., GO was used as carrier for adriamycin (ADR) to overcome ADR resistance in MCF-7/ADR breast cancer cells in vitro.33 GO showed a high ADR loading e±ciency of around 93.6% and demonstrated pH-dependent release of ADR. The in vitro studies revealed that GO could e±ciently deliver the drug into MCF-7/ADR cells and have signi¯cantly higher cytotoxicity against the drug resistant cancer cells in comparison to free ADR. Lipid monolayer membrane functionalized graphene sheets were developed by\n1750011-8\nR ep\n. A dv\n. P hy\ns. S\nci . 2\n01 7.\n01 . D\now nl\noa de\nd fr\nom w\nw w\n.w or\nld sc\nie nt\nif ic\n.c om\nby 1\n79 .2\n18 .7\n6. 13\n4 on\n0 3/\n01 /1\n8. F\nor p\ner so\nna l u\nse o\nnl y.\nLiu et al. as highly e±cient physiologically stable pH responsive drug delivery system, that showed excellent DOX loading capacity and acidic pH stimulated controlled release of the drug.34 Fan et al. reported the synthesis of a graphene–CNT– Fe3O4 nanoparticle hybrid (GN-CNT-Fe3O4Þ and showed its pH-dependent drug release properties.35 5-FU loaded GN-CNT-Fe3O4 nanohybrids showed high toxicity against HepG2 cells in vitro. Another targeted pH responsive drug delivery system was reported by Song et al. comprising of HA linked GO nanosheets that showed an acidic pH responsive DOX release property, which caused 17% higher tumor inhibition in H22 hepatic carcinoma cell tumors in mice as compared to only GO loaded DOX groups.36 In addition to these studies, there are several other reports on the development of pH responsive graphene-based drug delivery systems that further highlight the potential and importance of graphene-based nanomaterials in drug delivery.37–39\nWen et al. exploited the high levels of glutathione (GSH) in cancer cells and tumors as a stimulus to induce drug release and developed a NGO-based drug delivery system consisting of a redox-responsive PEG shell attached to NGO sheets via disul¯de linkages.40 In presence of GSH in the environment, the PEG shells got detached from the system due to disul¯de bond breakage and caused 1.55 times faster drug release than in the absence of GSH (Fig. 2(iii)). Another study reported GSH-triggered anti-cancer drug release from PEGylated graphene oxide (PEG-GO) nanocarriers, both in in vitro and in vivo.41\n2.2.2. External stimuli responsive systems\nA NIR responsive photothermally triggered cytosolic drug delivery system was developed by Kim et al. using PEG and BPEI dual polymer functionalized rGO nanosheets (PEG-BPEI-rGO).42 The PEG-BPEI-rGO nanocomposites showed high drug loading e±ciency with absorbance in the NIR region. Drug release was mediated by both GSH and photothermal e®ect of NIR light irradiation. It was observed that after cellular uptake, the nanocomposites escaped the endosomes via photothermally induced endosome disruption and proton sponge e®ect and subsequently released the drug into the cytosol in response to high GSH concentrations inside cancer cells (Fig. 2(iv)). This photothermal e®ect on the drug release was found to cause more cytotoxicity against cancer cells in comparison to those not irradiated with NIR light.\nGraphene-based nanocomposites containing magnetite or iron oxide nanoparticles can be e®ectively used as a drug delivery system responsive to an external magnetic ¯eld. This was shown by Zhou et al. who synthesized graphene/Fe3O4 composites through a simple one-pot solvothermal process.43 These graphene/Fe3O4 composites showed good water dispersibility alongwith excellent magnetic properties ideal for a magnetically guided drug delivery system. Doxorubicin was loaded onto these composites with a high loading e±ciency of about 65%. The release of drugs from these composites could be controlled and guided by an external magnetic ¯eld.\n1750011-9\nR ep\n. A dv\n. P hy\ns. S\nci . 2\n01 7.\n01 . D\now nl\noa de\nd fr\nom w\nw w\n.w or\nld sc\nie nt\nif ic\n.c om\nby 1\n79 .2\n18 .7\n6. 13\n4 on\n0 3/\n01 /1\n8. F\nor p\ner so\nna l u\nse o\nnl y.\nIn another study, Li et al. reported the synthesis of Fe3O4 nano°owers encapsulated in graphene nanosheets (Fe3O4/GNS) and demonstrated the feasibility of these nanocomposites to be used as drug delivery systems under the in°uence of an external magnetic ¯eld by loading Rhodamine B onto them with a high loading e±ciency.44\nApart from magnetic ¯eld, electric ¯eld can also be used as a stimulus to control drug delivery. Liu et al. reported the development of an electrically modulated drug delivery system comprising of rGO sheets embedded in a matrix of PVA, forming a hydrogel.45 Lidocaine hydrochloride was loaded into this hydrogel as a model drug and its release properties were studied under the in°uence of an external electric ¯eld. In the absence of an electrical stimulus, drug release was not observed. Drug release occurred only in the presence of electric ¯eld, thereby demonstrating the electrical stimulus responsive properties of this hydrogel."
    }, {
      "heading" : "3. Graphene-Based Nanomaterials for Nucleic Acid Delivery",
      "text" : "The most sought after vectors for carrying out e±cient gene delivery to cells, both in vitro and in vivo have been viral vectors because of their very high transfection e±ciency.46 However, concerns related to the safety and biocompatibility of these viral vectors such as chances of random genomic integration, activation of oncogenes, stimulation of unwanted immune response in the host and re-activation of the inactivated viruses have limited the large scale application and clinical translation of these vectors for gene therapy.46 So, for the development of safer vectors, researchers have moved towards non-viral approaches of gene delivery.47 Di®erent types of materials such as cationic polymers, lipids, polysaccharides and dendrimers have been explored for the development of non-viral vectors, which demonstrated their abilities to carry and deliver genes into cells and tissues, however could not reach the high level of transfection e±ciencies as shown by viral vectors.47 In addition to this, cytotoxicity and biocompatibility issues were also observed with cationic lipids and polymers due to their high density of surface positive charges that are required for e±cient nucleic acid complexation. Thus, the search for an e±cient and safe vector which can provide high level of transfection e±ciency without inducing any toxicity or undesirable side-e®ects in the host is still on.\nThe structural, optical and biocompatible properties of graphene and its derivatives such as GO and rGO have raised a lot of interest in this material in the recent years, that have led to studies related to the synthesis and development of non-viral vectors using graphene-based materials as a novel carrier system for gene delivery.48 Small size, high surface area to mass ratio, easy surface functionalization, ability to load and condense nucleic acids even in the absence of cationic groups through – interactions, protection of nucleic acids from endonuclease digestion, high cellular uptake and low toxicity has made graphene and its derivatives a suitable candidate for gene delivery.5 The ease of functionalization of these materials with cationic polymers and targeting moieties to improve their biocompatibility, nucleic acid\n1750011-10\nR ep\n. A dv\n. P hy\ns. S\nci . 2\n01 7.\n01 . D\now nl\noa de\nd fr\nom w\nw w\n.w or\nld sc\nie nt\nif ic\n.c om\nby 1\n79 .2\n18 .7\n6. 13\n4 on\n0 3/\n01 /1\n8. F\nor p\ner so\nna l u\nse o\nnl y.\nloading e±ciency and overall therapeutic e±cacy is due to the presence of numerous oxygen containing functional groups on the surface of these materials that allow for easy conjugation and derivatization.5,8 Covalent and non-covalent functionalization of GO and rGO nanosheets with cationic polymers like polyethylenimine (PEI), polysaccharides like chitosan and dendrimers such as polyamidoamine (PAMAM) have been carried out to develop nanoconstructs with improved nucleic acid binding e±ciency and physiological stability for achieving better transfection and therapeutic outcomes.8,48 The cationic molecules provide a net positive charge on the surface of the nanoconstructs that help in improving the nucleic acid condensation e±ciency through electrostatic interactions. Incorporation of PEG alongwith these groups have also shown to improve the aqueous stability and biocompatibility of these nanoconstructs. In addition to this, these grafting strategies of cationic polymers and dendrimers onto the surface of GO and rGO also helped to minimize their cytotoxicity by decreasing the concentration of the positive charges in the nanoconstructs without a®ecting the e±cient nucleic acid binding capacities.\nThe ¯rst attempt towards successful delivery of a nucleic acid using graphenebased nanomaterial as a vector was made by Lu et al.49 The group used NGO sheets to deliver a molecular beacon (MB) to HeLa cells in culture for intracellular sensing of the expression level of survivin gene at the mRNA level (Fig. 3(i)). A molecular beacon is basically a single stranded DNA folded into a hairpin structure having a self-complementary stem alongwith a single stranded loop that is complementary to a speci¯c target. In the closed conformation, the stem brings together a °uorophore and a quencher attached to them in close proximity resulting in °uorescence quenching. However, in the presence of the target sequence, the MB undergoes a conformational change and opens up to hybridize with the target, thereby taking the °uorophore-quencher pair away from each other, which ultimately leads to restoration of the °uorescence. This °uorescence o®/on mechanism is used as a probe to detect the presence of a target sequence. In this study, the authors observed that the NGO sheets not only showed e±cient loading of the MB on its surface, but also protected it from endonuclease digestion. In addition to this, the MB retained its target sequence binding ability even after loading onto NGO which was evidenced by the appearance of °uorescence inside the HeLa cells, thereby also demonstrating successful intracellular delivery of the nucleic acid payload. Simultaneously in the same year, Wang et al. also demonstrated real-time biosensing of ATP in JB6 cells using an aptamer/GO nanocomplex.50 Apart from mRNA and biomolecule sensing, PEI grafted graphene nanoribbons (PEI-GNR) loaded with MB were also used as molecular probes by Dong et al. for sensing of miR-21 in cells.51 The PEI-GNR showed more e±cient delivery of MB as compared to PEI-MWCNTs and PEI alone. In a follow up study by the same group, the authors developed a multifunctional poly (L-lactide)-Polyethylene glycol-grafted graphene quantum dot-based platform for intracellular sensing of miR-21 combined with °uorescent tracking of the internalization of the complexes using GQDs.52\n1750011-11\nR ep\n. A dv\n. P hy\ns. S\nci . 2\n01 7.\n01 . D\now nl\noa de\nd fr\nom w\nw w\n.w or\nld sc\nie nt\nif ic\n.c om\nby 1\n79 .2\n18 .7\n6. 13\n4 on\n0 3/\n01 /1\n8. F\nor p\ner so\nna l u\nse o\nnl y.\n(i) Molecular Probing\n(ii) Gene Delivery\nFig. 3. Graphene-based nanomaterials for nucleic acid delivery. (i) Molecular probing. Schematic representation of NGO delivery of MB into HeLa cells to detect survivin mRNA. Reproduced with permission from Ref. 49. Copyright 2010 Royal Society of Chemistry. (ii) Gene delivery. (a) Schematic illustration of photothermal transfection mechanism. (b) Transfection of the BPEI (1.8 and 25K), PEG-BPEI-GO and PEG–BPEI–rGO with/without NIR irradiation in PC-3 and NIH/3T3 cell lines. Reproduced with permission from Ref. 60. Copyright 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim (iii) mRNA delivery. E±cient reprogramming from ¯broblasts into iNs by GO-PEI-mRNA complexes; (a) Representative images and (b) percentages of Tuj1-positive iNs induced by lentiviral ABM, GO-PEI-ABM, and Lipofectamine ABM; (c) qRT-PCR analysis of the neuronal genes Tuj1, Map2, NeuroD1, and Syp in Lentiviral ABM and GO-PEI-ABM transduced ¯broblasts; Three independent experiments were performed in triplicate. Data are presented as means standard errors of the mean (SEM); Student's t-test; p < 0:05, p < 0:01. (d) Immuno°uorescence of Map2, NeuN, PSD97, and vGlut1 in GO-PEI-ABMinduced neurons; Scale bars, 100 m. (e) Flow cytometry analysis of the induction of Tau-eGFPþ cells by GO-PEI-ABM; proportions of Tau-eGFPþ cells among treated cells are indicated as percentages. (f) GOPEI-ABM complexes induced iNs expressed Syp, vGlut1, and Glutamate; Scale bars, 100 m. (g) Number of Syp, vGlut1, and Glutamate positive iNs induced by Go-PEI-ABM complexes. (h) Con¯rmation of transgene integration using genomic-DNA PCR; Lane 1, Lipofectamine-ABM transfected ¯broblasts; Lane 2, lentiviral-ABM infected ¯broblasts; Lane 3, GO-PEI-ABM transfected ¯broblasts. Reproduced with permission from Ref. 61. Copyright 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.\n1750011-12\nR ep\n. A dv\n. P hy\ns. S\nci . 2\n01 7.\n01 . D\now nl\noa de\nd fr\nom w\nw w\n.w or\nld sc\nie nt\nif ic\n.c om\nby 1\n79 .2\n18 .7\n6. 13\n4 on\n0 3/\n01 /1\n8. F\nor p\ner so\nna l u\nse o\nnl y.\nIn addition to molecular sensing, graphene-based nanovectors have been extensively used for the delivery of foreign genes encoded in plasmid DNAs for expression in cells. However, most of these works have focussed mainly on the delivery of plasmid DNA encoding a °uorescent protein like EGFP to demonstrate the loading and transfection e±ciencies of di®erent surface functionalized graphene-based nanovectors, without any emphasis on therapeutic application. For example, Chen et al. used GO sheets covalently functionalized with BPEI as a gene delivery tool for delivering plasmid DNA encoding EGFP to HeLa cells.53 Similarly, in another study, Kim et al. used PEI functionalized GO sheets for delivering luciferase gene into cells for bioimaging applications.54 Several other studies utilized this PEI-GO\n(iii) mRNA Delivery\nFig. 3. (Continued )\n1750011-13\nR ep\n. A dv\n. P hy\ns. S\nci . 2\n01 7.\n01 . D\now nl\noa de\nd fr\nom w\nw w\n.w or\nld sc\nie nt\nif ic\n.c om\nby 1\n79 .2\n18 .7\n6. 13\n4 on\n0 3/\n01 /1\n8. F\nor p\ner so\nna l u\nse o\nnl y.\nnanoconstruct as a vector and demonstrated highly e±cient delivery of EGFP plasmid DNA into cells in vitro, either in a non-targeted or targeted manner.55–58 Recently, the concept of photothermally enhanced gene delivery was introduced for the ¯rst time by Feng et al. followed by a subsequent study by Kim et al., who independently showed that the transfection e±ciency of graphene-based nanovectors could be improved signi¯cantly by exploiting the NIR responsive photothermal properties of GO and rGO at the time of transfection.59,60 Feng and co-workers developed a PEG-PEI dual polymer functionalized nGO-based composite (NGOPEG-PEI) and demonstrated highly e±cient and greater EGFP transfection e±ciency as compared to GO-PEI and PEI alone, in presence of low power NIR irradiation due to the localized photothermal heating that enhanced the cellular uptake of the nanocarriers as a result of increased cell membrane permeability, without inducing any cytotoxicity.59 They further utilized this nanocarrier for siRNA delivery into cells and demonstrated enhanced downregulation of the target gene (Plk1) in presence of NIR laser mediated transfection. In a subsequent work, Kim et al. reported the application of PEG-PEI-rGO nanocomposites for photothermally enhanced gene delivery and further demonstrated that the enhancement in transfection e±ciency upon NIR irradiation was caused due to accelerated endosomal escape of polyplexes augmented by locally induced heat (Fig. 3(ii)).60 Li et al. reported a new method of gene delivery using patterned nGO matrixes as cell culture substrates onto which PEI/pDNA complexes were adsorbed. These substrates showed gradual release of the PEI/pDNA complexes which resulted in transfection of the cells being cultured on those substrates.61 In a remarkable study conducted by Khademhosseini and group, PEI functionalized GO nanosheets (fGO) incorporated in methacrylated gelatin (GelMA) hydrogel was used as a carrier (fGOVEGF/GelMA) for vascular endothelial growth factor-165 (VEGF) gene delivery for myocardial therapy.62 In a rat model of myocardial infarction, the fGOVEGF/GelMA hydrogels were injected intramyocardially in the peri-infarcted regions, which showed a signi¯cant increase in the microcapillary density in the infarcted region alongwith a reduction in scar area and improvement in cardiac function as compared to controls, without invoking any in°ammatory and toxic responses in the host. This study demonstrated the immense potential of graphene-based materials to serve as nonviral vectors in gene therapy. In another equally interesting study published recently by Choi et al., GO-PEI nanocomposites were exploited for the ¯rst time as mRNA delivery vectors for the generation of \\footprint-free\" induced pluripotent stem cells (iPSCs).63 Footprint-free iPSCs are very important from a clinical point of view because their creation do not involve genomic integration of the reprogramming factor genes, thereby minimizing the risk of insertional mutagenesis in humans. GOPEI nanocomplexes showed highly e±cient loading of mRNA of reprogramming transcription factors (Oct3/4, So2, Klf4, cMyc) and also provided protection to the mRNAs from RNAse degradation. In addition to this, the GO-PEI/RNA complexes could transfect adult adipose tissue-derived ¯broblasts in suspension cultures with a high e±ciency and successfully generated both rat and human iPSCs from them. The\n1750011-14\nR ep\n. A dv\n. P hy\ns. S\nci . 2\n01 7.\n01 . D\now nl\noa de\nd fr\nom w\nw w\n.w or\nld sc\nie nt\nif ic\n.c om\nby 1\n79 .2\n18 .7\n6. 13\n4 on\n0 3/\n01 /1\n8. F\nor p\ner so\nna l u\nse o\nnl y.\ngenerated iPSCs showed all markers of pluripotency like expression of pluripotency genes, epigenetic reprogramming, and di®erentiation into the three germ layers. This study laid the framework for the application of graphene-based materials as non-viral mRNA delivery vectors for generation of iPSCs and for potential applications in direct cell-reprogramming-based therapies for the treatment of a wide variety of diseases. Two very recent works demonstrated the application of GO-PEI complexes as mRNA and gene delivery vectors for direct reprogramming of human somatic cells into cells of neural and mesodermal lineage.64,65 Baek et al. demonstrated the reprogramming of ¯broblasts into integration-free induced neurons (iNs) through the transfer of mRNA of neural lineage speci¯c reprogramming factors using GO-PEI complexes, that alleviated Parkinson's disease symptoms in a mouse model (Fig. 3 (iii)).64 In another study, Chiang et al. demonstrated the direct reprogramming of human peripheral blood mononuclear cells into cells of the mesodermal lineage using\nTable 2. Summary of graphene-based nanomaterials for nucleic acid delivery.\nNanocomposite Nucleic acid cargo Target Reference\nNGO Molecular beacon for surviving gene sensing\nHeLa cells 49\nGO Aptamer for ATP sensing JB6 cells 50 PEI-GNR Molecular beacon for miR-21 sensing HeLa cells 51 PLA-PEG-GQD Molecular beacon for miR-21 sensing, miR-21 and surviving targeting\nantisense ODNs\nHeLa cells 52\nBPEI-GO pEGFP HeLa cells 53 PEI-GO Luciferase gene HeLa & PC-3 cells 54 PEI-GO pEGFP HeLa & 293 T cells 55 PEI-GO pEGFP H293T, U20 cells,\nzebra¯sh embryos\n56\nPEI-GO pEGFP HeLa cells 57 PEI-GO pEGFP HeLa cells 58 NGO-PEG-PEI pEGFP, Plk1 siRNA HeLa cells 59 PEG-PEI-rGO Luciferase gene NIH3T3 and PC-3 60 nGO matrix pGFP, luciferase HEK293T, HeLa &\nhMSC\n61\nPEI-GO/GelMA\nhydrogel\nVEGF-165 gene Mouse model of myo-\ncardial infarction\n62\nPEI-GO mRNA of Oct3/4, So2, Klf4, cMyc\ntranscription factors\nAdipose tissue derived\n¯broblasts\n63\nGO-PEI mRNA of neural lineage speci¯c\ntranscription factors\nFibroblasts 64\nGO-Fe3O4-PEI Episomal plasmids encoding pluripotent\nrelated factors\nPBMC 65\nGO-CS Luciferase gene HeLa cells 66 GO-PAMAM Luciferase gene HeLa & MG63\n¯broblasts\n67\nGO-PEI pGFP & anti-pGFP siRNA HEK293 & HeLa cells 68 GO-PEI anti-CXCR4 siRNA MDA-MB-231 cells 69 rGO-PL-PEG-\nOctarginine\nCell death siRNA MCF-7 cells 70\n1750011-15\nR ep\n. A dv\n. P hy\ns. S\nci . 2\n01 7.\n01 . D\now nl\noa de\nd fr\nom w\nw w\n.w or\nld sc\nie nt\nif ic\n.c om\nby 1\n79 .2\n18 .7\n6. 13\n4 on\n0 3/\n01 /1\n8. F\nor p\ner so\nna l u\nse o\nnl y.\nGO-Fe3O4-PEI complexes carrying three episomal plasmids encoding pluripotent related factors via a process of combined magnetic stirring and photothermal stimulation to enhance the transfection e±ciencies of the complexes in suspension culture.65 The transfected PBMCs were reprogrammed into iPSCs, which rapidly transdi®erentiated into mesodermal lineages without full reprogramming.\nChitosan functionalized GO nanovector was also explored as a gene delivery vector by Bao et al. for delivering luciferase gene into HeLa cells.66 However, the transfection e±ciency of such vectors was not found to be as high as PEI. Cationic dendrimers like PAMAM have also been explored for gene delivery. Liu et al. developed a PAMAM and oleic acid functionalized GO nanocomposite and demonstrated transfection of HeLa and MG63 ¯broblast cells with luciferase gene at a high transfection e±ciency.67 These composites also showed good physiological stability.\nGraphene-based nanomaterials have also been explored for delivering siRNAs to cells in vitro for downregulating the expression of speci¯c genes that are found to be overexpressed in pathological conditions such as cancer. Tripathi et al. used GO-PEI nanocomplex for delivering GFP expressing pDNA to cells in culture and using the same vector delivered a anti-GFP siRNA 3 h later.68 The authors reported 70% knockdown in the °uorescence levels. Using a similar GO-PEI nanocomplex, Huang et al. recently demonstrated suppression in cancer cell migration through e±cient knockdown of CXCR4 gene using anti-CXCR4 siRNA, which is strongly upregulated in cancer metastasis.69 In another recent study, Imani et al. reported the synthesis of a rGO-based nanocarrier functionalized with phospholipid-PEG and conjugated with a cell penetrating peptide octarginine.70 The nanocarrier was used to selectively deliver a cell death siRNA to MCF-7 cells in vitro. The nanocarriers showed good nucleic acid binding, endonuclease protection, high transfection e±ciency, superior bu®ering capacity in the acidic pH range of 4–6 and induced 51% cell death in treated cells as compared to non-treated ones. Table 2 summarizes the di®erent graphene-based nucleic acid delivery systems developed so far."
    }, {
      "heading" : "4. Graphene-Based Nanomaterials for Phototherapy",
      "text" : "Graphene and graphene-based materials such as GO and rGO have emerged as excellent nanomaterials for carrying out photothermal and photodynamic therapies of cancer because of their surface chemistry and intrinsic optical properties. Photothermal therapy is a widely exploited non-invasive cancer therapy procedure that involves the absorption of light of a particular wavelength especially NIR by nanomaterials or dyes or a combination of both, which are capable of converting this light energy into heat for photothermal killing or ablation of cancer cells and tumors, both in in vitro and in vivo.71 Large surface area, presence of sp2 clusters on the crystal lattice, strong absorption in the NIR region and small size have made both GO and\n1750011-16\nR ep\n. A dv\n. P hy\ns. S\nci . 2\n01 7.\n01 . D\now nl\noa de\nd fr\nom w\nw w\n.w or\nld sc\nie nt\nif ic\n.c om\nby 1\n79 .2\n18 .7\n6. 13\n4 on\n0 3/\n01 /1\n8. F\nor p\ner so\nna l u\nse o\nnl y.\nrGO to act as excellent photothermal agents in response to NIR irradiation and generate heat through plasmonic photothermal conversion.72 The NIR absorbance of rGO has been found to be six times more as compared to GO because of the highly intact aromatic structure of rGO created during reduction process. On the other hand, photodynamic therapy that involves the use of light responsive photosensitizers as therapeutic agents for generation of highly cytotoxic reactive oxygen species (ROS) upon irradiation with light, have also attracted a great deal of attention in cancer therapy. GO and rGO have been used as sca®olds or carriers for loading and delivering these photosensitizers into cancer cells and tissues for photodynamic cancer therapy.73 The presence of oxygen containing functional groups on both surfaces of GO nanosheets make them ideal platforms for highly e±cient loading of hydrophobic as well as hydrophilic photosensitizer molecules through several non-covalent interactions such as – interactions, hydrophobic interactions, hydrogen bonding and electrostatic interactions. The following section describes the progress that has been made in the development of di®erent kinds of graphene-based nanomaterials as e±cient photoagents for successful photothermal and photodynamic therapy of cancers. Table 3 summarizes the di®erent phototherapeutic applications of graphene-based nanomaterials.\n4.1. Photothermal therapy\nThe Liu group was the ¯rst to report the photothermal properties of PEGylated nano-GO in a tumor model of mice.74 The group demonstrated that nGO-PEG exhibited enhanced absorption in the NIR region and caused complete photothermal ablation of tumors in mice, intravenously injected with the nanocomposites in response to NIR irradiation. Robinson et al. reported the use of rGO as a photothermal agent for the ¯rst time and showed that non-covalently PEGylated nanosized rGO sheets were more e±cient in the photothermal conversion as compared to covalently PEGylated GO sheets.75 The group demonstrated targeted photothermal ablation of U87MG cancer cells in vitro by using RGD peptide tagged PEGylated nano-rGO in response to NIR irradiation. The nanocomposites showed negligible toxicity in the absence of NIR irradiation, thereby establishing itself as novel biocompatible photothermal agents for cancer therapy. The Liu group carried out a detailed study to understand the e®ects of size and surface chemistry of graphene sheets on the photothermal properties and further validated the ¯ndings of Robinson et al. that noncovalently PEGylated nanosized reduced graphene oxide sheets were more e±cient in the photothermal conversion as compared to covalently PEGylated GO sheets.76 In their study, Liu and co-workers demonstrated 100% photothermal ablation of tumors in mice injected with nRGO-PEG and irradiated with a low-power NIR laser (0.15W/cm2Þ, which was one order of magnitude lower than that normally used for in vivo photothermal ablation by other nanomaterials. Following a di®erent approach, Akhavan et al. reported a novel strategy for the synthesis of reduced graphene oxide by using glucose as both, reducing and functionalizing agent.77\n1750011-17\nR ep\n. A dv\n. P hy\ns. S\nci . 2\n01 7.\n01 . D\now nl\noa de\nd fr\nom w\nw w\n.w or\nld sc\nie nt\nif ic\n.c om\nby 1\n79 .2\n18 .7\n6. 13\n4 on\n0 3/\n01 /1\n8. F\nor p\ner so\nna l u\nse o\nnl y.\nThe glucose reduced GO showed excellent biocompatibility and improved NIR absorbance as compared to hydrazine reduced GO, single and multi-walled CNTs and demonstrated e±cient photothermal killing of LNCaP prostate cancer cells in vitro at very low concentrations (0.05mg/ml). Li et al. exploited the NIR responsive photothermal properties of nano-GO sheets to induce dissociation of amyloid ¯brils (A ¯brils) by heat for the treatment of Alzhiemer's disease.78 The benzothiazole dye Thio°avin S (ThS) which has an a±nity to selectively bind to A ¯brils instead of A monomers was covalently linked to the nGO sheets resulting in the formation of GO–ThS–A , which upon irradiation with a low-power NIR laser showed dissociation of the A ¯brils. The dissociation of the ¯brils was monitored by the °uorescence change of ThS. In another study, green tea-rGO nanosheets (GT-rGO) were developed and used for the photothermal destruction of HT29 and SW48 colon cancer cells in vitro.79 Hou et al. reported selective photothermal killing of cancer cells in vitro under visible light irradiation using water dispersible Cu2O nanocrystal-rGO hybrids as photothermal agents.80 In order to enhance the photothermal properties of GO and rGO, several groups have reported the development of plasmonic\nTable 3. Summary of graphene-based nanomaterials for phototherapies.\nNanocomposite Therapeutic modality\nTarget Reference\nnGO-PEG PTT 4T1 tumor bearing Balb/c mice, KB, and\nU87MG tumor bearing nude mice\n74\nnRGO-PEG-RGD PTT U87MG cells 75 nRGO-PEG PTT 4T1 tumor bearing mouse 76 RGO PTT LNCaP cells 77 nGO–ThS PTT Amyloid ¯brils 78 RGO PTT HT29 & SW48 79 Cu2O NC-RGO PTT HK-2, MDA-MB-231, A549 cells 80 AuNS@RGO AuNR@RGO PTT HUVECs 81 AuNR-PEG-GO PTT A431 cells and tumors in mouse 82 GON PTT AGS cells 83 NGO-HA PTT Skin cancer tumors in mouse 84 ZnFe2O4-rGO PTT Prostate cancer in vitro, glioblastoma tumors in vivo 85 MUC-1 aptamer-AuNP-GO PTT MCF-7 cells 86 GO-Cypate PTT 4T1 cells in vitro & 4T1 tumor bearing mice 87 ZnPc-NGO-mPEG PDT MCF-7 cells 88 Ce6-GO-FA PDT MGC803 cells 89 GO-HB PDT SGC-7901, SMMC-7721, HeLa, and A549 cells 90 GO-HA PDT HeLa cells 91 GO/TiO2 PDT HeLa cells 92 ZnO-GO-FA PDT HeLa cells 93 Ce6-GO-HA PDT HeLa cells 94 MB-GO PDT 95\n1750011-18\nR ep\n. A dv\n. P hy\ns. S\nci . 2\n01 7.\n01 . D\now nl\noa de\nd fr\nom w\nw w\n.w or\nld sc\nie nt\nif ic\n.c om\nby 1\n79 .2\n18 .7\n6. 13\n4 on\n0 3/\n01 /1\n8. F\nor p\ner so\nna l u\nse o\nnl y.\nnanoparticle incorporated graphene-based nanocomposites. Lim et al. synthesized rGO coated plasmonic gold nanoshells and nanorods and demonstrated enhanced photothermal killing of cells in vitro as compared to non-coated or graphene oxidecoated gold nanoparticles.81 The enhanced photothermal e±ciency of the nanocomposites can be attributed to the presence of plasmonic nanoparticles that signi¯cantly enhanced the NIR absorption e±ciency of the nanocomposites. Gold nanorod-attached PEGylated graphene-oxide (AuNR-PEG GO) nanocomposites were synthesized by Dembereldorj et al. and used for photothermal therapy both in in vitro and in vivo.82 The presence of AuNRs signi¯cantly enhanced the NIR absorption e±ciency of the nanocomposites which resulted in 40% reduction in cell viability of A431 epidermoid carcinoma cells and also reduced tumor volumes in mice. Femtosecond laser beam mediated photothermal destruction of cancer cells was demonstrated by Li et al. using graphene oxide nanoparticles (GONs).83 The GONs generated microbubbles upon exposure to femtosecond laser beam that facilitated the killing of cancer cells. Jung et al. reported photothermal ablation of skin cancer cells using hyaluronic acid conjugated nano GO sheets.84 The NGO-HA conjugates were delivered transdermally to tumor tissues in the skin of mice, where they showed increased tumor uptake and resulted in complete destruction of the tumors in response to a NIR laser without any further recurrence of tumors (Fig. 4(i)). Magneto-PTT of cancers was demonstrated by Akhavan et al. using zinc ferrite spinel (ZnFe2O4Þ-rGO nanocomposites (ZnFe2O4-rGO) for carrying out in vitro and in vivo photothermal destruction of prostate cancer cells and glioblastoma tumors, respectively, under the guidance of a magnetic ¯eld.85 An aptamergold nanoparticle-hybridized graphene oxide nanocomposite was developed by Yang et al. for targeted photothermal destruction of MCF-7 cells.86 MCF-7 cells showed increased cellular uptake of the nanocomposites via speci¯c interaction between MUC-1-binding aptamer and MUC-1 that are present on the cell membrane of MCF-7 cells. In the presence of NIR irradiation, the nanocomposites exhibited excellent photothermal ablation activity at very low concentrations. Recently, Guo et al. reported the synthesis of a novel pH-responsive graphene oxide-based photothermal agent for improved photothermal killing of cancer cells.87 A cyanine dye (Cypate) was grafted onto the surface of GO, which participated in enhancing the photothermal properties of the composite via FRET in a pH-responsive manner. Under NIR irradiation, the Cypate molecules emitted near-infrared °uorescence (NIRF) that got transferred to the GO sheets via FRET and subsequently got converted into heat for improving photothermal therapy. A single dose intravenous injection of the GO-Cypate nanocomposites into a mouse bearing tumors followed by NIR irradiation resulted in signi¯cant photothermal destruction of the tumors.\n4.2. Photodynamic therapy\nPDT using GO was reported for the ¯rst time by Dong et al.88 They used methoxy PEG conjugated nano graphene oxide (NGO-mPEG) as a platform for loading of a\n1750011-19\nR ep\n. A dv\n. P hy\ns. S\nci . 2\n01 7.\n01 . D\now nl\noa de\nd fr\nom w\nw w\n.w or\nld sc\nie nt\nif ic\n.c om\nby 1\n79 .2\n18 .7\n6. 13\n4 on\n0 3/\n01 /1\n8. F\nor p\ner so\nna l u\nse o\nnl y.\n(i) Photothermal Therapy\nFig. 4. Graphene-based nanomaterials for photo-therapy. (i) Photothermal therapy. (a) Schematic illustration for the transdermal delivery of nanographene oxide–hyaluronic acid (NGO–HA) conjugates into melanoma skin cancer cells and the following photothermal ablation therapy using a NIR laser. Photographs showing the e®ect of photothermal ablation therapy with NIR irradiation on the tumor growth in SKH-1 mice inoculated with B16F1 cells on both dorsal °anks after topical administration of (b) PBS, (c) NGO, and (d) NGO–hyaluronic acid (HA). (e) Relative tumor volume (V =V0) with increasing time for a week. (f) Caspase-3 activity in tumor tissues by ELISA with increasing time for a day for the analysis of heat induced apoptosis (***P < 0:0001Þ. Reproduced with permission from Ref. 84. Copyright 2014 American Chemical Society. (ii) Photodynamic therapy. MTT cell viability of HeLa cells treated with HA–GO/Ce6 nanohybrids (WÞ or free Ce6 ( ) for 6 h, followed by the light irradiation of 1.8 J cm 2 (a), or without the light irradiation (b); LIVE/DEAD cell viability of HeLa cells treated with HA–GO/Ce6 nanohybrids or free Ce6 at a Ce6 concentration of 0.1 g mL 1 for 6 h of treatment (c). Reproduced with permission from Ref. 94. Copyright 2013 Royal Society of Chemistry.\n1750011-20\nR ep\n. A dv\n. P hy\ns. S\nci . 2\n01 7.\n01 . D\now nl\noa de\nd fr\nom w\nw w\n.w or\nld sc\nie nt\nif ic\n.c om\nby 1\n79 .2\n18 .7\n6. 13\n4 on\n0 3/\n01 /1\n8. F\nor p\ner so\nna l u\nse o\nnl y.\nphotosensitizer zinc phthalocyanine (ZnPc) onto the surface of NGO through – and hydrophobic interactions. The ZnPc-NGO-mPEG nanocomposites demonstrated signi¯cant cytotoxicity in MCF-7 cell lines in response to Xe light irradiation. Huang et al. reported the development of a targeted photodynamic agent by conjugating folic acid with GO sheets and loading it with the photosensitizer Chlorin e6 (Ce6).89 The loading e±ciency of Ce6 was found to be 80%, with FA conjugation helping in increasing the accumulation of the nanocomposites in MGC803 cells. The nanocomposites exhibited excellent targeted photodynamic killing of MGC803 cells in response to laser irradiation. Hypocrellin A (HA) and Hypocrellin B (HB) are another class of organic photosensitizers that have the potential to be used in PDT, but have gained limited attention due to their stability issues in aqueous conditions.\n(ii) Photodynamic Therapy\nFig. 4. (Continued )\n1750011-21\nR ep\n. A dv\n. P hy\ns. S\nci . 2\n01 7.\n01 . D\now nl\noa de\nd fr\nom w\nw w\n.w or\nld sc\nie nt\nif ic\n.c om\nby 1\n79 .2\n18 .7\n6. 13\n4 on\n0 3/\n01 /1\n8. F\nor p\ner so\nna l u\nse o\nnl y.\nIn order to improve their stability, Zhou et al. loaded HA and HB onto the surface of GO nanosheets (GO-HA and GO-HB) through hydrogen bonding and – interactions and observed improved stability of HA and HB as compared to their free forms in aqueous solutions.90,91 Further, in vitro studies using these GO-HA and GO-HB nanocomposites demonstrated excellent photodynamic damage to cancer cells in response to light. In addition to organic photosensitizers, inorganic photosensitizers such as TiO2 and ZnO have also been explored for UV and visible light mediated PDT. Hu et al. developed a GO/TiO2 hybrid and observed signi¯cantly increased production of intracellular ROS by the GO/TiO2 hybrids when exposed to visible light.92 The authors explained that this enhanced photodynamic activity of GO/TiO2 hybrids could be attributed to the excellent electrical conductivity of GO, which allowed the transfer of the photoelectrons generated by TiO2 in response to light to the surface of GO that ultimately reacted with oxygen to generate ROS. In another study by the same group, folic acid-conjugated grapheneZnO nanohybrid were synthesized for targeted PDT which showed e±cient generation of ROS in HeLa cells in response to visible light irradiation, that ultimately resulted in apoptosis.93 Li et al. reported the synthesis of hyaluronic acidconjugated GO nanocomposites loaded with Ce6 for targeted PDT of cancer cells in vitro and observed 10-fold increase in the PDT e±ciency as compared to free Ce6 molecules (Fig. 4(ii)).94 Methylene blue (MB) loaded GO nanosheets have also been exploited as a PDT agent by Wojtoniszak et al., where the authors reported enhanced e±ciency in singlet oxygen generation by MB-GO as compared to pristine MB.95"
    }, {
      "heading" : "5. Graphene-Based Nanomaterials for Combined Therapeutic Strategies",
      "text" : "5.1. Combined drug delivery and phototherapies\n5.1.1. Combined chemo-PTT\nThe ability to load drugs e±ciently onto the surface of graphene-based nanomaterials like GO and rGO due to the presence of a large surface area and also because of the presence of di®erent oxygen containing functional groups, combined with their excellent absorbance in the NIR region have led to the development of multifunctional therapeutic platforms capable of providing synergistic chemo-PTT for better treatment of cancers. Zhang et al. developed a simple platform consisting of PEGylated NGO sheets loaded with the anti-cancer drug doxorubicin and demonstrated e±cient killing of cancer cells both in vitro and in vivo.96 The therapeutic e±ciency of the combined treatment strategy was found to be much higher as compared to chemotherapy and PTT alone. Folic acid conjugated, polyvinylpyrrolidone functionalized nanographene oxide sheets (FA-NGO-PVP) loaded with doxorubicin were synthesized by Qin et al., which showed highly e±cient targeted delivery of drug and generated heat for e®ective chemo-photothermal\n1750011-22\nR ep\n. A dv\n. P hy\ns. S\nci . 2\n01 7.\n01 . D\now nl\noa de\nd fr\nom w\nw w\n.w or\nld sc\nie nt\nif ic\n.c om\nby 1\n79 .2\n18 .7\n6. 13\n4 on\n0 3/\n01 /1\n8. F\nor p\ner so\nna l u\nse o\nnl y.\ndestruction of tumors.97 Another targeted platform was developed by Yang et al. comprising of PEGylated NGO conjugated with EGFR antibody for targeting and loaded with the anti-cancer drug epirubicin for carrying out a synergistic tripletherapeutic treatment strategy involving growth signal blocking, chemotherapy and photothermal therapy.98 The NIR absorbance e±ciency of GO and rGO has been found to be enhanced remarkably by incorporating plasmonic nanoparticles like AuNPs into the nanocomposite design. Based on this concept, Xu et al. synthesized a highly e±cient chemo-photothermal therapeutic agent consisting of gold nanorods (AuNR) encapsulated in NGO shells and conjugated with hyaluronic acid for targeting.99 The NGO-HA-AuNR nanocomposites demonstrated 1.5 fold higher killing of Hu-7 cancer cells than chemotherapy alone and four fold higher photothermal ablation as compared to photothermal therapy alone. Wang et al. synthesized mesoporous silica coated graphene nanosheets conjugated with a targeting peptide (IP) and loaded with DOX as a chemo-photothermal agent for targeted therapy of glioma.100 The nanocomposites exhibited high drug loading e±ciency along with sustained release pro¯les in response to both pH and NIR mediated heat. The therapeutic e±ciency of the nanocomposites towards killing of glioma cells was found to be signi¯cantly enhanced due to the synergistic e®ect of chemo-photothermal therapy (Fig. 5(i)). A newer nanocomposite referred to as nanocookies was synthesized by Chen et al. that comprised of amorphous carbon coated mesoporous silica self-assembled on a nanosheet of reduced graphene oxide.101 These nanocookies were loaded with camptothecin and were used as novel chemo-photothermal agents for tumor treatment. A novel type of nanocapsule made up of lactoferrin shells stabilized by rGO was prepared by Hu et al. as a chemo-photothermal agent.102 Anti-cancer drugs could be e±ciently loaded into these nanocapsules and could be used for both in vitro and in vivo chemo-photothermal treatment of cancer with high therapeutic e±ciency. In addition to all these studies, several other graphene-based nanotherapeutic platforms such as CuS nanoparticle decorated GO, PEGylated graphene nanoribbons, Fe3O4 nanoparticle loaded GO nanocomposites have been developed for combined chemo-photothermal therapy of cancer.103–108\n5.1.2. Combined chemo-photodynamic therapy\nGO has also been used as a multimodal therapeutic platform for co-delivery of anticancer drugs and photosensitizers to cancer cells and tumors for synergistic chemophotodynamic therapy of cancer. Miao et al. reported the use of PEGylated GO nanosheets for co-delivery of doxorubicin and Ce6 to cancer cells both in vitro and in vivo.109 Both in vitro and in vivo studies showed enhanced therapeutic e®ect of the combined therapy in comparison to GO mediated chemotherapy and PDT alone. In a similar study, Zhou et al. showed a synergistic chemo-PDT of cancer by using GO sheets co-loaded with the anti-cancer drug 7-ethyl-10-hydroxycamptothecin (SN-38) and photosensitizer HA and observed signi¯cantly enhanced therapeutic e®ects of the combined therapy.110\n1750011-23\nR ep\n. A dv\n. P hy\ns. S\nci . 2\n01 7.\n01 . D\now nl\noa de\nd fr\nom w\nw w\n.w or\nld sc\nie nt\nif ic\n.c om\nby 1\n79 .2\n18 .7\n6. 13\n4 on\n0 3/\n01 /1\n8. F\nor p\ner so\nna l u\nse o\nnl y.\n5.2. Combined gene delivery and phototherapies\nGraphene-based nanocomposites functionalized with cationic polymers have been developed and exploited as gene delivery vectors. Some very recent works have also exploited these positively charged graphene nanocomposites as multifunctional therapeutic platforms for combined gene-PTT with the ultimate objective of improving the therapeutic e±ciency for better treatment of diseases like cancer. Cheng et al. reported the synthesis of PEGylated PEI-grafted graphene/Au composites (PPGA) as novel multifunctional gene delivery vectors and demonstrated e±cient loading and delivery of Bcl-2 siRNA into HL-60 cells with subsequent\n(i) Chemo-Photothermal Therapy (ii) Chemo-Gene Therapy\nFig. 5. Graphene-based nanomaterials for combined therapies. (i) Chemo-photothermal therapy. (a) Design of GSPID As a Multifunctional Drug Delivery System for Combined Chemo-Photothermal Targeted Therapy of Glioma (b) Cell viability pro¯les of glioma cells under di®erent treatments. Reproduced with permission from Ref. 100. Copyright 2013 American Chemical Society. (ii) Chemogene therapy. (a) Schematic of the PPG fabrication and MDR reversion. Relative survival rate of MCF-7 cells (b) and MCF-7/ADR cells (c) after being treated with ADR, anti-miR-21PPG, PPGADR and anti-miR-21PPGADR for 24 h. Untreated MCF-7 and MCF-7/ADR cells were served as control in each experiment. Reproduced with permission from Ref. 114. Copyright 2013. (iii) Chemo-gene-photothermal therapy. (a) Targeted gene-mediated thermochemotherapy for drug-resistant tumor. Apoptosis rate of MCF-7/ADR cells treated by (b) PBS ( Þ, (c) Dox ( Þ, (d) PPG-FA (þÞ, (e) PPG-FA/ Dox (þÞ, (f) PPG-FA/siRNA/Dox ( Þ and (g) PPG-FA/siRNA/Dox (þÞ were tested by °ow cytometry. They are measured by the average °uorescent intensity (FL) treated with Annexin V-FITC/PI. (þÞ; 808 nm irradiation (2W/cm2, 5min); ( Þ; without irradiation. Reproduced with permission from Ref. 115. Copyright 2017. (iv) Photothermal-photodynamic therapy. Photothermally enhanced delivery of PDT by graphene. (a)–(c) Confocal images of KB cells incubated with GO-PEG-Ce6 (5 M of Ce6 equivalent) at 37 C with (b) or without (a) 808 nm laser irradiation (360 J/cm2) and cells incubated at 43 C in the dark (c). (d) and (e) Cell uptake of GO-PEG-Ce6 under the three conditions at Ce6 concentrations of 2.5 M (d) and 5 M (e) determined by the measured °uorescence intensities of cell lysate samples. (f) and (g) Cell viability data of KB cells incubated with GO-PEG-Ce6, free Ce6, or GO-PEG, respectively, at Ce6 concentrations of 2.5 M (f) and 5 M (g). Black, red, blue, and green bars represent samples without any light exposure, with both 808 nm (360 J/cm2) and 660 nm (15 J/cm2) light irradiation, with only 660 nm light exposure, and with only 808 nm light exposure, respectively. Relative cell viabilities in all samples were normalized to the control saline-added samples without laser irradiation (100% viability). Reproduced with permission from Ref. 116. Copyright 2011 American Chemical Society.\n1750011-24\nR ep\n. A dv\n. P hy\ns. S\nci . 2\n01 7.\n01 . D\now nl\noa de\nd fr\nom w\nw w\n.w or\nld sc\nie nt\nif ic\n.c om\nby 1\n79 .2\n18 .7\n6. 13\n4 on\n0 3/\n01 /1\n8. F\nor p\ner so\nna l u\nse o\nnl y.\ndownregulation of the Bcl-2 protein expression.111 In addition to this, the PPGA nanocomposites showed enhanced photothermal activity in response to NIR irradiation as compared to PPG nanocomposites lacking the AuNPs, thereby making it also an e±cient photothermal agent. A PEG and PEI dual-polymer-functionalized GO nanocomposite (GO-PEG-PEI) was developed by Tao et al. for the delivery of immunostimulatory oligonucleotides like CpG both in in vitro and in vivo.112 It was observed that GO-PEG-PEI nanocomposites were successful in promoting the production of pro-in°ammatory cytokines as a response to CpGs. In addition to this, the researchers also observed that in the presence of NIR irradiation, the immunostimulation responses were much more enhanced possibly because of the photothermal properties of GO that generated local heat which resulted in accelerating the intracellular tra±cking of the nanocomposites. The in vivo studies revealed e±cient tumor reduction in the presence of NIR irradiation, which can be attributed to combined e®ects of both immunostimulation and photothermal ablation. In a very recent study published by Yin et al., PEGylated GO nanosheets have been used as a gene delivery vector for carrying out co-delivery of two siRNAs targeting the HDAC1 gene and the G12C mutant K-Ras gene in pancreatic cancer cells MIA PaCa-2.113 The PEGylated GO nanosheets successfully delivered the siRNAs to the cancer cells in vitro which ultimately resulted in induction of apoptosis and cell cycle arrest in the cells. In addition to this, in vivo studies demonstrated more than 80% inhibition\n(iii) Chemo-Gene-Photothermal Therapy (iv) Photothermal-Photodynamic Therapy\nFig. 5. (Continued )\n1750011-25\nR ep\n. A dv\n. P hy\ns. S\nci . 2\n01 7.\n01 . D\now nl\noa de\nd fr\nom w\nw w\n.w or\nld sc\nie nt\nif ic\n.c om\nby 1\n79 .2\n18 .7\n6. 13\n4 on\n0 3/\n01 /1\n8. F\nor p\ner so\nna l u\nse o\nnl y.\nin tumor growth under the in°uence of NIR irradiation due to a combined photothermal-gene silencing e®ect.\n5.3. Combined drug, gene and photo-therapies\nZhi et al. developed a treatment strategy to overcome multi-drug resistance (MDR) in breast cancer tumors through co-delivery of an anti-cancer drug with a MDR reversing agent such as miRNA.114 PEI and poly (sodium 4-styrenesulfonates) (PSS) dual-polymer-functionalized GO nanocomposites (PPG) were synthesized and sequentially loaded with adriamycin (ADR) and anti-miRNA-21 to form (anti-miR21)-PPGADR nanocomplexes. These nanocomposites successfully delivered the therapeutic agents into ADR resistant MCF-7 cells and showed enhanced cytotoxicity to the cancer cells as compared to free ADR. The enhanced therapeutic e±ciency of these nanocomposites was due to the combined e®ects of both chemotherapy and gene silencing, thereby making the ADR resistant cells responsive to the drug (Fig. 5(ii)). In a very recent study, Zeng and co-workers developed a multifunctional PEI-PEG-GO delivery system conjugated with folic acid and co-loaded with a siRNA and Dox for carrying out targeted gene silencing combined with chemo-PTT of drug resistant tumors.115 In the absence of NIR irradiation, the nanocomposites showed gene silencing mediated enhanced chemotherapy of drug resistant cancer cells; while in the presence of NIR irradiation, the overall therapeutic e±ciency was further enhanced due to the NIR responsive photothermal properties of GO (Fig. 5(iii)).\n5.4. Combined photothermal (PTT) and photodynamic\n(PDT) therapies\nBoth visible and NIR responsive properties of GO and rGO have enabled them to be used as phototherapeutic agents for combined PTT and PDT. Tian et al. for the ¯rst time showed that the photodynamic properties of GO can be signi¯cantly enhanced by incorporating the NIR responsive photothermal properties of GO into a single multifunctional therapeutic platform.116 In this study, the authors showed that GOPEG-Ce6 complexes o®ered signi¯cant photodynamic destruction of cancer cells as compared to free Ce6 molecules. In addition to this, it was also observed that the NIR responsive photothermal e®ect of GO can be used to promote the delivery of Ce6 molecules, thereby further enhancing the PDT e®ect (Fig. 5(iv)). In another important study, Sahu et al. reported the development of a multifunctional phototherapeutic platform based on nano GO sheets non-covalently functionalized with a Pluronic block copolymer and loaded with the photosensitizer MB via electrostatic interactions.117 In vitro studies showed increased cellular uptake of the nanocomposites by cancer cells as compared to normal cells, and signi¯cant cell death in response to NIR irradiation. In vivo studies also depicted high tumor accumulation of the nanocomposites and complete tumor ablation through a combined PTT-PDT approach. Photothermal enhancement of the photodynamic e±ciencies of\n1750011-26\nR ep\n. A dv\n. P hy\ns. S\nci . 2\n01 7.\n01 . D\now nl\noa de\nd fr\nom w\nw w\n.w or\nld sc\nie nt\nif ic\n.c om\nby 1\n79 .2\n18 .7\n6. 13\n4 on\n0 3/\n01 /1\n8. F\nor p\ner so\nna l u\nse o\nnl y.\ngraphene-based nanocomposites was also demonstrated by Chen et al.118 The group synthesized reduced graphene oxide–ZnO nanoparticles–hyaluronic acid (rGo-ZnOHA)-based multifunctional nanoplatform for a synergistic PTT-PDT of cancer. Visible light irradiation resulted in the generation of ROS by the ZnO nanoparticles, which helped in sensitizing the cancer cells for a subsequent NIR laser induced hyperthermia that resulted in more e±cient killing of the cancer cells. Jiang et al. synthesized a water-soluble graphene–phthalocyanine (GR–TSCuPc) hybrid material by a one-step method involving simple mixing of graphene with tetrasodium salt copper phthalocyanine (TSCuPc) through sonication.119 In the hybrid, graphene acted as the carrier of the photosensitizer and as a PTT agent, and TSCuPc served the role of a water-soluble PDT agent. In vitro studies showed that the GR–TSCuPc hybrid showed enhanced phototherapeutic e®ect as compared to free TSCuPc. Table 4 summarizes the applications of di®erent graphene-based nanomaterials for combined therapeutic strategies.\nTable 4. Summary of graphene-based nanomaterials for combined therapeutic strategies.\nNanocomposite Therapeutic modalities Therapeutic cargo Reference\nPEG-NGO Drug delivery & PTT DOX 96 FA-NGO-PVP Drug delivery & PTT DOX 97 PEG-NGO-EGFR Drug delivery & PTT Epirubicin 98 NGO-HA-AuNR Drug delivery & PTT DOX 99 mSiO2-GNS-IP Drug delivery & PTT DOX 100 RGO/Carbon/mSiO2\nNanocookies\nDrug delivery & PTT CPT 101\nLactoferrin stabilized RGO\nnanocapsule\nDrug delivery & PTT DOX 102\nPEG-GO/CuS Drug delivery & PTT DOX 103 NrGO/PEG Drug delivery & PTT Resveratrol 104 rNGO@mSiO2@pNIPAM-\nco-pAAm\nDrug delivery & PTT DOX 105\nNGO-PEG-DA Drug delivery & PTT DOX 106 PL-PEG-GONR Drug delivery & PTT DOX 107 GO-Fe3O4 Drug delivery & PTT CPT & MTX 108 PEG-GO Drug delivery & PDT DOX & Ce6 109 GO Drug delivery & PDT SN-38 & HA 110 PEG-PEI-Graphene-Au\n(PPGA)\nGene delivery & PTT Bcl-2 siRNA 111\nGO-PEG-PEI Gene delivery & PTT CpG ODNs 112 PEG-GO Gene delivery & PTT HDAC1 & K-RAS siRNA 113 PEI-PSS-GO Drug delivery, Gene\ndelivery & PTT\nADR & anti-miR-21 114\nPEI-PEG-GO Drug delivery, Gene\ndelivery & PTT\nDOX & siRNA 115\nPEG-GO PTT & PDT Ce6 116 Pluronic F127-NGO PTT & PDT Methylene blue 117 rGO-ZnO-HA PTT & PDT ZnO NPs 118 GR– TSCuPc PTT & PDT TSCuPc 119\n1750011-27\nR ep\n. A dv\n. P hy\ns. S\nci . 2\n01 7.\n01 . D\now nl\noa de\nd fr\nom w\nw w\n.w or\nld sc\nie nt\nif ic\n.c om\nby 1\n79 .2\n18 .7\n6. 13\n4 on\n0 3/\n01 /1\n8. F\nor p\ner so\nna l u\nse o\nnl y."
    }, {
      "heading" : "6. Graphene-Based Nanomaterials for Bioimaging",
      "text" : "In addition to being used as carriers for delivering therapeutic drugs and nucleic acids to cells and as NIR responsive agents for photothermal and photodynamic therapy, graphene-based nanomaterials have also been extensively exploited for bioimaging of cells and tissues. The intrinsic photoluminescence and NIR responsive properties of graphene and its derivatives alongwith its biocompatibility makes them suitable for bioimaging applications. Graphene-based bioimaging can be grouped into two major categories: optical and non-optical imaging.120 Optical imaging includes °uorescence imaging, two-photon °uorescence imaging and Raman imaging, whereas non-optical imaging includes magnetic resonance imaging (MRI), radioactive imaging like PET and SPECT, photoacoustic imaging (PAI) and computed tomography (CT). The following section summarizes the di®erent imaging applications of graphene-based nanomaterials. In this section, studies related to only imaging using graphene and its derivatives have been reported. Studies related to imaging combined with di®erent therapeutic approaches have been summarized in a later section that includes PAI and CT-based imaging using graphene. Table 5 summarizes the applications of graphene-based nanomaterials in bioimaging.\n6.1. Fluorescence imaging\nThe intrinsic optical properties of graphene oxide make them suitable for °uorescence-based bioimaging of cells and tissues. The °uorescent properties of GO and\nTable 5. Summary of graphene-based nanomaterials for bioimaging.\nNanocomposite Imaging modality Target Reference\nGO, nGO-PEG Fluorescence Raji B cells 121 nGO-PEG-Cy7 Fluorescence Tumor xenografted mouse model 74 GO-PEG-Fluorescein Fluorescence HeLa cells 122 GO-IRDye800-VEGF Fluorescence Ischemic muscles in a murine model 123 N-GQD TPFI Tissue phantom 126 FA-GO-AgNP Raman A549 & HeLa cells 130 GO-AuNP Raman Ca Ski cells 131 Alkyne-PEG functionalized\ngraphitic silver nanoparticles (ACG NPs)\nRaman MCF-7 cells 132\nGd-GNR MRI 133 AMD-Fe3O4-GO MRI HeLa cells 134 64Cu-NOTA-nGO-PEG-\nTRC105\nPET 4T1 murine breast tumors 136\n66Ga-NOTA-nGO-PEG-\nTRC105\nPET 4T1 murine breast tumors 137\n198;199Au-NGO SPECT Fibrosarcoma tumor in rats 138 111BnDTPA-NGO- Trastu-\nzumab\nSPECT Her2 positive tumors in mouse 139\n1750011-28\nR ep\n. A dv\n. P hy\ns. S\nci . 2\n01 7.\n01 . D\now nl\noa de\nd fr\nom w\nw w\n.w or\nld sc\nie nt\nif ic\n.c om\nby 1\n79 .2\n18 .7\n6. 13\n4 on\n0 3/\n01 /1\n8. F\nor p\ner so\nna l u\nse o\nnl y.\nnano-GO was ¯rst reported by the Dai group, where they observed that both GO and nGO-PEG exhibited broad °uorescence emission from the visible region to the IR-A region.121 They exploited this IR responsive intrinsic photoluminescence property of GO and synthesized Rituxan (anti-CD20 mAb) conjugated nGO-PEG nanocomposites for targeted °uorescence imaging of CD20 positive Raji B cells using a 658 nm excitation laser. The main drawback of this study was that the quantum yield of this intrinsic °uorescence of nGO-PEG was very low, that was not suitable for carrying out further in vivo studies. As a result, to overcome this limitation and further improve the °uorescent properties of GO, several di®erent approaches have been carried out which includes loading or linking of organic °uorophores or dyes, inorganic nanomaterials like QDs, upconversion nanoparticles and GQDs onto the surface of GO and rGO sheets. A great deal of attention has been devoted towards the chemistry behind loading and linking these organic and inorganic °uorophores with GO sheets, as direct loading can result in °uorescence quenching of the °uorophore by GO/rGO through energy/charge transfer processes. As a result, spacers such as PEG are used to link these °uorophore moieties to GO/rGO sheets. Yang et al. demonstrated in vivo °uorescence imaging of tumor xenografted mouse models using a NIR dye (Cy7) conjugated nGO-PEG composite.74 The authors observed that with time the nGO-PEG-Cy7 nanocomposites accumulated in the tumor regions through passive targeting and showed intense °uorescence signals upon NIR irradiation. In another study, Peng et al. attached °uorescein to PEGylated GO sheets where PEG acted as a spacer between the °uorophore and GO and used it as °uorescent probe for in vitro imaging of HeLa cells (Fig. 6(i)).122 Sun et al. reported synthesis of IRDye800-conjugated GO loaded with VEGF as a targeted °uorescent probe for imaging of ischemic muscles in a murine model.123 In addition to GO and rGO, another class of graphene-based nanomaterials have gained a great deal of attention in the recent years especially in the ¯eld of biomedical imaging. GQDs are nanosized materials in the range of 3–10 nm having excellent tunable intrinsic photoluminescence or °uorescence properties in the visible region with high biocompatibility, easy surface functionalization and photostable.124 Because of these properties, GQDs have emerged as novel biocompatible imaging and diagnostic agents for both in vitro and in vivo applications. Zhu et al. reported the synthesis of biocompatible, water soluble green °uorescent GQDs by a one-step solvothermal process and used it for labeling and imaging of cells in vitro.125 In addition to this, there are several reports on synthesis and bioimaging applications of di®erent kinds of GQDs. For a detailed understanding of the bioimaging and theranostic applications of GQDs, readers are requested to refer to the excellent review by Schroeder et al.124\n6.2. Two photon °uorescence imaging\nTwo photon °uorescence imaging (TPFI) is an improved alternative to single/ one photon °uorescence imaging (OPFI) in the ¯eld of bioimaging and diagnostics\n1750011-29\nR ep\n. A dv\n. P hy\ns. S\nci . 2\n01 7.\n01 . D\now nl\noa de\nd fr\nom w\nw w\n.w or\nld sc\nie nt\nif ic\n.c om\nby 1\n79 .2\n18 .7\n6. 13\n4 on\n0 3/\n01 /1\n8. F\nor p\ner so\nna l u\nse o\nnl y.\n(i) Fluorescence Imaging\n(ii) Raman Imaging\nFig. 6. Graphene-based nanomaterials for bioimaging. (i) Fluorescent imaging. Confocal °uorescence microscopy images of HeLa cells treated with (a) 2.5 g mL 1 PEG–G and Fluo–G suspension for 6 h at (b) 37 C and (c) 4 C. Bright-¯eld images are marked 1, dark-¯eld images are marked 2, and overlap of images of dark and bright ¯eld are marked 3. Reproduced with permission from Ref. 122. Copyright 2010 WileyVCH Verlag GmbH & Co. KGaA, Weinheim. (ii) Raman imaging. Cell imaging with alkyne-PEG-functionalized ACGs. (a) Raman spectra of alkyne-PEG with (black) and without (red) ACGs. (b)–(f) Raman image of MCF-7 cells treated with alkyne-PEG-modi¯ed ACGs using 1 s integration/pixel. BF, bright ¯eld; scale bar, 10 m. Reproduced with permission from Ref. 132. Copyright 2014 American Chemical Society. (iii) Magnetic Resonance imaging. (a) HeLa cells (2 105 cells mL 1) incubated with the Fe3O4GO composites at di®erent concentrations for 24 h. (b) Fe3O4-GO composites (20 g Fe mL 1) incubated with HeLa cells at di®erent cell densities for 24 h. Reproduced with permission from Ref. 134. Copyright 2011 American Chemical Society. (iv) Radiolabeled imaging. Serial coronal PET images of 4T1 tumorbearing mice at di®erent time points postinjection of 64Cu-NOTA-GO-TRC105, 64Cu-NOTA-GO, or 64Cu-NOTA-GO-TRC105 after a preinjected blocking dose of TRC105. Tumors are indicated by arrowheads. Reproduced with permission from Ref. 136. Copyright 2012 American Chemical Society.\n1750011-30\nR ep\n. A dv\n. P hy\ns. S\nci . 2\n01 7.\n01 . D\now nl\noa de\nd fr\nom w\nw w\n.w or\nld sc\nie nt\nif ic\n.c om\nby 1\n79 .2\n18 .7\n6. 13\n4 on\n0 3/\n01 /1\n8. F\nor p\ner so\nna l u\nse o\nnl y.\nbecause of the several advantages that TPFI o®ers over OPFI such as deeper tissue penetration of NIR, minimal NIR absorbance by surrounding tissues, low auto°uorescence and negligible photobleaching. Since TPFI operates in the biologically favorable NIR window, so detailed imaging and investigation at deep tissue level to locate inaccessible solid tumors can be done. Liu et al. synthesized biocompatible nitrogen-doped graphene quantum dots (N-GQDs) and exploited them as optical probes for TPFI of cells and deep tissues.126 The authors reported that the N-GQDs could be identi¯ed even at a depth of 1800 m in the tissue phantom using TPFI as compared to OPFI which could image the N-GQDs only up to a depth of 400 m, thereby demonstrating the advantage and feasibility of graphene-based TPFI for deep tissue imaging.\n(iii) Magnetic Resonance Imaging\n(iv) Radiolabeled Imaging\nFig. 6. (Continued )\n1750011-31\nR ep\n. A dv\n. P hy\ns. S\nci . 2\n01 7.\n01 . D\now nl\noa de\nd fr\nom w\nw w\n.w or\nld sc\nie nt\nif ic\n.c om\nby 1\n79 .2\n18 .7\n6. 13\n4 on\n0 3/\n01 /1\n8. F\nor p\ner so\nna l u\nse o\nnl y.\n6.3. Raman imaging\nGO exhibits intrinsic Raman signals at 1600 cm 1 (G band) and 1350 cm 1 (D band), that can be signi¯cantly enhanced by using metal nanoparticles like gold or silver to form Raman probes for imaging of cancer cells and tissues. Many studies have been carried out for developing novel graphene-based Raman probes for bioimaging applications. Graphene-based Raman labels have been synthesized both by the in situ reduction of Agþ and AuCl 4 on the surface of GO sheets to form Ag/GO and Au/GO hybrids, respectively, and also by the direct deposition of Au and Ag nanoparticles onto the surface of GO sheets through non-covalent interactions like\n– stacking and other molecular forces to form Au/GO and Ag/GO nanocomposites.127–129 Liu et al. demonstrated targeted Raman imaging of cancer cells using folic acid conjugated Ag/GO hybrids as Raman probes and observed that cells incubated with the hybrids exhibited much stronger Raman signals from the GO sheets as compared to ones incubated with only GO sheets.130 Huang et al. studied the cellular uptake mechanisms of GO in the Ca Ski cell line by using Raman probes made up of AuNPs attached to the surface of GO sheets through amide linkages between PEG and DMSA.131 Song et al. reported the synthesis of a new type of graphene-based Raman probe for bioimaging.132 They synthesized alkyne-PEG functionalized graphitic silver nanoparticles (ACG NPs) using chemical vapor deposition method. Few layers of graphene were grown on the surface of AgCu NPs by CVD method following which the alkyne-PEG moieties were attached to the surface of GO through non-covalent interactions. These ACG NPs were then used for the Raman imaging of MCF-7 cells, which clearly showed the cellular uptake, localization and distribution of these nanoparticles throughout the cell cytoplasm (Fig. 6(ii)).\n6.4. Magnetic resonance imaging (MRI)\nMagnetic resonance imaging is a widely used imaging and diagnostic tool that allows for non-invasive visualization of organs and tissues in a quantitative manner. Commonly used MRI contrast agents include paramagnetic metals such as gadolinium and manganese which are somewhat toxic to the human body. As a result, to reduce the toxicity and also to enhance the performance of these existing contrast agents, graphene-based nanomaterials have been explored to act as substrates to carry these agents. Gizzatov et al. developed a new type of MRI contrast agent by using carboxyphenylated graphene nanoribbons as substrates to which Gd3þ ions were chelated (Gd-GNR).133 It was observed that Gd-GNRs exhibited enhanced MRI contrast and relaxivity as compared to Gd3þ-based agents. In another study, Chen et al. reported the synthesis of dextran coated Fe3O4 NP loaded GO composites as novel MRI contrast agents for bioimaging (Fig. 6(iii)).134 Coating of Fe3O4 NPs with dextran allowed formation of aggregates of Fe3O4 NPs on the surface of GO which in turn helped in enhancing the MRI contrast as compared to single Fe3O4 NPs. In addition to paramagnetic metals and iron oxide NPs, a non-magnetic carbon\n1750011-32\nR ep\n. A dv\n. P hy\ns. S\nci . 2\n01 7.\n01 . D\now nl\noa de\nd fr\nom w\nw w\n.w or\nld sc\nie nt\nif ic\n.c om\nby 1\n79 .2\n18 .7\n6. 13\n4 on\n0 3/\n01 /1\n8. F\nor p\ner so\nna l u\nse o\nnl y.\nnanoparticle-based MRI contrast agent was reported for the ¯rst time by Hu.135 He developed °uorinated GO sheets by creating dipolar C–F bonds which acted as the paramagnetic centers and demonstrated good T2 contrast.\n6.5. Radioactive imaging\nOptical imaging techniques such as °uorescence imaging su®ers from the limitations of photobleaching, auto°uorescence, absorption and scattering of light by surrounding tissues, thereby hampering the quality and contrast of the images. On the other hand, radioactive imaging is a technique that makes use of radioactive substances as labels that can be easily tracked and monitored inside a living system with high sensitivity. The two most commonly used radiolabel imaging techniques are Positron Emission Tomography (PET) and Single-photon emission computed tomography (SPECT). Graphene-based nanomaterials have also been explored as substrates for radiolabel imaging because of the surface properties of graphene that makes functionalization and loading of molecules and imaging agents much easier. Hong et al. developed a novel PET contrast agent by labeling nGO-PEG with 64Cu via a 1,4,7- triazacyclononane-1,4,7-triacetic acid (NOTA) linkage.136 They further conjugated this nanocomposite with a CD105 speci¯c antibody TRC105 and demonstrated targeted PET imaging of tumor vasculatures in 4T1 murine breast tumors (Fig. 6(iv)). In another study by the same group, the researchers developed another PET contrast agent by labeling nGO-PEG with 66Ga and demonstrated tumor targeted PET imaging.137 In addition to PET, graphene-based nanomaterials have also been used for developing SPECT imaging agents. Fazaeli et al. developed a SPECT imaging agent by labeling GO nanosheets with 198;199Au and demonstrated targeted SPECT imaging of tumors.138 In vivo SPECT imaging of Her2 positive tumors was demonstrated by Cornelissen et al. using 111In-benzyl-diethylenetriaminepentaacetic acid (BnDTPA) labelled anti-Her2 antibody conjugated nGO as the imaging agents.139 The authors observed that the radiolabeled nanoconstructs showed better pharmacokinetic pro¯les as compared to radiolabeled antibody alone."
    }, {
      "heading" : "7. Graphene-Based Theranostic Platforms",
      "text" : "Theranostics refer to diagnostics combined with therapy. Graphene-based nanocomposites have emerged as excellent platforms for theranostic applications in the recent years because of the surface properties of graphene and its derivatives, which allows easy incorporation of multiple modalities into a single platform. Di®erent kinds of multifunctional graphene-based nanotheranostic platforms have been synthesized and exploited for varied biomedical applications by combining imaging techniques with di®erent therapeutic approaches like drug/gene delivery, PTT and PDT. In this section, the theranostic applications of graphene based nanocomposites have been summarized under three main heads- (A) Imaging guided drug/gene\n1750011-33\nR ep\n. A dv\n. P hy\ns. S\nci . 2\n01 7.\n01 . D\now nl\noa de\nd fr\nom w\nw w\n.w or\nld sc\nie nt\nif ic\n.c om\nby 1\n79 .2\n18 .7\n6. 13\n4 on\n0 3/\n01 /1\n8. F\nor p\ner so\nna l u\nse o\nnl y.\ndelivery, (B) Imaging guided phototherapies and (C) Imaging guided chemo-phototherapies, based on the type of therapeutic approach being used. The applications have been further grouped into sections depending upon the type of imaging technique being employed, with the objective of presenting a better categorized appreciation of the immense potential of graphene as nanomedicine. Table 6 summarizes the theranostic applications of graphene-based nanomaterials.\nTable 6. Summary of graphene-based nano-theranostic platforms.\nTherapeutic modality\nImaging modality Nano-theranostic\nplatform\nTherapeutic\ncargo\nReference\nDrug delivery Fluorescence GNC-rGO DOX 140 Drug delivery Fluorescence Graphene-HQDs-Trf DOX 141 Drug delivery Fluorescence cRGD-Chitosan-GO-\nFluorescein\nDOX 142\nGene delivery Fluorescence BPEI-GO pDNA 54 Drug delivery Raman Au@NGO DOX 143 Drug delivery Raman rGO-AuNanostars DOX 144 Drug delivery MRI GO-DTPA-Gd DOX 145 Drug & Gene de-\nlivery\nMRI CMG DOX, pGFP 146\nDrug & Gene delivery\nMRI PAMAM-Gd-NGO Epirubicin, let-7g\nmiRNA\n147\nPTT Fluorescence CdSe/ZnS QD-rGO 148 PDT Fluorescence GO-PEG DVDMS 149 PTT & PDT UCL UCNP-nGO ZnPc 150 PDT Fluorescence GO-SS-Ce6 Ce6 151 PTT & PDT Fluorescence GO-HA-Ce6 Ce6 152 PTT Fluorescence rGONM-PEG-RGD-Cy7 153 PTT TPFI GO-PEG-Tf 154 PTT & PDT Raman PEG-Au@GON ZnPc 155 PTT MRI GO/IONP 156 PTT PA ICG-GO-FA ICG 157 PTT PA BSA-rGO 158 PTT MRI & CT GO/BaGdF5/PEG 159 PTT MRI & X-ray GO-IONP-Au 160 PTT Fluorescence, PA & MRI C18PMH–PEG- rGO/IONP 161 PTT Ultrasonic/CT Polylactic acid (PLA) micro-\ncapsules encapsulating GO and AuNPs\n162\nPDT Fluorescence & PET PEG-GO 64Cu -HPPH 163 PTT & PDT Fluorescence & PA PEG-GO DVDMS 164 PTT & PDT Fluorescence & MRI Magnetic °uorescent graphene SiNc4 165 Drug delivery &\nPTT\nRaman & TPFI Graphene-isolated-Au-nano-\ncrystal (GIAN)\nDOX 166\nDrug delivery & PTT\nX-ray GO@Ag-DOX-NGR DOX 167\nDrug delivery &\nPTT\nMRI Magnetic graphene-based\nmesoporous silica (MGMS)\nDOX 168\nDrug delivery & PTT\nMRI FeCo/GC nanocrystals DOX 169\n1750011-34\nR ep\n. A dv\n. P hy\ns. S\nci . 2\n01 7.\n01 . D\now nl\noa de\nd fr\nom w\nw w\n.w or\nld sc\nie nt\nif ic\n.c om\nby 1\n79 .2\n18 .7\n6. 13\n4 on\n0 3/\n01 /1\n8. F\nor p\ner so\nna l u\nse o\nnl y.\n7.1. Image guided drug/gene delivery\n7.1.1. Fluorescence imaging-guided drug/gene delivery\nWang et al. utilized the NIR photoluminescence properties of gold nanoclusters (GNC) for bioimaging applications and loaded them onto rGO sheets to form GNCrGO nanotheranostic platforms for carrying out combined drug delivery and °uorescence imaging of cells in vitro.140 Chen et al. developed an imaging probe consisting of QDs coated with hybrid SiO2 shells conjugated to graphene and functionalized with transferrin.141 This functionalized nanocomposite was then loaded with doxorubicin and exploited for QD and DOX mediated dual-colored °uorescence imaging-guided tracking and delivery of drug to cancer cells in vitro (Fig. 7(i)). Fluorescein conjugated GO loaded with DOX and coated with cyclicRGD modi¯ed chitosan was synthesized by Wang et al. for targeted drug delivery combined with °uorescent imaging of hepatocellular carcinoma cells in vitro.142 Kim et al. synthesized a graphene-based gene delivery vehicle by conjugating low molecular weight branched polyethylenimine (BPEI) to GO sheets, thereby imparting a positive surface charge to the nanoconstruct that ultimately facilitated complexation with negatively charged plasmid DNA through electrostatic interactions and showed e±cient gene delivery to HeLa and PC3 cells in vitro.54 In addition to this, the authors exploited the intrinsic °uorescence properties of GO for imaging the cellular uptake of the nanoconstructs.\n7.1.2. Raman imaging-guided drug delivery\nGraphene-based Raman probes for theranostic applications have also been developed for combining other therapeutic strategies such as drug delivery with Raman imaging into a single multifunctional platform. Ma et al. reported the synthesis of nanoGO wrapped AuNPs (Au@NGO) as theranostic tools for Raman imaging and drug delivery to HeLa cells.143 Similarly, Wang et al. synthesized rGO supported gold nanostars (rGO-NS) as novel sensitive SERS substrates and used them to monitor the loading and release of the drug doxorubicin using SERS. These rGO-NS nanocomposites have the potential to be exploited as a theranostic platform for combined drug delivery and Raman imaging.144\n7.1.3. MRI guided-drug/gene delivery\nZhang et al. developed a graphene-based positive T1 MRI contrast agent through conjugation of diethylenetriaminepentaacetic acid (DTPA) to GO followed by complexation with gadolinium ions (GO-DTPA-Gd) and successfully used it as a theranostic platform for carrying out MRI imaging combined with delivery of doxorubicin to HepG2 cancer cells in vitro.145 The nanocomposite showed improved MRI T1 relaxivity and better cellular MRI contrast as compared to a commercially used contrast agent. Wang et al. combined drug delivery, gene delivery and MRI imaging into a single theranostic platform by synthesizing chitosan functionalized\n1750011-35\nR ep\n. A dv\n. P hy\ns. S\nci . 2\n01 7.\n01 . D\now nl\noa de\nd fr\nom w\nw w\n.w or\nld sc\nie nt\nif ic\n.c om\nby 1\n79 .2\n18 .7\n6. 13\n4 on\n0 3/\n01 /1\n8. F\nor p\ner so\nna l u\nse o\nnl y.\nFig. 7. Graphene-based nanotheranostic platforms. (i) Imaging guided drug delivery. (A) Preparation of Water Dispersible DOX-Graphene-HQDs-Trf (B) Fluorescent microscopic images of HeLa cells directly labeled by graphene-HQDs-Trf-1 for 4 h (a), and DOX-graphene-HQDs-Trf-1 for 6 h (b), 12 h (c), and 24 h (d). ((i), °uorescent images by blue light excitation; (ii), °uorescent images by green light excitation.) Reproduced with permission from Ref. 141. Copyright 2013 American Chemical Society. (ii) Multimodal imaging guided phototherapies. (A) In vivo °uorescence images and (B) ultrasound/photoacoustic images and quantitative analysis of PA signal of PC9 bearing mice treated with GO-PEG-DVDMS (GO-PEG 1mg kg 1, DVDMS 2mg kg 1) at 2, 4 and 24 h post-injection. (C) In vivo synergistic therapies of GOPEG-DVDMS. (A) Representative photos of PC9 tumor-bearing mice from di®erent groups after treatment of PDT, PTT or their synergism on day 14. (D) Tumor growth curves of di®erent groups of tumorbearing mice after di®erent treatments. (E) Body weight curves of PC9 tumor mice after di®erent treatments. Reproduced with permission from Ref. 164. Copyright 2015 Royal Society of Chemistry. (iii) Multimodal imaging guided chemo-phototherapy. (A) Schematic illustration of NIR photothermal enhanced chemotherapy mechanism of GIAN/DOX complexes. (B) UV–Vis characterization of the DOXloaded GIANs. Inset: digital photo of the DOX, GIAN, and GIAN/DOX solutions. (C) Fluorescence spectroscopy characterization of the DOX loading e±ciency. (D) Cell viability of MCF-7 cells with and without NIR laser irradiation after incubation with free DOX, GIAN, and GIAN/DOX, respectively. (E) Bright ¯eld microscopy images of trypan blue-stained MCF-7 cells after di®erent NIR photothermal treatments. Scale bar: 50 m. (F) and (G), relative cell viability after treatment with di®erent GIAN concentrations and di®erent 808 nm laser irradiation times, respectively. Reproduced with permission from Ref. 166. Copyright 2014 Nature publishing group.\n1750011-36\nR ep\n. A dv\n. P hy\ns. S\nci . 2\n01 7.\n01 . D\now nl\noa de\nd fr\nom w\nw w\n.w or\nld sc\nie nt\nif ic\n.c om\nby 1\n79 .2\n18 .7\n6. 13\n4 on\n0 3/\n01 /1\n8. F\nor p\ner so\nna l u\nse o\nnl y.\nmagnetic graphene nanocomposites (CMG) loaded with the anti-cancer drug DOX and a plasmid DNA encoding GFP and demonstrated e±cient delivery of both drug and DNA to A549 lung cancer cells and C42b prostate cancer cells in vitro and also to tumor bearing mice in vivo.146 In addition to this, the CMGs acted as strong T2 contrast-enhancing agent thereby enabling MR imaging of the cells and organs. In another study, Yang et al. reported the synthesis of poly (amidoamine) dendrimergrafted gadolinium-functionalized nanographene oxide (Gd-NGO) as theranostic nanocarriers for combined delivery of a chemotherapy drug epirubicin along with Let-7g miRNA.147 The Gd-NGO/Let-7g/EPI nanocomposites exhibited higher transfection e±ciency and better inhibition of cancer cell growth as compared to chemotherapy or gene therapy alone. The nanocomposites were also used as MRI contrast agents for imaging the integrity of blood–brain barrier and tumor tissue uptake.\n7.2. Imaging-guided phototherapies\n7.2.1. Fluorescence imaging-guided phototherapy\nChen et al. exploited the strong °uorescence properties of semiconductor QDs and developed a CdSe/ZnS QD labeled, polypeptide functionalized rGO (QD-rGO) nanotheranostic platform for combined °uorescence imaging and photothermal therapy of cancers.148 Chen and co-workers demonstrated in vivo PDT of cancer combined with enhanced °uorescence imaging by using PEGylated GO loaded with novel photosensitizer sinoporphyrin sodium (DVDMS) and observed intense °uorescent signals in mice from tumor regions showing enhanced uptake of the nanocomposites by tumors through passive targeting and achieved 100% tumor elimination in mice intravenously injected with GO-PEG-DVDMS without any loss in body weight and reappearance of tumors.149 In another study, Wang et al.\nFig. 7. (Continued )\n1750011-37\nR ep\n. A dv\n. P hy\ns. S\nci . 2\n01 7.\n01 . D\now nl\noa de\nd fr\nom w\nw w\n.w or\nld sc\nie nt\nif ic\n.c om\nby 1\n79 .2\n18 .7\n6. 13\n4 on\n0 3/\n01 /1\n8. F\nor p\ner so\nna l u\nse o\nnl y.\nreported the synthesis of a novel, multifunctional nanotheranostic platform capable of performing synergistically photothermal and photodynamic therapy combined with imaging.150 They covalently linked core-shell structured upconversion nanoparticles (UCNP) to the surface of nGO sheets via a PEG spacer, followed by loading a photosensitizer such as phthalocyanine (ZnPc) onto the surface of nGO to form UCNP-nGO/ZnPc nanocomposites. The researchers successfully demonstrated NIR responsive PTT and PDT combined with UCL based imaging both in vitro and in vivo using this nanocomposite, where, in response to a single light stimulus (NIR) the UCNPs generated upconversion luminescence signals for imaging of cells and whole body animals, nGO converted the NIR light into heat for PTT and ZnPc generated cytotoxic singlet oxygen species for PDT. A redox responsive graphene-based theranostic platform was developed by Cho et al. by conjugating Ce6 to GO nanosheets via redox-responsive cleavable disul¯de linker (GO-SS-Ce6).151 GO-SS-Ce6 in its native form remains non-°uorescent and non-toxic even in the presence of light irradiation due to quenching by GO. However, when these nanocomposites are taken up by cancer cells, the high concentration of glutathione inside cancer cells results in the cleavage of the disul¯de bond, thereby releasing Ce6 into the cells. The released Ce6 molecules regain their °uorescent properties and participate in the generation of ROS upon irradiation with light. In a follow-up study by the same group, the researchers reported the synthesis of an enzyme activatable theranostic agent by forming a non-covalent complex between GO and Hyaluronic acid-Ce6 (HA-Ce6) through physical adsorption of HA-Ce6 on the surface of GO (GO-HA-Ce6).152 Hyaluronidase mediated cleavage of GO-HA-Ce6 inside cancer cells resulted in the release of HA-Ce6 with recovery of °uorescence and ROS generation. In addition to this, the GO-HA-Ce6 nanocomposites also exhibited generation of heat due to the NIR responsive properties of GO resulting in stimulus mediated °uorescent imaging guided dual PDT/PTT of cancer cells in vitro. A new class of theranostic platform known as reduced GO nanomesh (rGONM) was developed by Akhavan et al. through the photocatalytic degradation of GO nanoplateletes by using TiO2 nanoparticles.153 The rGONMs were functionalized with PEG and conjugated with RGD peptide and cyanine 7 for carrying out targeted °uorescence imaging and photothermal ablation of U87MG glioblastoma tumors in mouse models. The rGONMPEG-RGD-Cy7 nanocomposites showed 100% elimination of tumors in mice within 48 h of treatment.\n7.2.2. Two photon °uorescence imaging (TPFI)-guided phototherapy\nLi et al. demonstrated for the ¯rst time a theranostic strategy based on TPFI coupled with photothermal therapy using graphene-based nanomaterials.154 They synthesized transferrin conjugated GO-PEG nanocomposites as non-bleaching imaging probes for targeted three-dimensional (3D) TPFI of the gastric cancer cell line AGS, using a low power pulsed laser for excitation. In addition to imaging, the authors also observed that the GO nanoparticles could e±ciently induce intensive microbubbling\n1750011-38\nR ep\n. A dv\n. P hy\ns. S\nci . 2\n01 7.\n01 . D\now nl\noa de\nd fr\nom w\nw w\n.w or\nld sc\nie nt\nif ic\n.c om\nby 1\n79 .2\n18 .7\n6. 13\n4 on\n0 3/\n01 /1\n8. F\nor p\ner so\nna l u\nse o\nnl y.\ninside the cells leading to cell death at a laser power as low as 4 mW, owing to the photothermal properties of GO.\n7.2.3. Raman imaging guided-phototherapy\nKim et al. synthesized a novel theranostic platform for a combined photothermalphotodynamic therapy of cancer guided by Raman imaging.155 They synthesized core-shell nanoparticles comprising of an Au core surrounded by graphene oxide nanocolloid (GON) shell by a one-pot technique, where GONs acted as both reducing agent and stabilizer for the formation of the AuNPs. PEGylation followed by loading of the photosensitizer zinc phthalocyanine (ZnPc) onto these nanoparticles resulted in the formation of biocompatible ZnPc-PEG-Au@GON nano-theranostic platforms, that demonstrated enhanced photo-therapeutic e®ects on HeLa cells due to the combination of PTT and PDT, and at the same time acted as an e±cient Raman probe for in vitro bioimaging of cells.\n7.2.4. MRI guided phototherapy\nMRI guided detection and subsequent photothermal ablation of regional lymph node (RLN) metastasis of pancreatic cancer was demonstrated by Wang et al. using iron oxide nanoparticles (IONP) loaded GO nanocomposites (GO/IONP) as a theranostic agent.156 The IONPs helped in providing the MRI contrast which was enhanced due to the presence of GO as a substrate, thereby making RLNs easily distinguishable from the surrounding tissues. The NIR responsive photothermal properties of GO was also enhanced by IONP and was used for the photothermal ablation of the tumors.\n7.2.5. PAI guided phototherapy\nPhotoacoustic imaging (PAI) is a non-invasive deep tissue/organ imaging technique that works on the principle of generation of acoustic waves from a sample via absorption of short laser pulses. Biological tissues or organs upon absorbing these short laser pulses tend to generate localized heat that leads to thermal expansion. During contraction, acoustic waves are generated which if recorded by an ultrasonic transducer can result in the formation of an image of the sample by mapping the initial absorbed energy distribution. In this context, RGO have attracted attention as a PA contrast agent because of its better NIR absorbance properties as compared to GO. Wang et al. combined photoacoustic imaging with photothermal therapy into a single platform by loading the NIR absorbing dye indocyanine green (ICG) onto GO and demonstrated targeted photothermal ablation of HeLa cells in vitro alongwith PAI through conjugation of folic acid as the targeting ligand with the ICG-GO nanocomposites.157 In vivo PAI alongwith PTT was demonstrated by Sheng et al. using bovine serum albumin functionalized nano-rGO (BSA-rGO) in a mouse bearing MCF-7 xenograft.158 Post 2 h intravenous injection of the BSA-rGO\n1750011-39\nR ep\n. A dv\n. P hy\ns. S\nci . 2\n01 7.\n01 . D\now nl\noa de\nd fr\nom w\nw w\n.w or\nld sc\nie nt\nif ic\n.c om\nby 1\n79 .2\n18 .7\n6. 13\n4 on\n0 3/\n01 /1\n8. F\nor p\ner so\nna l u\nse o\nnl y.\nnanocomposites, signi¯cant photoacoustic signals were observed from the tumor regions showing increased accumulation of nanocomposites in the tumors. The NIR responsive photothermal property of rGO was then used for the photothermal ablation of the tumors.\n7.2.6. Multimodal imaging-guided phototherapy\nGraphene-based nanocomposites capable of performing imaging through multiple modalities such as MRI, CT, °uorescence combined with photo-therapies into a single platform has also been explored. Such systems provide the bene¯ts of better diagnosis by incorporating the advantages of each imaging modality for performing improved and enhanced detection. Zhang et al. demonstrated dual modal MRI/CT imaging of tumors in vivo alongwith photothermal ablation using PEGylated GO nanosheets loaded with BaGdF5 nanoparticles (GO/BaGdF5/ PEG).159 The nanocomposites exhibited enhanced magnetic resonance contrast and better X-ray attenuation property than Iohexol which is a standard contrast agent used in radiographic imaging of arteries, veins, ventricles, joints, etc. Intravenous injection of the nanocomposites performed e±cient photothermal ablation of the tumors with no toxicity to the host. Shi et al. developed a multifunctional magnetic and plasmonic graphene-based nanocomposite by loading IONP onto the surface of GO sheets followed by growing a layer of gold on it.160 This GO-IONP-Au nanocomposite was then functionalized with PEG and used for photothermal ablation of cancer cells and tumors both in vitro and in vivo alongwith dual-modal MRI and X-ray imaging. The gold layer helped in enhancing the NIR absorbance of the nanocomposite and IONP and Au together contributed towards contrast generation for imaging. Yang et al. developed a graphene-based nanotheranostic platform for triple modal °uorescence, photoacoustic, and magnetic resonance imaging of tumors in vivo combined with photothermal therapy and successfully demonstrated multimodal imaging guided photothermal ablation of 4T1-tumors in mice by using C18PMH–PEG functionalized rGO/IONP nanocomposites synthesized via a hydrothermal process.161 PLA microcapsules encapsulating GO and AuNPs were developed as nanotheranostic agent by Jin et al. for photothermal ablation of tumors under the guidance of bimodal ultrasonic/CT imaging.162 Rong et al. demonstrated bimodal °uorescence/PET imaging guided photodynamic therapy of tumors using PEGylated GO sheets loaded with a radiolabeled photosensitizer 64Cu -HPPH.163 Similarly, in a separate study, Yan et al. demonstrated bimodal °uorescence/PA imaging guided combined photothermal-photodynamic therapy of tumors using PEGylated GO sheets loaded with DVDMS (Fig. 7(ii)).164 In another study, Gollavelli et al. developed SiNc4 photosensitizer loaded magnetic °uorescent graphene and demonstrated bimodal °uorescence/MRI imaging guided combined photothermal-photodynamic therapy of HeLa cells in vitro.165\n1750011-40\nR ep\n. A dv\n. P hy\ns. S\nci . 2\n01 7.\n01 . D\now nl\noa de\nd fr\nom w\nw w\n.w or\nld sc\nie nt\nif ic\n.c om\nby 1\n79 .2\n18 .7\n6. 13\n4 on\n0 3/\n01 /1\n8. F\nor p\ner so\nna l u\nse o\nnl y.\n7.3. Imaging guided chemo-phototherapies\nBian et al. reported the synthesis of graphene-isolated-Au-nanocrystal (GIAN) nanostructures by depositing a thin layer of graphene on the surfaces of Au nanocrystals using CVD method.166 These nanostructures were used as imaging probes for dual modal Raman and TPFI imaging of cells and also as a substrate for loading of anti-cancer drug doxorubicin and NIR mediated photothermal therapy of cancer (Fig. 7(iii)). Shi et al. demonstrated tumor targeted chemo-PTT of cancer combined with X-ray imaging of the tumors using GO@Ag nanocomposites.167 The GO@Ag nanocomposites were loaded with doxorubicin and conjugated with NGR peptide for active targeting of tumors (GO@Ag-DOX-NGR). The GO@Ag-DOX-NGR showed excellent targeted chemo-photothermal e±cacy along with X-ray imaging ability both in in vitro and in vivo studies. Magnetic graphene-based mesoporous silica (MGMS) nanocomposites have emerged as novel theranostic agents for carrying out magnetic imaging-guided therapy. Wang et al. developed a theranostic platform based on magnetic graphene-based mesoporous silica for MRI guided targeted chemo-photothermal therapy of gliomas.168 The MGMS nanocomposites were tagged with a IL-13 targeting peptide and loaded with DOX for targeted delivery of the drugs to U251 glioma cells. The magnetic properties of the nanocomposite due to the presence of IONPs on the surface of GO sheets provided improved contrast for MR imaging as seen from increased T2 relaxation rates and at the same time enhanced the optical absorbance of the nanocomposites in the NIR region thereby making them suitable for photothermal applications also. Sherlock et al. reported a new type of theranostic platform by synthesizing ultrasmall FeCo/graphitic carbon shell nanocrystals (FeCo/GC) having size in the range of 3–4 nm in diameter.169 The FeCo/GC nanocrystals exhibited excellent magnetization, high doxorubicin loading e±ciency and both pH and NIR responsive drug release abilities that resulted in enhanced cytotoxicity towards cancer cells. NIR induced hyperthermia also increased the cellular uptake of these nanocrystals thereby further enhancing the cytotoxic e®ects. In addition to this, the nanocrystals were also used as MRI contrast agents for imaging their cellular uptake."
    }, {
      "heading" : "8. Conclusion and Outlook",
      "text" : "In this review, we provide a systematic and detailed overview regarding the current progress on the di®erent biomedical applications of graphene-based nanomaterials in the ¯eld of drug delivery, gene delivery, phototherapy, bioimaging and combined therapeutic and theranostic approaches in a highly categorized manner. The versatility of graphene and its derivatives in the ¯eld of biomedical research can be attributed to the unique structural, optical, electrical, thermal and biocompatible properties of these nanomaterials. The monolayer single-atomic 2D nanosheets of graphene oxide and rGO provide ultra-high surface area and numerous functional groups on their surface for highly e±cient loading of di®erent kinds of therapeutic\n1750011-41\nR ep\n. A dv\n. P hy\ns. S\nci . 2\n01 7.\n01 . D\now nl\noa de\nd fr\nom w\nw w\n.w or\nld sc\nie nt\nif ic\n.c om\nby 1\n79 .2\n18 .7\n6. 13\n4 on\n0 3/\n01 /1\n8. F\nor p\ner so\nna l u\nse o\nnl y.\nand theranostic cargo such as anti-cancer drugs, nucleic acids like DNA, RNA, siRNA, miRNA, imaging agents like °uorophores, quantum dots, dyes, inorganic materials like plasmonic and magnetic nanoparticles, etc., through hydrophobic and\n– interactions. It also allows easy functionalization with biocompatible polymers like PEG and targeting moieties like peptides, vitamins and antibodies through covalent and non-covalent interactions for the development of novel multifunctional biocompatible theranostic platforms for imaging guided therapy. This ability to combine multiple treatment and diagnostic modalities into a single platform have signi¯cantly increased the therapeutic e±ciency and importance of graphene in the ¯eld of nanomedicine and has made it a material of choice for exploring di®erent novel biological applications. However, in spite of this tremendous progress, most of the research that has been carried out so far on graphene and its derivatives have mainly explored its therapeutic potential at the in vitro level, with very little focus on understanding the interactions of graphene with cells and tissues at the organismal level, which is very crucial for a successful translation of a graphene-based nanomedicine from bench to bedside. Detailed mechanistic studies in small as well as large animal models should be done to get a clear understanding of how graphene-based nanomaterials behave once they are inside the body of a host, how they interact with the cells of the immune system and reticuloendothelial system, whether they induce any local or systemic in°ammatory response, their pharmacokinetics and biodistribution pro¯les and most importantly, their toxicity pro¯les. Some studies have shown that the toxicity and interaction of graphene-based materials with cells and tissues are greatly a®ected by the size distribution of these materials, with larger size having more toxicity and higher chances of getting phagocytosed and cleared o® the circulation by phagocytic cells. However, the large size distribution of these materials that arise in each batch during their synthesis makes it very di±cult to correlate size with toxicity and hence requires the development of new synthesis methods that will provide uniformity in the size of these nanoparticles. In addition to synthesis, new surface functionalization strategies for reducing toxicity and improving physiological stability should also be developed. So, by looking at the progress that have been made in the ¯eld of graphene research over the years, we can surely say that graphene holds a lot of promise and hope as a future nanomedicine. However, to take it to the clinic a signi¯cant amount of e®ort from scientists and researchers from di®erent disciplines of chemistry, material science, engineering and specially biology is needed to understand the systemic toxicity and immunogenicity of the material.\nAcronym list\nGO Graphene oxide rGO Reduced graphene oxide GQD Graphene quantum dot NIR Near infrared\n1750011-42\nR ep\n. A dv\n. P hy\ns. S\nci . 2\n01 7.\n01 . D\now nl\noa de\nd fr\nom w\nw w\n.w or\nld sc\nie nt\nif ic\n.c om\nby 1\n79 .2\n18 .7\n6. 13\n4 on\n0 3/\n01 /1\n8. F\nor p\ner so\nna l u\nse o\nnl y.\nPTT Photothermal therapy PDT Photodynamic therapy PEG Poly-ethylene glycol DOX Doxorubicin PTX Paclitaxel CPT Camptothecin DNA deoxyribonucleic acid RNA ribonucleic acid mRNA messenger RNA siRNA small interfering RNA miRNA micro RNA MRI Magnetic resonance imaging PAI Photoacoustic imaging TPFI Two photon °uorescence imaging PET Positron emission tomography SPECT Single-photon emission computed tomography"
    }, {
      "heading" : "Acknowledgment",
      "text" : "The authors would like to acknowledge the ¯nancial and infrastructural support provided by BioX Centre, Indian Institute of Technology Mandi. SR would like to acknowledge DST INSPIRE Fellowship programme [IF160513] for providing doctoral fellowship."
    } ],
    "references" : [ {
      "title" : "Electric ̄eld e®ect in atomically thin carbon",
      "author" : [ "K.S. Novoselov", "A.K. Geim", "S.V. Morozov", "D. Jiang", "Y. Zhang", "S.V. Dubonos" ],
      "venue" : "̄lms, Science",
      "citeRegEx" : "2",
      "shortCiteRegEx" : "2",
      "year" : 2004
    }, {
      "title" : "Geim, Graphene: Status and prospects",
      "author" : [ "K. A" ],
      "venue" : "Science",
      "citeRegEx" : "3",
      "shortCiteRegEx" : "3",
      "year" : 2009
    }, {
      "title" : "A roadmap for graphene",
      "author" : [ "K.S. Novoselov", "V. Fal", "L. Colombo", "P. Gellert", "M. Schwab", "K. Kim" ],
      "venue" : "Nature",
      "citeRegEx" : "4",
      "shortCiteRegEx" : "4",
      "year" : 2012
    }, {
      "title" : "The chemistry of graphene oxide",
      "author" : [ "D.R. Dreyer", "S. Park", "C.W. Bielawski", "R.S. Ruo" ],
      "venue" : "Chem. Soc. Rev",
      "citeRegEx" : "5",
      "shortCiteRegEx" : "5",
      "year" : 2010
    }, {
      "title" : "Graphene synthesis: Relationship to applications, Nanoscale",
      "author" : [ "R.S. Edwards", "K.S. Coleman" ],
      "venue" : null,
      "citeRegEx" : "6",
      "shortCiteRegEx" : "6",
      "year" : 2013
    }, {
      "title" : "Covalent and non-covalent approaches, derivatives and applications, Chem",
      "author" : [ "V. Georgakilas", "M. Otyepka", "A.B. Bourlinos", "V. Chandra", "N. Kim", "K.C. Kemp et al.", "Functionalization of graphene" ],
      "venue" : "Rev 112",
      "citeRegEx" : "8",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Preparation and functionalization of graphene nanocomposites for biomedical applications",
      "author" : [ "K. Yang", "L. Feng", "H. Hong", "W. Cai", "Z. Liu" ],
      "venue" : "Nat. Protocols",
      "citeRegEx" : "9",
      "shortCiteRegEx" : "9",
      "year" : 2013
    }, {
      "title" : "Graphene-based platforms for cancer therapeutics, Therap. Deliv",
      "author" : [ "S.C. Patel", "S. Lee", "G. Lalwani", "C. Suhrland", "S.M. Chowdhury", "B. Sitharaman" ],
      "venue" : null,
      "citeRegEx" : "10",
      "shortCiteRegEx" : "10",
      "year" : 2016
    }, {
      "title" : "Graphene-based nanomaterials for drug delivery and tissue",
      "author" : [ "S. Goenka", "V. Sant", "S. Sant" ],
      "venue" : "engineering, J. Control. Release",
      "citeRegEx" : "11",
      "shortCiteRegEx" : "11",
      "year" : 2014
    }, {
      "title" : "Graphene as cancer theranostic tool: Progress and future challenges, Theranostics",
      "author" : [ "M. Orecchioni", "R. Cabizza", "A. Bianco", "L.G. Delogu" ],
      "venue" : null,
      "citeRegEx" : "12",
      "shortCiteRegEx" : "12",
      "year" : 2015
    }, {
      "title" : "Current applications of graphene oxide in nanomedicine",
      "author" : [ "S.-Y. Wu", "S.S.A. An", "J. Hulme" ],
      "venue" : "Int. J. Nanomed",
      "citeRegEx" : "13",
      "shortCiteRegEx" : "13",
      "year" : 2015
    }, {
      "title" : "Drug/gene delivery, imaging, polymeric modi ̄cation, toxicology, therapeutics and challenges, RSC Adv",
      "author" : [ "M. Nurunnabi", "K. Parvez", "M. Na ̄ujjaman", "V. Revuri", "H.A. Khan", "X. Feng et al.", "Bioapplication of graphene oxide derivatives" ],
      "venue" : "5",
      "citeRegEx" : "14",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Theranostic applications, Chem",
      "author" : [ "K. Yang", "L. Feng", "X. Shi", "Z. Liu", "Nano-graphene in biomedicine" ],
      "venue" : "Soc. Rev. 42",
      "citeRegEx" : "15",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "PEGylated nanographene oxide for delivery of water-insoluble cancer",
      "author" : [ "Z. Liu", "J.T. Robinson", "X. Sun", "H. Dai" ],
      "venue" : "drugs, J. Am. Chem. Soc",
      "citeRegEx" : "16",
      "shortCiteRegEx" : "16",
      "year" : 2008
    }, {
      "title" : "High-e±ciency loading and controlled release of doxorubicin hydrochloride on graphene oxide",
      "author" : [ "X. Yang", "X. Zhang", "Z. Liu", "Y. Ma", "Y. Huang", "Y. Chen" ],
      "venue" : "J. Phys. Chem. C",
      "citeRegEx" : "17",
      "shortCiteRegEx" : "17",
      "year" : 2008
    }, {
      "title" : "Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs",
      "author" : [ "L. Zhang", "J. Xia", "Q. Zhao", "L. Liu", "Z. Zhang" ],
      "venue" : null,
      "citeRegEx" : "18",
      "shortCiteRegEx" : "18",
      "year" : 2010
    }, {
      "title" : "Systemic administration of polymer-coated nano-graphene to deliver drugs to glioblastoma, Part",
      "author" : [ "T.L. Moore", "R. Podilakrishna", "A. Rao", "F. Alexis" ],
      "venue" : "Part. Syst. Char",
      "citeRegEx" : "19",
      "shortCiteRegEx" : "19",
      "year" : 2014
    }, {
      "title" : "Delivery of paclitaxel using PEGylated graphene oxide as a nanocarrier",
      "author" : [ "Z. Xu", "S. Zhu", "M. Wang", "Y. Li", "P. Shi", "X. Huang" ],
      "venue" : "ACS Appl. Mater. Interfaces",
      "citeRegEx" : "20",
      "shortCiteRegEx" : "20",
      "year" : 2015
    }, {
      "title" : "Environmentally friendly, one-pot synthesis of folic acid-decorated graphene oxide-based drug delivery",
      "author" : [ "Q. Lin", "X. Huang", "J. Tang", "Y. Han", "H. Chen" ],
      "venue" : "system, J. Nanopart. Res",
      "citeRegEx" : "22",
      "shortCiteRegEx" : "22",
      "year" : 2013
    }, {
      "title" : "Cholesteryl hyaluronic acid-coated, reduced graphene oxide nanosheets for anti-cancer drug delivery, Biomaterials",
      "author" : [ "W. Miao", "G. Shim", "C.M. Kang", "S. Lee", "Y.S. Choe", "H.-G. Choi" ],
      "venue" : null,
      "citeRegEx" : "23",
      "shortCiteRegEx" : "23",
      "year" : 2013
    }, {
      "title" : "Hyaluronic acid conjugated graphene oxide for targeted drug",
      "author" : [ "H. Wu", "H. Shi", "Y. Wang", "X. Jia", "C. Tang", "J. Zhang" ],
      "venue" : "delivery, Carbon",
      "citeRegEx" : "24",
      "shortCiteRegEx" : "24",
      "year" : 2014
    }, {
      "title" : "In vitro and in vivo evaluations, ACS Appl",
      "author" : [ "G. Liu", "H. Shen", "J. Mao", "L. Zhang", "Z. Jiang", "T. Sun et al.", "Transferrin modi ̄ed graphene oxide for glioma-targeted drug delivery" ],
      "venue" : "Mater. Interfaces 5",
      "citeRegEx" : "25",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Chlorotoxin-conjugated graphene oxide for targeted delivery of an anticancer drug",
      "author" : [ "H. Wang", "W. Gu", "N. Xiao", "L. Ye", "Q. Xu" ],
      "venue" : "Int. J. Nanomed",
      "citeRegEx" : "26",
      "shortCiteRegEx" : "26",
      "year" : 2014
    }, {
      "title" : "Graphene nanoribbons elicit cell speci ̄c uptake and delivery via activation of epidermal growth factor receptor enhanced by human papillomavirus E5 protein",
      "author" : [ "S.M. Chowdhury", "P. Manepalli", "B. Sitharaman" ],
      "venue" : "Acta Biomater",
      "citeRegEx" : "28",
      "shortCiteRegEx" : "28",
      "year" : 2014
    }, {
      "title" : "Graphene nanoribbons as a drug delivery agent for lucanthone mediated therapy of glioblastoma multiforme, Nanomed",
      "author" : [ "S.M. Chowdhury", "C. Surhland", "Z. Sanchez", "P. Chaudhary", "M.S. Kumar", "S. Lee" ],
      "venue" : "Nanotechnol. Biol. Med",
      "citeRegEx" : "29",
      "shortCiteRegEx" : "29",
      "year" : 2015
    }, {
      "title" : "A pH-sensitive graphene oxide composite hydrogel",
      "author" : [ "H. Bai", "C. Li", "X. Wang", "G. Shi" ],
      "venue" : "Chem. Commun",
      "citeRegEx" : "30",
      "shortCiteRegEx" : "30",
      "year" : 2010
    }, {
      "title" : "Synthesis, loading e±ciency and drug release response, Mater",
      "author" : [ "D. Depan", "J. Shah", "R. Misra", "Controlled release of drug from folate-decorated", "graphene mediated drug delivery system" ],
      "venue" : "Sci. Eng. C 31",
      "citeRegEx" : "31",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "Functionalized graphene oxide as nanocarrier for loading and delivery of ellagic acid",
      "author" : [ "M. Kakran", "N.G. Sahoo", "H. Bao", "Y. Pan", "L. Li" ],
      "venue" : "Current Med. Chem",
      "citeRegEx" : "32",
      "shortCiteRegEx" : "32",
      "year" : 2011
    }, {
      "title" : "Synthesis of phospholipid monolayer membrane functionalized graphene for drug delivery",
      "author" : [ "J. Liu", "S. Guo", "L. Han", "T. Wang", "W. Hong", "Y. Liu" ],
      "venue" : "J. Mater. Chem",
      "citeRegEx" : "34",
      "shortCiteRegEx" : "34",
      "year" : 2012
    }, {
      "title" : "The preparation and drug delivery of a graphene–carbon nanotube–Fe 3 O 4 nanoparticle hybrid",
      "author" : [ "X. Fan", "G. Jiao", "L. Gao", "P. Jin", "X. Li" ],
      "venue" : "J. Mater. Chem. B",
      "citeRegEx" : "35",
      "shortCiteRegEx" : "35",
      "year" : 2013
    }, {
      "title" : "Hyaluronic acid-decorated graphene oxide nanohybrids as nanocarriers for targeted and pH-responsive anticancer drug delivery",
      "author" : [ "E. Song", "W. Han", "C. Li", "D. Cheng", "L. Li", "L. Liu" ],
      "venue" : "ACS Appl. Mater. Interfaces",
      "citeRegEx" : "36",
      "shortCiteRegEx" : "36",
      "year" : 2014
    }, {
      "title" : "Albumin–graphene oxide conjugates; carriers for anticancer drugs",
      "author" : [ "S. Jokar", "A. Pourjavadi", "M. Adeli" ],
      "venue" : "Rsc Adv",
      "citeRegEx" : "37",
      "shortCiteRegEx" : "37",
      "year" : 2014
    }, {
      "title" : "Functional materials from the covalent modi ̄cation of reduced graphene oxide and -cyclodextrin as a drug delivery carrier",
      "author" : [ "G. Wei", "R. Dong", "D. Wang", "L. Feng", "S. Dong", "A. Song" ],
      "venue" : "New J. Chem",
      "citeRegEx" : "38",
      "shortCiteRegEx" : "38",
      "year" : 2014
    }, {
      "title" : "Controlled release of doxorubicin from graphene oxide based charge-reversal nanocarrier, Biomaterials",
      "author" : [ "T. Zhou", "X. Zhou", "D. Xing" ],
      "venue" : null,
      "citeRegEx" : "39",
      "shortCiteRegEx" : "39",
      "year" : 2014
    }, {
      "title" : "Engineered redox-responsive PEG detachment mechanism in PEGylated nano-graphene oxide for intracellular drug",
      "author" : [ "H. Wen", "C. Dong", "H. Dong", "A. Shen", "W. Xia", "X. Cai" ],
      "venue" : null,
      "citeRegEx" : "40",
      "shortCiteRegEx" : "40",
      "year" : 2012
    }, {
      "title" : "A spatiotemporal anticancer drug release platform of PEGylated graphene oxide triggered by glutathione in vitro and in vivo",
      "author" : [ "U. Dembereldorj", "M. Kim", "S. Kim", "E.-O. Ganbold", "S.Y. Lee", "S.-W. Joo" ],
      "venue" : "J. Mater. Chem",
      "citeRegEx" : "41",
      "shortCiteRegEx" : "41",
      "year" : 2012
    }, {
      "title" : "Photothermally triggered cytosolic drug delivery via endosome disruption using a functionalized reduced graphene oxide",
      "author" : [ "H. Kim", "D. Lee", "J. Kim", "T.-i. Kim", "W.J. Kim" ],
      "venue" : "ACS Nano",
      "citeRegEx" : "42",
      "shortCiteRegEx" : "42",
      "year" : 2013
    }, {
      "title" : "One-pot preparation of graphene/Fe 3 O 4 composites by a solvothermal reaction",
      "author" : [ "K. Zhou", "Y. Zhu", "X. Yang", "C. Li" ],
      "venue" : "New J. Chem",
      "citeRegEx" : "43",
      "shortCiteRegEx" : "43",
      "year" : 2010
    }, {
      "title" : "Synthesis of 3D hierarchical Fe3O4/graphene composites with high lithium storage capacity and for controlled drug delivery",
      "author" : [ "X. Li", "X. Huang", "D. Liu", "X. Wang", "S. Song", "L. Zhou" ],
      "venue" : "J. Phys. Chem. C",
      "citeRegEx" : "44",
      "shortCiteRegEx" : "44",
      "year" : 2011
    }, {
      "title" : "Characterization and drug release behavior of highly responsive chip-like electrically modulated reduced graphene oxide–poly (vinyl alcohol) membranes",
      "author" : [ "H.-W. Liu", "S.-H. Hu", "Y.-W. Chen", "S.-Y. Chen" ],
      "venue" : "J. Mater. Chem",
      "citeRegEx" : "45",
      "shortCiteRegEx" : "45",
      "year" : 2012
    }, {
      "title" : "Progress and problems with the use of viral vectors for gene therapy",
      "author" : [ "C.E. Thomas", "A. Ehrhardt", "M.A. Kay" ],
      "venue" : "Nat. Rev. Genet",
      "citeRegEx" : "46",
      "shortCiteRegEx" : "46",
      "year" : 2003
    }, {
      "title" : "Graphene materials as 2D non-viral gene transfer vector platforms, Gene Therapy",
      "author" : [ "M. Vincent", "I. de L azaro", "K. Kostarelos" ],
      "venue" : null,
      "citeRegEx" : "48",
      "shortCiteRegEx" : "48",
      "year" : 2017
    }, {
      "title" : "Aptamer/graphene oxide nanocomplex for in situ molecular probing in living cells",
      "author" : [ "Y. Wang", "Z. Li", "D. Hu", "C.-T. Lin", "J. Li", "Y. Lin" ],
      "venue" : "J. Am. Chem. Soc",
      "citeRegEx" : "50",
      "shortCiteRegEx" : "50",
      "year" : 2010
    }, {
      "title" : "The use of polyethylenimine-grafted graphene nanoribbon for cellular delivery of locked nucleic acid modi ̄ed molecular beacon for recognition of microRNA, Biomaterials",
      "author" : [ "H. Dong", "L. Ding", "F. Yan", "H. Ji", "H. Ju" ],
      "venue" : null,
      "citeRegEx" : "51",
      "shortCiteRegEx" : "51",
      "year" : 2011
    }, {
      "title" : "Multifunctional poly (l-lactide)– polyethylene glycol-grafted graphene quantum dots for intracellular microRNA imaging and combined speci ̄c-gene-targeting agents delivery for improved therapeutics",
      "author" : [ "H. Dong", "W. Dai", "H. Ju", "H. Lu", "S. Wang", "L. Xu" ],
      "venue" : "ACS Appl. Mater. Interfaces",
      "citeRegEx" : "52",
      "shortCiteRegEx" : "52",
      "year" : 2015
    }, {
      "title" : "Polyethylenimine-functionalized graphene oxide as an e±cient gene delivery vector",
      "author" : [ "B. Chen", "M. Liu", "L. Zhang", "J. Huang", "J. Yao", "Z. Zhang" ],
      "venue" : "J. Mater. Chem",
      "citeRegEx" : "53",
      "shortCiteRegEx" : "53",
      "year" : 2011
    }, {
      "title" : "Graphene oxide–polyethylenimine nanoconstruct as a gene delivery vector and bioimaging tool",
      "author" : [ "H. Kim", "R. Namgung", "K. Singha", "I.-K. Oh", "W.J. Kim" ],
      "venue" : "Bioconjugate Chem",
      "citeRegEx" : "54",
      "shortCiteRegEx" : "54",
      "year" : 2011
    }, {
      "title" : "Engineered polyethylenimine/graphene oxide nanocomposite for nuclear localized gene delivery",
      "author" : [ "T. Ren", "L. Li", "X. Cai", "H. Dong", "S. Liu", "Y. Li" ],
      "venue" : "Polymer Chem",
      "citeRegEx" : "55",
      "shortCiteRegEx" : "55",
      "year" : 2012
    }, {
      "title" : "Ultra-small graphene oxide functionalized with polyethylenimine (PEI) for very e±cient gene delivery in cell and zebra ̄sh embryos",
      "author" : [ "X. Zhou", "F. Laroche", "G.E. Lamers", "V. Torraca", "P. Voskamp", "T. Lu" ],
      "venue" : null,
      "citeRegEx" : "56",
      "shortCiteRegEx" : "56",
      "year" : 2012
    }, {
      "title" : "Graphene based gene transfection",
      "author" : [ "L. Feng", "S. Zhang", "Z. Liu" ],
      "venue" : "Nanoscale",
      "citeRegEx" : "57",
      "shortCiteRegEx" : "57",
      "year" : 2011
    }, {
      "title" : "Encapsulating gold nanoparticles or nanorods in graphene oxide shells as a novel gene vector",
      "author" : [ "C. Xu", "D. Yang", "L. Mei", "B. Lu", "L. Chen", "Q. Li" ],
      "venue" : "ACS Appl. Mater. Interfaces",
      "citeRegEx" : "58",
      "shortCiteRegEx" : "58",
      "year" : 2013
    }, {
      "title" : "Polyethylene glycol and polyethylenimine dual-functionalized nano-graphene oxide for photothermally enhanced gene",
      "author" : [ "L. Feng", "X. Yang", "X. Shi", "X. Tan", "R. Peng", "J. Wang" ],
      "venue" : null,
      "citeRegEx" : "59",
      "shortCiteRegEx" : "59",
      "year" : 2013
    }, {
      "title" : "Photothermally controlled gene delivery by reduced graphene oxide–polyethylenimine nanocomposite",
      "author" : [ "H. Kim", "W.J. Kim" ],
      "venue" : "Small",
      "citeRegEx" : "60",
      "shortCiteRegEx" : "60",
      "year" : 2014
    }, {
      "title" : "Patterned substrates of nanographene oxide mediating highly localized and e±cient gene delivery",
      "author" : [ "K. Li", "L. Feng", "J. Shen", "Q. Zhang", "Z. Liu", "S.-T. Lee" ],
      "venue" : "ACS Appl. Mater. Interfaces",
      "citeRegEx" : "61",
      "shortCiteRegEx" : "61",
      "year" : 2014
    }, {
      "title" : "Injectable graphene oxide/hydrogel-based angiogenic gene delivery system for vasculogenesis and cardiac repair",
      "author" : [ "A. Paul", "A. Hasan", "H.A. Kindi", "A.K. Gaharwar", "V.T. Rao", "M. Nikkhah" ],
      "venue" : "ACS Nano",
      "citeRegEx" : "62",
      "shortCiteRegEx" : "62",
      "year" : 2014
    }, {
      "title" : "E±cient mRNA delivery with graphene oxide-polyethylenimine for generation of footprint-free human induced pluripotent stem cells",
      "author" : [ "H.Y. Choi", "T.-J. Lee", "G.-M. Yang", "J. Oh", "J. Won", "J. Han" ],
      "venue" : "J. Controlled Rel",
      "citeRegEx" : "63",
      "shortCiteRegEx" : "63",
      "year" : 2016
    }, {
      "title" : "Generation of IntegrationFree Induced Neurons Using Graphene",
      "author" : [ "S. Baek", "J. Oh", "J. Song", "H. Choi", "J. Yoo", "G.Y. Park" ],
      "venue" : "Oxide-Polyethylenimine, Small",
      "citeRegEx" : "64",
      "shortCiteRegEx" : "64",
      "year" : 2017
    }, {
      "title" : "Direct reprogramming of human suspension cells into mesodermal cell lineages via combined magnetic targeting and photothermal stimulation by magnetic graphene oxide complexes, Small (2017)",
      "author" : [ "M.Y. Chiang", "Y.Z. Lin", "S.J. Chang", "W.C. Shyu", "H.E. Lu", "S.Y. Chen" ],
      "venue" : null,
      "citeRegEx" : "65",
      "shortCiteRegEx" : "65",
      "year" : 2017
    }, {
      "title" : "Chitosanfunctionalized graphene oxide as a nanocarrier for drug and gene",
      "author" : [ "H. Bao", "Y. Pan", "Y. Ping", "N.G. Sahoo", "T. Wu", "L. Li" ],
      "venue" : null,
      "citeRegEx" : "66",
      "shortCiteRegEx" : "66",
      "year" : 2011
    }, {
      "title" : "Polyamidoamine dendrimer and oleic acid-functionalized graphene as biocompatible and e±cient gene delivery vectors",
      "author" : [ "X. Liu", "D. Ma", "H. Tang", "L. Tan", "Q. Xie", "Y. Zhang" ],
      "venue" : "ACS Appl. Mater. Interfaces",
      "citeRegEx" : "67",
      "shortCiteRegEx" : "67",
      "year" : 2014
    }, {
      "title" : "Functionalized graphene oxide mediated nucleic acid",
      "author" : [ "S.K. Tripathi", "R. Goyal", "K.C. Gupta", "P. Kumar" ],
      "venue" : "delivery, Carbon",
      "citeRegEx" : "68",
      "shortCiteRegEx" : "68",
      "year" : 2013
    }, {
      "title" : "Suppression of breast cancer cell migration by small interfering RNA delivered by polyethylenimine-functionalized graphene oxide",
      "author" : [ "Y.-P. Huang", "C.-M. Hung", "Y.-C. Hsu", "C.-Y. Zhong", "W.-R. Wang", "C.-C. Chang" ],
      "venue" : "Nanoscale Res. Lett",
      "citeRegEx" : "69",
      "shortCiteRegEx" : "69",
      "year" : 2016
    }, {
      "title" : "Dual-functionalized graphene oxide for enhanced siRNA delivery to breast cancer cells, Colloids Surf",
      "author" : [ "R. Imani", "W. Shao", "S. Taherkhani", "S.H. Emami", "S. Prakash", "S. Faghihi" ],
      "venue" : "B, Biointerfaces",
      "citeRegEx" : "70",
      "shortCiteRegEx" : "70",
      "year" : 2016
    }, {
      "title" : "Near-infrared light-responsive nanomaterials in cancer",
      "author" : [ "V. Shanmugam", "S. Selvakumar", "C.-S. Yeh" ],
      "venue" : "therapeutics, Chem. Soc. Rev",
      "citeRegEx" : "71",
      "shortCiteRegEx" : "71",
      "year" : 2014
    }, {
      "title" : "Functionalized graphene nanocomposites for enhancing photothermal therapy in tumor treatment, Adv",
      "author" : [ "Y.-W. Chen", "Y.-L. Su", "S.-H. Hu", "S.-Y. Chen" ],
      "venue" : "Drug Deliv. Rev",
      "citeRegEx" : "72",
      "shortCiteRegEx" : "72",
      "year" : 2016
    }, {
      "title" : "Graphene-based nanovehicles for photodynamic medical therapy",
      "author" : [ "Y. Li", "H. Dong", "D. Shi" ],
      "venue" : "Int. J. Nanomed",
      "citeRegEx" : "73",
      "shortCiteRegEx" : "73",
      "year" : 2015
    }, {
      "title" : "Ultrahigh in vivo tumor uptake and e±cient photothermal therapy, Nano Lett",
      "author" : [ "K. Yang", "S. Zhang", "G. Zhang", "X. Sun", "S.-T. Lee", "Z. Liu", "Graphene in mice" ],
      "venue" : "10",
      "citeRegEx" : "74",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "Ultrasmall reduced graphene oxide with high near-infrared absorbance for photothermal therapy",
      "author" : [ "J.T. Robinson", "S.M. Tabakman", "Y. Liang", "H. Wang", "H. Sanchez Casalongue", "D. Vinh" ],
      "venue" : "J. Am. Chem. Soc",
      "citeRegEx" : "75",
      "shortCiteRegEx" : "75",
      "year" : 2011
    }, {
      "title" : "The in°uence of surface chemistry and size of nanoscale graphene oxide on photothermal therapy of cancer using ultra-low laser power, Biomaterials",
      "author" : [ "K. Yang", "J. Wan", "S. Zhang", "B. Tian", "Y. Zhang", "Z. Liu" ],
      "venue" : null,
      "citeRegEx" : "76",
      "shortCiteRegEx" : "76",
      "year" : 2012
    }, {
      "title" : "The use of a glucosereduced graphene oxide suspension for photothermal cancer",
      "author" : [ "O. Akhavan", "E. Ghaderi", "S. Aghayee", "Y. Fereydooni", "A. Talebi" ],
      "venue" : "therapy, J. Mater. Chem",
      "citeRegEx" : "77",
      "shortCiteRegEx" : "77",
      "year" : 2012
    }, {
      "title" : "Using graphene oxide high near-infrared absorbance for photothermal treatment of Alzheimer's disease",
      "author" : [ "M. Li", "X. Yang", "J. Ren", "K. Qu", "X. Qu" ],
      "venue" : "Adv. Mater",
      "citeRegEx" : "78",
      "shortCiteRegEx" : "78",
      "year" : 2012
    }, {
      "title" : "Polyphenols attached graphene nanosheets for high e±ciency NIR mediated photodestruction of cancer",
      "author" : [ "M. Abdolahad", "M. Janmaleki", "S. Mohajerzadeh", "O. Akhavan", "S. Abbasi" ],
      "venue" : "cells, Mater. Sci. Eng. C",
      "citeRegEx" : "79",
      "shortCiteRegEx" : "79",
      "year" : 2013
    }, {
      "title" : "Facile synthesis of waterdispersible Cu 2 O nanocrystal–reduced graphene oxide hybrid as a promising cancer therapeutic agent, Nanoscale",
      "author" : [ "C. Hou", "H. Quan", "Y. Duan", "Q. Zhang", "H. Wang", "Y. Li" ],
      "venue" : null,
      "citeRegEx" : "80",
      "shortCiteRegEx" : "80",
      "year" : 2013
    }, {
      "title" : "Enhanced photothermal e®ect of plasmonic nanoparticles coated with reduced graphene oxide",
      "author" : [ "D.-K. Lim", "A. Barhoumi", "R.G. Wylie", "G. Reznor", "R.S. Langer", "D.S. Kohane" ],
      "venue" : "Nano Lett",
      "citeRegEx" : "81",
      "shortCiteRegEx" : "81",
      "year" : 2013
    }, {
      "title" : "PEGylated graphene-oxide nanocomposites for photothermal cancer therapy, Photochem. Photobiol",
      "author" : [ "U. Dembereldorj", "S.Y. Choi", "E.O. Ganbold", "N.W. Song", "D. Kim", "J. Choo et al", "Gold nanorod-assembled" ],
      "venue" : null,
      "citeRegEx" : "82",
      "shortCiteRegEx" : "82",
      "year" : 2014
    }, {
      "title" : "Graphene oxide nanoparticles for enhanced photothermal cancer cell therapy under the irradiation of a femtosecond laser beam",
      "author" : [ "J.L. Li", "X.L. Hou", "H.C. Bao", "L. Sun", "B. Tang", "J.F. Wang" ],
      "venue" : "J. Biomed. Mater. Res. A",
      "citeRegEx" : "83",
      "shortCiteRegEx" : "83",
      "year" : 2014
    }, {
      "title" : "Nanographene oxide–hyaluronic acid conjugate for photothermal ablation therapy of skin cancer",
      "author" : [ "H.S. Jung", "W.H. Kong", "D.K. Sung", "M.-Y. Lee", "S.E. Beack", "D.H. Keum" ],
      "venue" : "ACS Nano",
      "citeRegEx" : "84",
      "shortCiteRegEx" : "84",
      "year" : 2014
    }, {
      "title" : "Zinc ferrite spinel-graphene in magneto-photothermal therapy of cancer",
      "author" : [ "O. Akhavan", "A. Meidanchi", "E. Ghaderi", "S. Khoei" ],
      "venue" : "J. Mater. Chem. B",
      "citeRegEx" : "85",
      "shortCiteRegEx" : "85",
      "year" : 2014
    }, {
      "title" : "Photothermal therapeutic response of cancer cells to aptamer–gold nanoparticle-hybridized graphene oxide under NIR illumination",
      "author" : [ "L. Yang", "Y.-T. Tseng", "G. Suo", "L. Chen", "J. Yu", "W.-J. Chiu" ],
      "venue" : "ACS Appl. Mater. Interfaces",
      "citeRegEx" : "86",
      "shortCiteRegEx" : "86",
      "year" : 2015
    }, {
      "title" : "pH-responsive cyaninegrafted graphene oxide for °uorescence resonance energy transfer-enhanced photothermal therapy",
      "author" : [ "M. Guo", "J. Huang", "Y. Deng", "H. Shen", "Y. Ma", "M. Zhang" ],
      "venue" : "Adv. Function. Mater",
      "citeRegEx" : "87",
      "shortCiteRegEx" : "87",
      "year" : 2015
    }, {
      "title" : "Poly (ethylene glycol) conjugated nano-graphene oxide for photodynamic therapy, Sci",
      "author" : [ "H. Dong", "Z. Zhao", "H. Wen", "F. Guo", "A. Shen", "F. Pilger" ],
      "venue" : "China Chem",
      "citeRegEx" : "88",
      "shortCiteRegEx" : "88",
      "year" : 2010
    }, {
      "title" : "Folic acid-conjugated graphene oxide loaded with photosensitizers for targeting photodynamic therapy, Theranostics",
      "author" : [ "P. Huang", "C. Xu", "J. Lin", "C. Wang", "X. Wang", "C. Zhang" ],
      "venue" : null,
      "citeRegEx" : "89",
      "shortCiteRegEx" : "89",
      "year" : 2011
    }, {
      "title" : "High-e±ciency loading of hypocrellin B on graphene oxide for photodynamic therapy",
      "author" : [ "L. Zhou", "H. Jiang", "S. Wei", "X. Ge", "J. Zhou", "J. Shen" ],
      "venue" : "Carbon",
      "citeRegEx" : "90",
      "shortCiteRegEx" : "90",
      "year" : 2012
    }, {
      "title" : "Graphene oxide noncovalent photosensitizer and its anticancer activity in vitro, Chem",
      "author" : [ "L. Zhou", "W. Wang", "J. Tang", "J.H. Zhou", "H.J. Jiang", "J. Shen" ],
      "venue" : "A Eur. J",
      "citeRegEx" : "91",
      "shortCiteRegEx" : "91",
      "year" : 2011
    }, {
      "title" : "Visible light driven photodynamic anticancer activity of graphene oxide/TiO 2 hybrid",
      "author" : [ "Z. Hu", "Y. Huang", "S. Sun", "W. Guan", "Y. Yao", "P. Tang" ],
      "venue" : "Carbon",
      "citeRegEx" : "92",
      "shortCiteRegEx" : "92",
      "year" : 2012
    }, {
      "title" : "Folic acid-conjugated graphene–ZnO nanohybrid for targeting photodynamic therapy under visible light irradiation",
      "author" : [ "Z. Hu", "J. Li", "C. Li", "S. Zhao", "N. Li", "Y. Wang" ],
      "venue" : "J. Mater. Chem. B",
      "citeRegEx" : "93",
      "shortCiteRegEx" : "93",
      "year" : 2013
    }, {
      "title" : "Hyaluronic acid-conjugated graphene oxide/photosensitizer nanohybrids for cancer targeted photodynamic therapy",
      "author" : [ "F. Li", "S.-J. Park", "D. Ling", "W. Park", "J.Y. Han", "K. Na" ],
      "venue" : "J. Mater. Chem. B",
      "citeRegEx" : "94",
      "shortCiteRegEx" : "94",
      "year" : 2013
    }, {
      "title" : "Synergistic e®ect of chemo-photothermal therapy using PEGylated graphene oxide, Biomaterials",
      "author" : [ "W. Zhang", "Z. Guo", "D. Huang", "Z. Liu", "X. Guo", "H. Zhong" ],
      "venue" : null,
      "citeRegEx" : "96",
      "shortCiteRegEx" : "96",
      "year" : 2011
    }, {
      "title" : "Biol",
      "author" : [ "X. Qin", "Z. Guo", "Z. Liu", "W. Zhang", "M. Wan", "B. Yang", "Folic acid-conjugated graphene oxide for cancer targeted chemo-photothermal therapy", "J. Photochem. Photobiol. B" ],
      "venue" : "120",
      "citeRegEx" : "97",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Targeting chemophotothermal therapy of hepatoma by gold nanorods/graphene oxide core/shell nanocomposites",
      "author" : [ "C. Xu", "D. Yang", "L. Mei", "Q. Li", "H. Zhu", "T. Wang" ],
      "venue" : "ACS Appl. Mater. Interfaces",
      "citeRegEx" : "99",
      "shortCiteRegEx" : "99",
      "year" : 2013
    }, {
      "title" : "Multifunctional mesoporous silica-coated graphene nanosheet used for chemo-photothermal synergistic targeted therapy of glioma",
      "author" : [ "Y. Wang", "K. Wang", "J. Zhao", "X. Liu", "J. Bu", "X. Yan" ],
      "venue" : "J. Am. Chem. Soc",
      "citeRegEx" : "100",
      "shortCiteRegEx" : "100",
      "year" : 2013
    }, {
      "title" : "NIR-triggered synergic photo-chemothermal therapy delivered by reduced graphene oxide/carbon/mesoporous silica nanocookies",
      "author" : [ "Y.W. Chen", "P.J. Chen", "S.H. Hu", "I.W. Chen", "S.Y. Chen" ],
      "venue" : "Adv. Funct. Mater",
      "citeRegEx" : "101",
      "shortCiteRegEx" : "101",
      "year" : 2014
    }, {
      "title" : "Photoresponsive protein–graphene–protein hybrid capsules with dual targeted heat-triggered drug delivery approach for enhanced tumor",
      "author" : [ "S.H. Hu", "R.H. Fang", "Y.W. Chen", "B.J. Liao", "I.W. Chen", "S.Y. Chen" ],
      "venue" : "therapy, Adv. Funct. Mater",
      "citeRegEx" : "102",
      "shortCiteRegEx" : "102",
      "year" : 2014
    }, {
      "title" : "Multifunctional PEG-GO/CuS nanocomposites for near-infrared chemo-photothermal therapy, Biomater",
      "author" : [ "J. Bai", "Y. Liu", "X. Jiang" ],
      "venue" : null,
      "citeRegEx" : "103",
      "shortCiteRegEx" : "103",
      "year" : 2014
    }, {
      "title" : "One-step reduction and PEGylation of graphene oxide for photothermally controlled drug delivery, Biomaterials",
      "author" : [ "J. Chen", "H. Liu", "C. Zhao", "G. Qin", "G. Xi", "T. Li" ],
      "venue" : null,
      "citeRegEx" : "104",
      "shortCiteRegEx" : "104",
      "year" : 2014
    }, {
      "title" : "Facile fabrication of a nearinfrared responsive nanocarrier for spatiotemporally controlled chemo-photothermal synergistic cancer",
      "author" : [ "H. Wan", "Y. Zhang", "Z. Liu", "G. Xu", "G. Huang", "Y. Ji" ],
      "venue" : "therapy, Nanoscale",
      "citeRegEx" : "105",
      "shortCiteRegEx" : "105",
      "year" : 2014
    }, {
      "title" : "Smart pH-responsive nanocarriers based on nano-graphene oxide for combined chemo-and photothermal therapy overcoming drug resistance, Adv",
      "author" : [ "L. Feng", "K. Li", "X. Shi", "M. Gao", "J. Liu", "Z. Liu" ],
      "venue" : "Healthcare Mater",
      "citeRegEx" : "106",
      "shortCiteRegEx" : "106",
      "year" : 2014
    }, {
      "title" : "Graphene oxide– Fe 3 O 4 nanocomposite for combination of dual-drug chemotherapy with photothermal therapy",
      "author" : [ "J.-M. Shen", "F.-Y. Gao", "L.-P. Guan", "W. Su", "Y.-J. Yang", "Q.-R. Li" ],
      "venue" : "RSC Adv",
      "citeRegEx" : "108",
      "shortCiteRegEx" : "108",
      "year" : 2014
    }, {
      "title" : "Combination of chemotherapy and photodynamic therapy using graphene oxide as drug delivery",
      "author" : [ "L. Zhou", "S. Wei", "X. Ge", "J. Zhou", "H. Jiang", "F. Li" ],
      "venue" : "system, J. Photochem. Photobiol. B, Biol",
      "citeRegEx" : "110",
      "shortCiteRegEx" : "110",
      "year" : 2014
    }, {
      "title" : "Highly dispersible PEGylated graphene/Au composites as gene delivery vector and potential cancer therapeutic agent",
      "author" : [ "F.-F. Cheng", "W. Chen", "L.-H. Hu", "G. Chen", "H.-T. Miao", "C. Li" ],
      "venue" : "J. Mater. Chem. B",
      "citeRegEx" : "111",
      "shortCiteRegEx" : "111",
      "year" : 2013
    }, {
      "title" : "Immunostimulatory oligonucleotides-loaded cationic graphene oxide with photothermally enhanced immunogenicity for photothermal/immune cancer",
      "author" : [ "Y. Tao", "E. Ju", "J. Ren", "X. Qu" ],
      "venue" : "therapy, Biomaterials",
      "citeRegEx" : "112",
      "shortCiteRegEx" : "112",
      "year" : 2014
    }, {
      "title" : "SiRNA Delivery with PEGylated graphene oxide nanosheets for combined photothermal and genetherapy for pancreatic cancer, Theranostics",
      "author" : [ "F. Yin", "K. Hu", "Y. Chen", "M. Yu", "D. Wang", "Q. Wang" ],
      "venue" : null,
      "citeRegEx" : "113",
      "shortCiteRegEx" : "113",
      "year" : 2017
    }, {
      "title" : "Functionalized graphene oxide mediated adriamycin delivery and miR-21 gene silencing to overcome tumor multidrug resistance in vitro",
      "author" : [ "F. Zhi", "H. Dong", "X. Jia", "W. Guo", "H. Lu", "Y. Yang" ],
      "venue" : "PloS One",
      "citeRegEx" : "114",
      "shortCiteRegEx" : "114",
      "year" : 2013
    }, {
      "title" : "Multifunctional nanographene oxide for targeted gene-mediated thermochemotherapy of drug-resistant tumour",
      "author" : [ "Y. Zeng", "Z. Yang", "H. Li", "Y. Hao", "C. Liu", "L. Zhu" ],
      "venue" : null,
      "citeRegEx" : "115",
      "shortCiteRegEx" : "115",
      "year" : 2017
    }, {
      "title" : "Photothermally enhanced photodynamic therapy delivered by nano-graphene oxide, ACS Nano",
      "author" : [ "B. Tian", "C. Wang", "S. Zhang", "L. Feng", "Z. Liu" ],
      "venue" : null,
      "citeRegEx" : "116",
      "shortCiteRegEx" : "116",
      "year" : 2011
    }, {
      "title" : "Graphene oxide mediated delivery of methylene blue for combined photodynamic and photothermal therapy, Biomaterials",
      "author" : [ "A. Sahu", "W.I. Choi", "J.H. Lee", "G. Tae" ],
      "venue" : null,
      "citeRegEx" : "117",
      "shortCiteRegEx" : "117",
      "year" : 2013
    }, {
      "title" : "A multi-synergistic platform for sequential irradiation-activated high-performance apoptotic cancer",
      "author" : [ "Z. Chen", "Z. Li", "J. Wang", "E. Ju", "L. Zhou", "J. Ren" ],
      "venue" : "therapy, Adv. Funct. Mater",
      "citeRegEx" : "118",
      "shortCiteRegEx" : "118",
      "year" : 2014
    }, {
      "title" : "Graphene loading water-soluble phthalocyanine for dual-modality photothermal/photodynamic therapy via a one-step method",
      "author" : [ "B.-P. Jiang", "L.-F. Hu", "D.-J. Wang", "S.-C. Ji", "X.-C. Shen", "H. Liang" ],
      "venue" : "J. Mater. Chem. B",
      "citeRegEx" : "119",
      "shortCiteRegEx" : "119",
      "year" : 2014
    }, {
      "title" : "Graphene-based nanomaterials for bioimaging, Adv",
      "author" : [ "J. Lin", "X. Chen", "P. Huang" ],
      "venue" : "Drug Deliv. Rev",
      "citeRegEx" : "120",
      "shortCiteRegEx" : "120",
      "year" : 2016
    }, {
      "title" : "Nano-graphene oxide for cellular imaging and drug delivery",
      "author" : [ "X. Sun", "Z. Liu", "K. Welsher", "J.T. Robinson", "A. Goodwin", "S. Zaric" ],
      "venue" : "Nano Res",
      "citeRegEx" : "121",
      "shortCiteRegEx" : "121",
      "year" : 2008
    }, {
      "title" : "Intracellular imaging with a graphenebased °uorescent",
      "author" : [ "C. Peng", "W. Hu", "Y. Zhou", "C. Fan", "Q. Huang" ],
      "venue" : null,
      "citeRegEx" : "122",
      "shortCiteRegEx" : "122",
      "year" : 2010
    }, {
      "title" : "VEGF-loaded graphene oxide as theranostics for multi-modality imaging-monitored targeting therapeutic angiogenesis of ischemic muscle, Nanoscale",
      "author" : [ "Z. Sun", "P. Huang", "G. Tong", "J. Lin", "A. Jin", "P. Rong" ],
      "venue" : null,
      "citeRegEx" : "123",
      "shortCiteRegEx" : "123",
      "year" : 2013
    }, {
      "title" : "Strongly green-photoluminescent graphene quantum dots for bioimaging",
      "author" : [ "S. Zhu", "J. Zhang", "C. Qiao", "S. Tang", "Y. Li", "W. Yuan" ],
      "venue" : "applications, Chem. Commun",
      "citeRegEx" : "125",
      "shortCiteRegEx" : "125",
      "year" : 2011
    }, {
      "title" : "Strong two-photon-induced °uorescence from photostable, biocompatible nitrogen-doped graphene quantum dots for cellular and deep-tissue imaging",
      "author" : [ "Q. Liu", "B. Guo", "Z. Rao", "B. Zhang", "J.R. Gong" ],
      "venue" : "Nano Lett",
      "citeRegEx" : "126",
      "shortCiteRegEx" : "126",
      "year" : 2013
    }, {
      "title" : "In situ synthesis of metal nanoparticles on single-layer graphene oxide and reduced graphene oxide surfaces",
      "author" : [ "X. Zhou", "X. Huang", "X. Qi", "S. Wu", "C. Xue", "F.Y. Boey" ],
      "venue" : "J. Phys. Chem. C",
      "citeRegEx" : "127",
      "shortCiteRegEx" : "127",
      "year" : 2009
    }, {
      "title" : "Green controllable synthesis of silver nanomaterials on graphene oxide sheets via spontaneous reduction",
      "author" : [ "X. Wang", "P. Huang", "L. Feng", "M. He", "S. Guo", "G. Shen" ],
      "venue" : "RSC Adv",
      "citeRegEx" : "128",
      "shortCiteRegEx" : "128",
      "year" : 2012
    }, {
      "title" : "Nanocomposites of sizecontrolled gold nanoparticles and graphene oxide: Formation and applications in SERS and catalysis, Nanoscale",
      "author" : [ "J. Huang", "L. Zhang", "B. Chen", "N. Ji", "F. Chen", "Y. Zhang" ],
      "venue" : null,
      "citeRegEx" : "129",
      "shortCiteRegEx" : "129",
      "year" : 2010
    }, {
      "title" : "Graphene oxide based surfaceenhanced Raman scattering probes for cancer cell imaging",
      "author" : [ "Z. Liu", "Z. Guo", "H. Zhong", "X. Qin", "M. Wan", "B. Yang" ],
      "venue" : "Phys. Chem. Chem. Phys",
      "citeRegEx" : "130",
      "shortCiteRegEx" : "130",
      "year" : 2013
    }, {
      "title" : "Mechanism of cellular uptake of graphene oxide studied by surface-enhanced raman spectroscopy",
      "author" : [ "J. Huang", "C. Zong", "H. Shen", "M. Liu", "B. Chen", "B. Ren" ],
      "venue" : null,
      "citeRegEx" : "131",
      "shortCiteRegEx" : "131",
      "year" : 2012
    }, {
      "title" : "Alkyne-functionalized superstable graphitic silver nanoparticles for Raman imaging",
      "author" : [ "Z.-L. Song", "Z. Chen", "X. Bian", "L.-Y. Zhou", "D. Ding", "H. Liang" ],
      "venue" : "J. Am. Chem. Soc",
      "citeRegEx" : "132",
      "shortCiteRegEx" : "132",
      "year" : 2014
    }, {
      "title" : "Enhanced MRI relaxivity of aquated Gd 3+ ions by carboxyphenylated water-dispersed graphene nanoribbons, Nanoscale",
      "author" : [ "A. Gizzatov", "V. Keshishian", "A. Guven", "A.M. Dimiev", "F. Qu", "R. Muthupillai" ],
      "venue" : null,
      "citeRegEx" : "133",
      "shortCiteRegEx" : "133",
      "year" : 2014
    }, {
      "title" : "Composites of aminodextran-coated Fe3O4 nanoparticles and graphene oxide for cellular magnetic resonance imaging",
      "author" : [ "W. Chen", "P. Yi", "Y. Zhang", "L. Zhang", "Z. Deng", "Z. Zhang" ],
      "venue" : "ACS Appl. Mater. Interfaces",
      "citeRegEx" : "134",
      "shortCiteRegEx" : "134",
      "year" : 2011
    }, {
      "title" : "The ̄rst magnetic-nanoparticle-free carbon-based contrast agent of magnetic-resonance imaging-°uorinated graphene",
      "author" : [ "Y.H. Hu" ],
      "venue" : "oxide, Small",
      "citeRegEx" : "135",
      "shortCiteRegEx" : "135",
      "year" : 2014
    }, {
      "title" : "In vivo targeting and imaging of tumor vasculature with radiolabeled, antibody-conjugated nanographene",
      "author" : [ "H. Hong", "K. Yang", "Y. Zhang", "J.W. Engle", "L. Feng", "Y. Yang" ],
      "venue" : "ACS Nano",
      "citeRegEx" : "136",
      "shortCiteRegEx" : "136",
      "year" : 2012
    }, {
      "title" : "In vivo targeting and positron emission tomography imaging of tumor vasculature with 66",
      "author" : [ "H. Hong", "Y. Zhang", "J.W. Engle", "T.R. Nayak", "C.P. Theuer", "R.J. Nickles" ],
      "venue" : "Galabeled nano-graphene, Biomaterials",
      "citeRegEx" : "137",
      "shortCiteRegEx" : "137",
      "year" : 2012
    }, {
      "title" : "Afarideh, In vivo SPECT imaging of tumors by 198,199 Au-labeled graphene oxide nanostructures, Mater",
      "author" : [ "Y. Fazaeli", "O. Akhavan", "R. Rahighi", "M.R. Aboudzadeh", "H.E. Karimi" ],
      "venue" : "Sci. Eng. C",
      "citeRegEx" : "138",
      "shortCiteRegEx" : "138",
      "year" : 2014
    }, {
      "title" : "Jurkshat et al., Nanographene oxide-based radioimmunoconstructs for in vivo targeting and SPECT imaging of HER2-positive tumors, Biomaterials",
      "author" : [ "B. Cornelissen", "S. Able", "V. Kersemans", "P.A. Waghorn", "K.S. Myhra" ],
      "venue" : null,
      "citeRegEx" : "139",
      "shortCiteRegEx" : "139",
      "year" : 2013
    }, {
      "title" : "Gold nanoclusters and graphene nanocomposites for drug delivery and imaging of cancer",
      "author" : [ "C. Wang", "J. Li", "C. Amatore", "Y. Chen", "H. Jiang", "X.M. Wang" ],
      "venue" : "cells, Angew. Chem. Int. Edn",
      "citeRegEx" : "140",
      "shortCiteRegEx" : "140",
      "year" : 2011
    }, {
      "title" : "Quantum-dot-conjugated graphene as a probe for simultaneous cancer-targeted °uorescent imaging, tracking and monitoring drug delivery",
      "author" : [ "M.-L. Chen", "Y.-J. He", "X.-W. Chen", "J.-H. Wang" ],
      "venue" : "Bioconjugate Chem",
      "citeRegEx" : "141",
      "shortCiteRegEx" : "141",
      "year" : 2013
    }, {
      "title" : "Cyclic RGD-modi ̄ed chitosan/graphene oxide polymers for drug delivery and cellular imaging, Colloids Surf",
      "author" : [ "C. Wang", "B. Chen", "M. Zou", "G. Cheng" ],
      "venue" : "B, Biointerfaces",
      "citeRegEx" : "142",
      "shortCiteRegEx" : "142",
      "year" : 2014
    }, {
      "title" : "Graphene oxide wrapped gold nanoparticles for intracellular Raman imaging and drug delivery",
      "author" : [ "X. Ma", "Q. Qu", "Y. Zhao", "Z. Luo", "K.W. Ng" ],
      "venue" : "J. Mater. Chem. B",
      "citeRegEx" : "143",
      "shortCiteRegEx" : "143",
      "year" : 2013
    }, {
      "title" : "Reduced graphene oxide-supported gold nanostars for improved SERS sensing and drug delivery",
      "author" : [ "Y. Wang", "L. Polavarapu", "L.M. Liz-Marz  an" ],
      "venue" : "ACS Appl. Mater. Interfaces",
      "citeRegEx" : "144",
      "shortCiteRegEx" : "144",
      "year" : 2014
    }, {
      "title" : "Graphene oxide based theranostic platform for T 1-weighted magnetic resonance imaging and drug delivery",
      "author" : [ "M. Zhang", "Y. Cao", "Y. Chong", "Y. Ma", "H. Zhang", "Z. Deng" ],
      "venue" : "ACS Appl. Mater. Interfaces",
      "citeRegEx" : "145",
      "shortCiteRegEx" : "145",
      "year" : 2013
    }, {
      "title" : "A theranostic platform for tumortargeted co-delivery of drugs, genes and MRI contrast agents, J",
      "author" : [ "C. Wang", "S. Ravi", "U.S. Garapati", "M. Das", "M. Howell", "J. Mallela et al.", "Multifunctional chitosan magnetic-graphene (CMG) nanoparticles" ],
      "venue" : "Mater. Chem. B 1",
      "citeRegEx" : "146",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Quantum-dot-tagged reduced graphene oxide nanocomposites for bright °uorescence bioimaging and photothermal therapy monitored in situ",
      "author" : [ "S.H. Hu", "Y.W. Chen", "W.T. Hung", "I.W. Chen", "S.Y. Chen" ],
      "venue" : "Adv. Mater",
      "citeRegEx" : "148",
      "shortCiteRegEx" : "148",
      "year" : 2012
    }, {
      "title" : "Enhanced °uorescence imaging guided photodynamic therapy of sinoporphyrin sodium loaded graphene oxide, Biomaterials",
      "author" : [ "X. Yan", "G. Niu", "J. Lin", "A.J. Jin", "H. Hu", "Y. Tang" ],
      "venue" : null,
      "citeRegEx" : "149",
      "shortCiteRegEx" : "149",
      "year" : 2015
    }, {
      "title" : "Graphene oxide covalently grafted upconversion nanoparticles for combined NIR mediated imaging and photothermal/photodynamic cancer therapy, Biomaterials",
      "author" : [ "Y. Wang", "H. Wang", "D. Liu", "S. Song", "X. Wang", "H. Zhang" ],
      "venue" : null,
      "citeRegEx" : "150",
      "shortCiteRegEx" : "150",
      "year" : 2013
    }, {
      "title" : "Graphene oxide–photosensitizer conjugate as a redox-responsive theranostic",
      "author" : [ "Y. Cho", "Y. Choi" ],
      "venue" : "agent, Chem. Commun",
      "citeRegEx" : "151",
      "shortCiteRegEx" : "151",
      "year" : 2012
    }, {
      "title" : "A graphene oxide–photosensitizer complex as an enzymeactivatable theranostic",
      "author" : [ "Y. Cho", "H. Kim", "Y. Choi" ],
      "venue" : "agent, Chem. Commun",
      "citeRegEx" : "152",
      "shortCiteRegEx" : "152",
      "year" : 2013
    }, {
      "title" : "Graphene nanomesh promises extremely e±cient in vivo photothermal therapy",
      "author" : [ "O. Akhavan", "E. Ghaderi" ],
      "venue" : "Small",
      "citeRegEx" : "153",
      "shortCiteRegEx" : "153",
      "year" : 2013
    }, {
      "title" : "Graphene oxide nanoparticles as a nonbleaching optical probe for two-photon luminescence imaging and cell therapy",
      "author" : [ "J.L. Li", "H.C. Bao", "X.L. Hou", "L. Sun", "X.G. Wang", "M. Gu" ],
      "venue" : "Angew. Chem. Int. Edn",
      "citeRegEx" : "154",
      "shortCiteRegEx" : "154",
      "year" : 2012
    }, {
      "title" : "One-pot synthesis of multifunctional Au@ graphene oxide nanocolloid Core@ shell nanoparticles for raman bioimaging",
      "author" : [ "Y.K. Kim", "H.K. Na", "S. Kim", "H. Jang", "S.J. Chang", "D.H. Min" ],
      "venue" : "Photothermal and Photodynamic Therapy,",
      "citeRegEx" : "155",
      "shortCiteRegEx" : "155",
      "year" : 2015
    }, {
      "title" : "Magnetic graphene-based nanotheranostic agent for dual-modality mapping guided photothermal therapy in regional lymph nodal metastasis of pancreatic cancer, Biomaterials",
      "author" : [ "S. Wang", "Q. Zhang", "X.F. Luo", "J. Li", "H. He", "F. Yang" ],
      "venue" : null,
      "citeRegEx" : "156",
      "shortCiteRegEx" : "156",
      "year" : 2014
    }, {
      "title" : "Dye-enhanced graphene oxide for photothermal therapy and photoacoustic imaging",
      "author" : [ "Y.-W. Wang", "Y.-Y. Fu", "Q. Peng", "S.-S. Guo", "G. Liu", "J. Li" ],
      "venue" : "J. Mater. Chem. B",
      "citeRegEx" : "157",
      "shortCiteRegEx" : "157",
      "year" : 2013
    }, {
      "title" : "Protein-assisted fabrication of nano-reduced graphene oxide for combined in vivo photoacoustic imaging and photothermal therapy, Biomaterials",
      "author" : [ "Z. Sheng", "L. Song", "J. Zheng", "D. Hu", "M. He", "M. Zheng" ],
      "venue" : null,
      "citeRegEx" : "158",
      "shortCiteRegEx" : "158",
      "year" : 2013
    }, {
      "title" : "Graphene oxide-BaGdF 5 nanocomposites for multi-modal imaging and photothermal therapy, Biomaterials",
      "author" : [ "H. Zhang", "H. Wu", "J. Wang", "Y. Yang", "D. Wu", "Y. Zhang" ],
      "venue" : null,
      "citeRegEx" : "159",
      "shortCiteRegEx" : "159",
      "year" : 2015
    }, {
      "title" : "Graphene-based magnetic plasmonic nanocomposite for dual bioimaging and photothermal therapy, Biomaterials",
      "author" : [ "X. Shi", "H. Gong", "Y. Li", "C. Wang", "L. Cheng", "Z. Liu" ],
      "venue" : null,
      "citeRegEx" : "160",
      "shortCiteRegEx" : "160",
      "year" : 2013
    }, {
      "title" : "Multimodal imaging guided photothermal therapy using functionalized graphene nanosheets anchored with magnetic nanoparticles",
      "author" : [ "K. Yang", "L. Hu", "X. Ma", "S. Ye", "L. Cheng", "X. Shi" ],
      "venue" : "Adv. Mater",
      "citeRegEx" : "161",
      "shortCiteRegEx" : "161",
      "year" : 2012
    }, {
      "title" : "Graphene oxide modi ̄ed PLA microcapsules containing gold nanoparticles for ultrasonic/CT bimodal imaging guided photothermal tumor therapy, Biomaterials",
      "author" : [ "Y. Jin", "J. Wang", "H. Ke", "S. Wang", "Z. Dai" ],
      "venue" : null,
      "citeRegEx" : "162",
      "shortCiteRegEx" : "162",
      "year" : 2013
    }, {
      "title" : "Photosensitizer loaded nano-graphene for multimodality imaging guided tumor photodynamic therapy, Theranostics",
      "author" : [ "P. Rong", "K. Yang", "A. Srivastan", "D.O. Kiesewetter", "X. Yue", "F. Wang" ],
      "venue" : null,
      "citeRegEx" : "163",
      "shortCiteRegEx" : "163",
      "year" : 2014
    }, {
      "title" : "Optical and photoacoustic dual-modality imaging guided synergistic photodynamic/photothermal therapies, Nanoscale",
      "author" : [ "X. Yan", "H. Hu", "J. Lin", "A.J. Jin", "G. Niu", "S. Zhang" ],
      "venue" : null,
      "citeRegEx" : "164",
      "shortCiteRegEx" : "164",
      "year" : 2015
    }, {
      "title" : "Magnetic and °uorescent graphene for dual modal imaging and single light induced photothermal and photodynamic therapy of cancer",
      "author" : [ "G. Gollavelli", "Y.-C. Ling" ],
      "venue" : "cells, Biomaterials",
      "citeRegEx" : "165",
      "shortCiteRegEx" : "165",
      "year" : 2014
    }, {
      "title" : "Fabrication of graphene-isolated-Au-nanocrystal nanostructures for multimodal cell imaging and photothermal-enhanced chemotherapy",
      "author" : [ "X. Bian", "Z.-L. Song", "Y. Qian", "W. Gao", "Z.-Q. Cheng", "L. Chen" ],
      "venue" : null,
      "citeRegEx" : "166",
      "shortCiteRegEx" : "166",
      "year" : 2014
    }, {
      "title" : "A tumor-targeting near-infrared laser-triggered drug delivery system based on GO@ Ag nanoparticles for chemo-photothermal therapy and X-ray imaging, Biomaterials",
      "author" : [ "J. Shi", "L. Wang", "J. Zhang", "R. Ma", "J. Gao", "Y. Liu" ],
      "venue" : null,
      "citeRegEx" : "167",
      "shortCiteRegEx" : "167",
      "year" : 2014
    }, {
      "title" : "MRI-visualized, dualtargeting, combined tumor therapy using magnetic graphene-based mesoporous silica",
      "author" : [ "Y. Wang", "R. Huang", "G. Liang", "Z. Zhang", "P. Zhang", "S. Yu" ],
      "venue" : null,
      "citeRegEx" : "168",
      "shortCiteRegEx" : "168",
      "year" : 2014
    }, {
      "title" : "Photothermally enhanced drug delivery by ultrasmall multifunctional FeCo/graphitic shell nanocrystals",
      "author" : [ "S.P. Sherlock", "S.M. Tabakman", "L. Xie", "H. Dai" ],
      "venue" : "ACS Nano",
      "citeRegEx" : "169",
      "shortCiteRegEx" : "169",
      "year" : 2011
    } ],
    "referenceMentions" : [ {
      "referenceID" : 3,
      "context" : "Graphene is a two-dimensional (2D) nanomaterial having a monoatomic layer of sp2 hybridized carbon atoms organized in the form of a honeycomb lattice.(5) Synthesis of graphene oxide (GO) and reduced graphene oxide (rGO) have been made possible with the development of new synthesis methods that have further enhanced interest in this material speci ̄cally in the biomedical  ̄eld due to the incorporation of new features and novel properties in these derivatives (Fig.",
      "startOffset" : 150,
      "endOffset" : 153
    }, {
      "referenceID" : 3,
      "context" : "Additionally, these materials also provide a distribution of delocalized electrons on the surface giving it an aromatic character, that help in increasing the loading and binding e±ciency of graphene-based nanomaterials with other molecules of therapeutic interest through hydrophobic interactions and – stacking.(5) The synthesis procedures of GO introduce wide variety of oxygen containing functional groups like carboxyl, hydroxyl, carbonyl, ethoxy, epoxy, etc.",
      "startOffset" : 313,
      "endOffset" : 316
    }, {
      "referenceID" : 3,
      "context" : "This also provides easy functionalization and derivatization of these materials through both covalent and non-covalent modi ̄cations with di®erent biocompatible polymers like PEG, chitosan and conjugation with targeting moieties like peptides and antibodies, to develop biofunctionalized nanocomposite systems with improved biological properties.(5,8,9) Apart from these surface properties, GO and rGO also possess exciting intrinsic optical properties like photoluminescence and increased absorbance in the near-infrared region (NIR) of electromagnetic spectrum, that make them excellent photo-responsive agents for cancer therapies like photothermal therapy (PTT) and photodynamic therapy (PDT).",
      "startOffset" : 346,
      "endOffset" : 353
    }, {
      "referenceID" : 5,
      "context" : "This also provides easy functionalization and derivatization of these materials through both covalent and non-covalent modi ̄cations with di®erent biocompatible polymers like PEG, chitosan and conjugation with targeting moieties like peptides and antibodies, to develop biofunctionalized nanocomposite systems with improved biological properties.(5,8,9) Apart from these surface properties, GO and rGO also possess exciting intrinsic optical properties like photoluminescence and increased absorbance in the near-infrared region (NIR) of electromagnetic spectrum, that make them excellent photo-responsive agents for cancer therapies like photothermal therapy (PTT) and photodynamic therapy (PDT).",
      "startOffset" : 346,
      "endOffset" : 353
    }, {
      "referenceID" : 6,
      "context" : "This also provides easy functionalization and derivatization of these materials through both covalent and non-covalent modi ̄cations with di®erent biocompatible polymers like PEG, chitosan and conjugation with targeting moieties like peptides and antibodies, to develop biofunctionalized nanocomposite systems with improved biological properties.(5,8,9) Apart from these surface properties, GO and rGO also possess exciting intrinsic optical properties like photoluminescence and increased absorbance in the near-infrared region (NIR) of electromagnetic spectrum, that make them excellent photo-responsive agents for cancer therapies like photothermal therapy (PTT) and photodynamic therapy (PDT).",
      "startOffset" : 346,
      "endOffset" : 353
    }, {
      "referenceID" : 3,
      "context" : "Apart from these surface properties, GO and rGO also possess exciting intrinsic optical properties like photoluminescence and increased absorbance in the near-infrared region (NIR) of electromagnetic spectrum, that make them excellent photo-responsive agents for cancer therapies like photothermal therapy (PTT) and photodynamic therapy (PDT).(5) Similar to plasmonic nanomaterials, GO and rGO show photothermal conversion properties in response to NIR irradiation that has been widely explored as a therapeutic strategy for treating cancers.",
      "startOffset" : 343,
      "endOffset" : 346
    }, {
      "referenceID" : 3,
      "context" : "presence of more defects and greater aromaticity in its structure that are introduced into it during reduction of GO.(5) Owing to these excellent physicochemical and biocompatible properties, graphene-based nanomaterials have found a wide variety of applications in the  ̄eld of biomedicine, mostly in cancer research, ranging from serving as nanocarriers and photoagents for drug/gene delivery to cancer cells and for photothermal and photodynamic therapies of cancer, both in vitro and in vivo, till its use as bioimaging agents for developing multifunctional theranostic platforms for carrying out more e±cient detection and treatment of cancers.",
      "startOffset" : 117,
      "endOffset" : 120
    }, {
      "referenceID" : 7,
      "context" : "Owing to these excellent physicochemical and biocompatible properties, graphene-based nanomaterials have found a wide variety of applications in the  ̄eld of biomedicine, mostly in cancer research, ranging from serving as nanocarriers and photoagents for drug/gene delivery to cancer cells and for photothermal and photodynamic therapies of cancer, both in vitro and in vivo, till its use as bioimaging agents for developing multifunctional theranostic platforms for carrying out more e±cient detection and treatment of cancers.(10) In this review, we provide a detailed and systematic description of the journey that graphene-based nanomaterials have undertaken in the  ̄eld of biomedical sciences in the last decade by discussing the di®erent applications in drug delivery, gene delivery, phototherapy, bioimaging and theranostics.",
      "startOffset" : 528,
      "endOffset" : 532
    }, {
      "referenceID" : 7,
      "context" : "In the recent years, graphene-based nanomaterials such as GO and rGO have emerged as excellent nanocarriers for drug delivery owing to their structural and surface properties that make them very suitable for biomedical applications.(10,11) The monolayer 2D structure of GO and rGO provide ultrahigh speci ̄c surface area and delocalized electrons on the surface that allow highly e±cient loading of hydrophobic anti-cancer drugs through hydrophobic interactions and – stacking, and also provide di®erent oxygen containing functional groups for easy biofunctionalization.",
      "startOffset" : 232,
      "endOffset" : 239
    }, {
      "referenceID" : 8,
      "context" : "In the recent years, graphene-based nanomaterials such as GO and rGO have emerged as excellent nanocarriers for drug delivery owing to their structural and surface properties that make them very suitable for biomedical applications.(10,11) The monolayer 2D structure of GO and rGO provide ultrahigh speci ̄c surface area and delocalized electrons on the surface that allow highly e±cient loading of hydrophobic anti-cancer drugs through hydrophobic interactions and – stacking, and also provide di®erent oxygen containing functional groups for easy biofunctionalization.",
      "startOffset" : 232,
      "endOffset" : 239
    }, {
      "referenceID" : 13,
      "context" : "in 2008.(16) They used PEGylated GO to load a hydrophobic Graphene-Based Nanomaterials for Theranostic Applications",
      "startOffset" : 8,
      "endOffset" : 12
    }, {
      "referenceID" : 14,
      "context" : "also showed highly e±cient loading and delivery of another very commonly used hydrophobic cancer drug, doxorubicin using GO as a nanocarrier.(17) To further improve the therapeutic e±ciency, Zhang et al.",
      "startOffset" : 141,
      "endOffset" : 145
    }, {
      "referenceID" : 15,
      "context" : "loaded both doxorubicin and camptothecin onto GO sheets and demonstrated e±cient killing of MCF-7 breast cancer cells by combining the e±cacies of both drugs into a single platform.(18) Moore et al.",
      "startOffset" : 181,
      "endOffset" : 185
    }, {
      "referenceID" : 16,
      "context" : "using biodegradable polylactic acid (PLA) coated nanographene (nGr) functionalized with PEG (nGr-PLA-PEG) as a biocompatible drug delivery system.(19)",
      "startOffset" : 146,
      "endOffset" : 150
    }, {
      "referenceID" : 17,
      "context" : "In a recent study, PEGylated GO was used as a nanocarrier for the delivery of PTX to A549 human lung cancer cells and MCF-7 breast cancer cells in vitro.(20) PTX was ̄rst attached to a 6-armed PEG which was then covalently conjugated to GO sheets.",
      "startOffset" : 153,
      "endOffset" : 157
    }, {
      "referenceID" : 18,
      "context" : "reported the synthesis of folic acid decorated, polydopamine capped GO nanocomposites by a one-pot method and demonstrated targeted delivery of doxorubicin to cancer cells in vitro with high therapeutic e±ciency.(22) Cholesteryl hyaluronic acid (HA) conjugated GO loaded with doxorubicin was developed by Miao et al.",
      "startOffset" : 212,
      "endOffset" : 216
    }, {
      "referenceID" : 19,
      "context" : "for targeted delivery of doxorubicin to KB epidermal carcinoma cells both in in vitro and in vivo.(23) In vitro studies showed that the targeted nanocomposite induced 40.",
      "startOffset" : 98,
      "endOffset" : 102
    }, {
      "referenceID" : 20,
      "context" : "In another study, HA was linked to GO via an adipic acid dihydrazide (ADH) linkage to form HA tagged GO-based targeted drug delivery system that was used for delivering doxorubicin to mice with subcutaneous HeLa tumors.(24) Within 16 days, the targeted nanocomposites showed 12% and 17% greater tumor inhibition rates as compared to free doxorubicin and non-targeted nanocomposites, respectively.",
      "startOffset" : 219,
      "endOffset" : 223
    }, {
      "referenceID" : 21,
      "context" : "synthesized Tf conjugated PEGylated nanographene oxide composites loaded with doxorubicin (Tf-PEG-GODox) for targeted delivery of drug to glioma cells.(25) The nanocomposites showed a drug loading ratio of up to 115.",
      "startOffset" : 151,
      "endOffset" : 155
    }, {
      "referenceID" : 22,
      "context" : ", where they conjugated GO with chlorotoxin (CTX-GO) as the targeting agent for selective delivery of doxorubicin to glioma cells.(26) Chlorotoxin is a toxin derived from Leiurus quinquestriatus having high a±nity for matrix-metalloprotease-2 proteins that are known to be overexpressed in gliomas.",
      "startOffset" : 130,
      "endOffset" : 134
    }, {
      "referenceID" : 23,
      "context" : "(apurinic endonuclease-1 (APE-1) inhibitor) to EGFR over-expressing glioblastoma multiforme cells in culture.(28,29) Lucathone-GONR nanocomposites showed signi ̄cant cytotoxicity against glioblastoma multiforme cells but demonstrated no toxicity to EGFR negative glial precursor cells, thereby showing the speci ̄city of GONRs as a novel drug delivery system.",
      "startOffset" : 109,
      "endOffset" : 116
    }, {
      "referenceID" : 24,
      "context" : "(apurinic endonuclease-1 (APE-1) inhibitor) to EGFR over-expressing glioblastoma multiforme cells in culture.(28,29) Lucathone-GONR nanocomposites showed signi ̄cant cytotoxicity against glioblastoma multiforme cells but demonstrated no toxicity to EGFR negative glial precursor cells, thereby showing the speci ̄city of GONRs as a novel drug delivery system.",
      "startOffset" : 109,
      "endOffset" : 116
    }, {
      "referenceID" : 25,
      "context" : "reported a pH-sensitive composite hydrogel consisting of GO and poly (vinyl alcohol) (GO/PVA) that showed pH-responsive gel–sol transition properties, thereby allowing e±cient loading and release of drugs at di®erent pH conditions.(30) Depan et al.",
      "startOffset" : 231,
      "endOffset" : 235
    }, {
      "referenceID" : 26,
      "context" : "developed a doxorubicin loaded GO-chitosan-FA nanocomposite (DOX-GO-CH-FA) and studied its drug release properties in response to di®erent pH values.(31) It was observed that the nanocomposites showed higher and faster release of DOX at an acidic pH than physiological pH, and also showed morphological transition from non-porous to porous structure after drug release.",
      "startOffset" : 149,
      "endOffset" : 153
    }, {
      "referenceID" : 27,
      "context" : "which showed good loading of a poorly water soluble anti-cancer drug ellagic acid and increased release pro ̄les at acidic pH.(32) In an interesting study by Wu et al.",
      "startOffset" : 126,
      "endOffset" : 130
    }, {
      "referenceID" : 28,
      "context" : "as highly e±cient physiologically stable pH responsive drug delivery system, that showed excellent DOX loading capacity and acidic pH stimulated controlled release of the drug.(34) Fan et al.",
      "startOffset" : 176,
      "endOffset" : 180
    }, {
      "referenceID" : 29,
      "context" : "reported the synthesis of a graphene–CNT– Fe3O4 nanoparticle hybrid (GN-CNT-Fe3O4Þ and showed its pH-dependent drug release properties.(35) 5-FU loaded GN-CNT-Fe3O4 nanohybrids showed high toxicity against HepG2 cells in vitro.",
      "startOffset" : 135,
      "endOffset" : 139
    }, {
      "referenceID" : 30,
      "context" : "comprising of HA linked GO nanosheets that showed an acidic pH responsive DOX release property, which caused 17% higher tumor inhibition in H22 hepatic carcinoma cell tumors in mice as compared to only GO loaded DOX groups.(36) In addition to these studies, there are several other reports on the development of pH responsive graphene-based drug delivery systems that further highlight the potential and importance of graphene-based nanomaterials in drug delivery.",
      "startOffset" : 223,
      "endOffset" : 227
    }, {
      "referenceID" : 34,
      "context" : "exploited the high levels of glutathione (GSH) in cancer cells and tumors as a stimulus to induce drug release and developed a NGO-based drug delivery system consisting of a redox-responsive PEG shell attached to NGO sheets via disul ̄de linkages.(40) In presence of GSH in the environment, the PEG shells got detached from the system due to disul ̄de bond breakage and caused 1.",
      "startOffset" : 247,
      "endOffset" : 251
    }, {
      "referenceID" : 35,
      "context" : "Another study reported GSH-triggered anti-cancer drug release from PEGylated graphene oxide (PEG-GO) nanocarriers, both in in vitro and in vivo.(41)",
      "startOffset" : 144,
      "endOffset" : 148
    }, {
      "referenceID" : 36,
      "context" : "using PEG and BPEI dual polymer functionalized rGO nanosheets (PEG-BPEI-rGO).(42) The PEG-BPEI-rGO nanocomposites showed high drug loading e±ciency with absorbance in the NIR region.",
      "startOffset" : 77,
      "endOffset" : 81
    }, {
      "referenceID" : 37,
      "context" : "who synthesized graphene/Fe3O4 composites through a simple one-pot solvothermal process.(43) These graphene/Fe3O4 composites showed good water dispersibility alongwith excellent magnetic properties ideal for a magnetically guided drug delivery system.",
      "startOffset" : 88,
      "endOffset" : 92
    }, {
      "referenceID" : 38,
      "context" : "reported the synthesis of Fe3O4 nano°owers encapsulated in graphene nanosheets (Fe3O4/GNS) and demonstrated the feasibility of these nanocomposites to be used as drug delivery systems under the in°uence of an external magnetic  ̄eld by loading Rhodamine B onto them with a high loading e±ciency.(44) Apart from magnetic  ̄eld, electric  ̄eld can also be used as a stimulus to control drug delivery.",
      "startOffset" : 295,
      "endOffset" : 299
    }, {
      "referenceID" : 39,
      "context" : "reported the development of an electrically modulated drug delivery system comprising of rGO sheets embedded in a matrix of PVA, forming a hydrogel.(45) Lidocaine hydrochloride was loaded into this hydrogel as a model drug and its release properties were studied under the in°uence of an external electric  ̄eld.",
      "startOffset" : 148,
      "endOffset" : 152
    }, {
      "referenceID" : 40,
      "context" : "The most sought after vectors for carrying out e±cient gene delivery to cells, both in vitro and in vivo have been viral vectors because of their very high transfection e±ciency.(46) However, concerns related to the safety and biocompatibility of these viral vectors such as chances of random genomic integration, activation of oncogenes, stimulation of unwanted immune response in the host and re-activation of the inactivated viruses have limited the large scale application and clinical translation of these vectors for gene therapy.",
      "startOffset" : 178,
      "endOffset" : 182
    }, {
      "referenceID" : 40,
      "context" : "However, concerns related to the safety and biocompatibility of these viral vectors such as chances of random genomic integration, activation of oncogenes, stimulation of unwanted immune response in the host and re-activation of the inactivated viruses have limited the large scale application and clinical translation of these vectors for gene therapy.(46) So, for the development of safer vectors, researchers have moved towards non-viral approaches of gene delivery.",
      "startOffset" : 353,
      "endOffset" : 357
    }, {
      "referenceID" : 41,
      "context" : "The structural, optical and biocompatible properties of graphene and its derivatives such as GO and rGO have raised a lot of interest in this material in the recent years, that have led to studies related to the synthesis and development of non-viral vectors using graphene-based materials as a novel carrier system for gene delivery.(48)",
      "startOffset" : 334,
      "endOffset" : 338
    }, {
      "referenceID" : 3,
      "context" : "Small size, high surface area to mass ratio, easy surface functionalization, ability to load and condense nucleic acids even in the absence of cationic groups through – interactions, protection of nucleic acids from endonuclease digestion, high cellular uptake and low toxicity has made graphene and its derivatives a suitable candidate for gene delivery.(5) The ease of functionalization of these materials with cationic polymers and targeting moieties to improve their biocompatibility, nucleic acid S.",
      "startOffset" : 355,
      "endOffset" : 358
    }, {
      "referenceID" : 3,
      "context" : "loading e±ciency and overall therapeutic e±cacy is due to the presence of numerous oxygen containing functional groups on the surface of these materials that allow for easy conjugation and derivatization.(5,8) Covalent and non-covalent functionalization of GO and rGO nanosheets with cationic polymers like polyethylenimine (PEI), polysaccharides like chitosan and dendrimers such as polyamidoamine (PAMAM) have been carried out to develop nanoconstructs with improved nucleic acid binding e±ciency and physiological stability for achieving better transfection and therapeutic outcomes.",
      "startOffset" : 204,
      "endOffset" : 209
    }, {
      "referenceID" : 5,
      "context" : "loading e±ciency and overall therapeutic e±cacy is due to the presence of numerous oxygen containing functional groups on the surface of these materials that allow for easy conjugation and derivatization.(5,8) Covalent and non-covalent functionalization of GO and rGO nanosheets with cationic polymers like polyethylenimine (PEI), polysaccharides like chitosan and dendrimers such as polyamidoamine (PAMAM) have been carried out to develop nanoconstructs with improved nucleic acid binding e±ciency and physiological stability for achieving better transfection and therapeutic outcomes.",
      "startOffset" : 204,
      "endOffset" : 209
    }, {
      "referenceID" : 5,
      "context" : "Covalent and non-covalent functionalization of GO and rGO nanosheets with cationic polymers like polyethylenimine (PEI), polysaccharides like chitosan and dendrimers such as polyamidoamine (PAMAM) have been carried out to develop nanoconstructs with improved nucleic acid binding e±ciency and physiological stability for achieving better transfection and therapeutic outcomes.(8,48) The cationic molecules provide a net positive charge on the surface of the nanoconstructs that help in improving the nucleic acid condensation e±ciency through electrostatic interactions.",
      "startOffset" : 376,
      "endOffset" : 382
    }, {
      "referenceID" : 41,
      "context" : "Covalent and non-covalent functionalization of GO and rGO nanosheets with cationic polymers like polyethylenimine (PEI), polysaccharides like chitosan and dendrimers such as polyamidoamine (PAMAM) have been carried out to develop nanoconstructs with improved nucleic acid binding e±ciency and physiological stability for achieving better transfection and therapeutic outcomes.(8,48) The cationic molecules provide a net positive charge on the surface of the nanoconstructs that help in improving the nucleic acid condensation e±ciency through electrostatic interactions.",
      "startOffset" : 376,
      "endOffset" : 382
    }, {
      "referenceID" : 42,
      "context" : "also demonstrated real-time biosensing of ATP in JB6 cells using an aptamer/GO nanocomplex.(50) Apart from mRNA and biomolecule sensing, PEI grafted graphene nanoribbons (PEI-GNR) loaded with MB were also used as molecular probes by Dong et al.",
      "startOffset" : 91,
      "endOffset" : 95
    }, {
      "referenceID" : 43,
      "context" : "for sensing of miR-21 in cells.(51) The PEI-GNR showed more e±cient delivery of MB as compared to PEI-MWCNTs and PEI alone.",
      "startOffset" : 31,
      "endOffset" : 35
    }, {
      "referenceID" : 44,
      "context" : "In a follow up study by the same group, the authors developed a multifunctional poly (L-lactide)-Polyethylene glycol-grafted graphene quantum dot-based platform for intracellular sensing of miR-21 combined with °uorescent tracking of the internalization of the complexes using GQDs.(52) Graphene-Based Nanomaterials for Theranostic Applications",
      "startOffset" : 282,
      "endOffset" : 286
    }, {
      "referenceID" : 45,
      "context" : "used GO sheets covalently functionalized with BPEI as a gene delivery tool for delivering plasmid DNA encoding EGFP to HeLa cells.(53) Similarly, in another study, Kim et al.",
      "startOffset" : 130,
      "endOffset" : 134
    }, {
      "referenceID" : 46,
      "context" : "used PEI functionalized GO sheets for delivering luciferase gene into cells for bioimaging applications.(54) Several other studies utilized this PEI-GO (iii) mRNA Delivery",
      "startOffset" : 104,
      "endOffset" : 108
    }, {
      "referenceID" : 51,
      "context" : ", who independently showed that the transfection e±ciency of graphene-based nanovectors could be improved signi ̄cantly by exploiting the NIR responsive photothermal properties of GO and rGO at the time of transfection.(59,60) Feng and co-workers developed a PEG-PEI dual polymer functionalized nGO-based composite (NGOPEG-PEI) and demonstrated highly e±cient and greater EGFP transfection e±ciency as compared to GO-PEI and PEI alone, in presence of low power NIR irradiation due to the localized photothermal heating that enhanced the cellular uptake of the nanocarriers as a result of increased cell membrane permeability, without inducing any cytotoxicity.",
      "startOffset" : 219,
      "endOffset" : 226
    }, {
      "referenceID" : 52,
      "context" : ", who independently showed that the transfection e±ciency of graphene-based nanovectors could be improved signi ̄cantly by exploiting the NIR responsive photothermal properties of GO and rGO at the time of transfection.(59,60) Feng and co-workers developed a PEG-PEI dual polymer functionalized nGO-based composite (NGOPEG-PEI) and demonstrated highly e±cient and greater EGFP transfection e±ciency as compared to GO-PEI and PEI alone, in presence of low power NIR irradiation due to the localized photothermal heating that enhanced the cellular uptake of the nanocarriers as a result of increased cell membrane permeability, without inducing any cytotoxicity.",
      "startOffset" : 219,
      "endOffset" : 226
    }, {
      "referenceID" : 51,
      "context" : "Feng and co-workers developed a PEG-PEI dual polymer functionalized nGO-based composite (NGOPEG-PEI) and demonstrated highly e±cient and greater EGFP transfection e±ciency as compared to GO-PEI and PEI alone, in presence of low power NIR irradiation due to the localized photothermal heating that enhanced the cellular uptake of the nanocarriers as a result of increased cell membrane permeability, without inducing any cytotoxicity.(59) They further utilized this nanocarrier for siRNA delivery into cells and demonstrated enhanced downregulation of the target gene (Plk1) in presence of NIR laser mediated transfection.",
      "startOffset" : 433,
      "endOffset" : 437
    }, {
      "referenceID" : 53,
      "context" : "These substrates showed gradual release of the PEI/pDNA complexes which resulted in transfection of the cells being cultured on those substrates.(61) In a remarkable study conducted by Khademhosseini and group, PEI functionalized GO nanosheets (fGO) incorporated in methacrylated gelatin (GelMA) hydrogel was used as a carrier (fGOVEGF/GelMA) for vascular endothelial growth factor-165 (VEGF) gene delivery for myocardial therapy.",
      "startOffset" : 145,
      "endOffset" : 149
    }, {
      "referenceID" : 54,
      "context" : "In a remarkable study conducted by Khademhosseini and group, PEI functionalized GO nanosheets (fGO) incorporated in methacrylated gelatin (GelMA) hydrogel was used as a carrier (fGOVEGF/GelMA) for vascular endothelial growth factor-165 (VEGF) gene delivery for myocardial therapy.(62) In a rat model of myocardial infarction, the fGOVEGF/GelMA hydrogels were injected intramyocardially in the peri-infarcted regions, which showed a signi ̄cant increase in the microcapillary density in the infarcted region alongwith a reduction in scar area and improvement in cardiac function as compared to controls, without invoking any in°ammatory and toxic responses in the host.",
      "startOffset" : 280,
      "endOffset" : 284
    }, {
      "referenceID" : 55,
      "context" : ", GO-PEI nanocomposites were exploited for the  ̄rst time as mRNA delivery vectors for the generation of \\footprint-free\" induced pluripotent stem cells (iPSCs).(63) Footprint-free iPSCs are very important from a clinical point of view because their creation do not involve genomic integration of the reprogramming factor genes, thereby minimizing the risk of insertional mutagenesis in humans.",
      "startOffset" : 161,
      "endOffset" : 165
    }, {
      "referenceID" : 56,
      "context" : "Two very recent works demonstrated the application of GO-PEI complexes as mRNA and gene delivery vectors for direct reprogramming of human somatic cells into cells of neural and mesodermal lineage.(64,65) Baek et al.",
      "startOffset" : 197,
      "endOffset" : 204
    }, {
      "referenceID" : 57,
      "context" : "Two very recent works demonstrated the application of GO-PEI complexes as mRNA and gene delivery vectors for direct reprogramming of human somatic cells into cells of neural and mesodermal lineage.(64,65) Baek et al.",
      "startOffset" : 197,
      "endOffset" : 204
    }, {
      "referenceID" : 56,
      "context" : "3 (iii)).(64) In another study, Chiang et al.",
      "startOffset" : 9,
      "endOffset" : 13
    }, {
      "referenceID" : 57,
      "context" : "GO-Fe3O4-PEI complexes carrying three episomal plasmids encoding pluripotent related factors via a process of combined magnetic stirring and photothermal stimulation to enhance the transfection e±ciencies of the complexes in suspension culture.(65) The transfected PBMCs were reprogrammed into iPSCs, which rapidly transdi®erentiated into mesodermal lineages without full reprogramming.",
      "startOffset" : 244,
      "endOffset" : 248
    }, {
      "referenceID" : 58,
      "context" : "for delivering luciferase gene into HeLa cells.(66) However, the transfection e±ciency of such vectors was not found to be as high as PEI.",
      "startOffset" : 47,
      "endOffset" : 51
    }, {
      "referenceID" : 59,
      "context" : "developed a PAMAM and oleic acid functionalized GO nanocomposite and demonstrated transfection of HeLa and MG63  ̄broblast cells with luciferase gene at a high transfection e±ciency.(67) These composites also showed good physiological stability.",
      "startOffset" : 182,
      "endOffset" : 186
    }, {
      "referenceID" : 60,
      "context" : "used GO-PEI nanocomplex for delivering GFP expressing pDNA to cells in culture and using the same vector delivered a anti-GFP siRNA 3 h later.(68) The authors reported 70% knockdown in the °uorescence levels.",
      "startOffset" : 142,
      "endOffset" : 146
    }, {
      "referenceID" : 61,
      "context" : "recently demonstrated suppression in cancer cell migration through e±cient knockdown of CXCR4 gene using anti-CXCR4 siRNA, which is strongly upregulated in cancer metastasis.(69) In another recent study, Imani et al.",
      "startOffset" : 174,
      "endOffset" : 178
    }, {
      "referenceID" : 62,
      "context" : "reported the synthesis of a rGO-based nanocarrier functionalized with phospholipid-PEG and conjugated with a cell penetrating peptide octarginine.(70)",
      "startOffset" : 146,
      "endOffset" : 150
    }, {
      "referenceID" : 63,
      "context" : "Photothermal therapy is a widely exploited non-invasive cancer therapy procedure that involves the absorption of light of a particular wavelength especially NIR by nanomaterials or dyes or a combination of both, which are capable of converting this light energy into heat for photothermal killing or ablation of cancer cells and tumors, both in in vitro and in vivo.(71) Large surface area, presence of sp2 clusters on the crystal lattice, strong absorption in the NIR region and small size have made both GO and S.",
      "startOffset" : 366,
      "endOffset" : 370
    }, {
      "referenceID" : 64,
      "context" : "rGO to act as excellent photothermal agents in response to NIR irradiation and generate heat through plasmonic photothermal conversion.(72) The NIR absorbance of rGO has been found to be six times more as compared to GO because of the highly intact aromatic structure of rGO created during reduction process.",
      "startOffset" : 135,
      "endOffset" : 139
    }, {
      "referenceID" : 65,
      "context" : "GO and rGO have been used as sca®olds or carriers for loading and delivering these photosensitizers into cancer cells and tissues for photodynamic cancer therapy.(73) The presence of oxygen containing functional groups on both surfaces of GO nanosheets make them ideal platforms for highly e±cient loading of hydrophobic as well as hydrophilic photosensitizer molecules through several non-covalent interactions such as – interactions, hydrophobic interactions, hydrogen bonding and electrostatic interactions.",
      "startOffset" : 162,
      "endOffset" : 166
    }, {
      "referenceID" : 66,
      "context" : "The Liu group was the  ̄rst to report the photothermal properties of PEGylated nano-GO in a tumor model of mice.(74) The group demonstrated that nGO-PEG exhibited enhanced absorption in the NIR region and caused complete photothermal ablation of tumors in mice, intravenously injected with the nanocomposites in response to NIR irradiation.",
      "startOffset" : 112,
      "endOffset" : 116
    }, {
      "referenceID" : 67,
      "context" : "reported the use of rGO as a photothermal agent for the  ̄rst time and showed that non-covalently PEGylated nanosized rGO sheets were more e±cient in the photothermal conversion as compared to covalently PEGylated GO sheets.(75) The group demonstrated targeted photothermal ablation of U87MG cancer cells in vitro by using RGD peptide tagged PEGylated nano-rGO in response to NIR irradiation.",
      "startOffset" : 224,
      "endOffset" : 228
    }, {
      "referenceID" : 68,
      "context" : "that noncovalently PEGylated nanosized reduced graphene oxide sheets were more e±cient in the photothermal conversion as compared to covalently PEGylated GO sheets.(76) In their study, Liu and co-workers demonstrated 100% photothermal ablation of tumors in mice injected with nRGO-PEG and irradiated with a low-power NIR laser (0.",
      "startOffset" : 164,
      "endOffset" : 168
    }, {
      "referenceID" : 69,
      "context" : "reported a novel strategy for the synthesis of reduced graphene oxide by using glucose as both, reducing and functionalizing agent.(77) Graphene-Based Nanomaterials for Theranostic Applications",
      "startOffset" : 131,
      "endOffset" : 135
    }, {
      "referenceID" : 70,
      "context" : "exploited the NIR responsive photothermal properties of nano-GO sheets to induce dissociation of amyloid  ̄brils (A  ̄brils) by heat for the treatment of Alzhiemer's disease.(78) The benzothiazole dye Thio°avin S (ThS) which has an a±nity to selectively bind to A  ̄brils instead of A monomers was covalently linked to the nGO sheets resulting in the formation of GO–ThS–A , which upon irradiation with a low-power NIR laser showed dissociation of the A  ̄brils.",
      "startOffset" : 174,
      "endOffset" : 178
    }, {
      "referenceID" : 71,
      "context" : "In another study, green tea-rGO nanosheets (GT-rGO) were developed and used for the photothermal destruction of HT29 and SW48 colon cancer cells in vitro.(79) Hou et al.",
      "startOffset" : 154,
      "endOffset" : 158
    }, {
      "referenceID" : 72,
      "context" : "reported selective photothermal killing of cancer cells in vitro under visible light irradiation using water dispersible Cu2O nanocrystal-rGO hybrids as photothermal agents.(80) In order to enhance the photothermal properties of GO and rGO, several groups have reported the development of plasmonic Table 3.",
      "startOffset" : 173,
      "endOffset" : 177
    }, {
      "referenceID" : 73,
      "context" : "synthesized rGO coated plasmonic gold nanoshells and nanorods and demonstrated enhanced photothermal killing of cells in vitro as compared to non-coated or graphene oxidecoated gold nanoparticles.(81) The enhanced photothermal e±ciency of the nanocomposites can be attributed to the presence of plasmonic nanoparticles that signi ̄cantly enhanced the NIR absorption e±ciency of the nanocomposites.",
      "startOffset" : 196,
      "endOffset" : 200
    }, {
      "referenceID" : 74,
      "context" : "and used for photothermal therapy both in in vitro and in vivo.(82) The presence of AuNRs signi ̄cantly enhanced the NIR absorption e±ciency of the nanocomposites which resulted in 40% reduction in cell viability of A431 epidermoid carcinoma cells and also reduced tumor volumes in mice.",
      "startOffset" : 63,
      "endOffset" : 67
    }, {
      "referenceID" : 75,
      "context" : "using graphene oxide nanoparticles (GONs).(83) The GONs generated microbubbles upon exposure to femtosecond laser beam that facilitated the killing of cancer cells.",
      "startOffset" : 42,
      "endOffset" : 46
    }, {
      "referenceID" : 76,
      "context" : "reported photothermal ablation of skin cancer cells using hyaluronic acid conjugated nano GO sheets.(84) The NGO-HA conjugates were delivered transdermally to tumor tissues in the skin of mice, where they showed increased tumor uptake and resulted in complete destruction of the tumors in response to a NIR laser without any further recurrence of tumors (Fig.",
      "startOffset" : 100,
      "endOffset" : 104
    }, {
      "referenceID" : 77,
      "context" : "using zinc ferrite spinel (ZnFe2O4Þ-rGO nanocomposites (ZnFe2O4-rGO) for carrying out in vitro and in vivo photothermal destruction of prostate cancer cells and glioblastoma tumors, respectively, under the guidance of a magnetic  ̄eld.(85) An aptamergold nanoparticle-hybridized graphene oxide nanocomposite was developed by Yang et al.",
      "startOffset" : 235,
      "endOffset" : 239
    }, {
      "referenceID" : 78,
      "context" : "for targeted photothermal destruction of MCF-7 cells.(86) MCF-7 cells showed increased cellular uptake of the nanocomposites via speci ̄c interaction between MUC-1-binding aptamer and MUC-1 that are present on the cell membrane of MCF-7 cells.",
      "startOffset" : 53,
      "endOffset" : 57
    }, {
      "referenceID" : 79,
      "context" : "reported the synthesis of a novel pH-responsive graphene oxide-based photothermal agent for improved photothermal killing of cancer cells.(87) A cyanine dye (Cypate) was grafted onto the surface of GO, which participated in enhancing the photothermal properties of the composite via FRET in a pH-responsive manner.",
      "startOffset" : 138,
      "endOffset" : 142
    }, {
      "referenceID" : 80,
      "context" : "PDT using GO was reported for the  ̄rst time by Dong et al.(88) They used methoxy PEG conjugated nano graphene oxide (NGO-mPEG) as a platform for loading of a Graphene-Based Nanomaterials for Theranostic Applications",
      "startOffset" : 59,
      "endOffset" : 63
    }, {
      "referenceID" : 81,
      "context" : "reported the development of a targeted photodynamic agent by conjugating folic acid with GO sheets and loading it with the photosensitizer Chlorin e6 (Ce6).(89) The loading e±ciency of Ce6 was found to be 80%, with FA conjugation helping in increasing the accumulation of the nanocomposites in MGC803 cells.",
      "startOffset" : 156,
      "endOffset" : 160
    }, {
      "referenceID" : 82,
      "context" : "loaded HA and HB onto the surface of GO nanosheets (GO-HA and GO-HB) through hydrogen bonding and – interactions and observed improved stability of HA and HB as compared to their free forms in aqueous solutions.(90,91) Further, in vitro studies using these GO-HA and GO-HB nanocomposites demonstrated excellent photodynamic damage to cancer cells in response to light.",
      "startOffset" : 211,
      "endOffset" : 218
    }, {
      "referenceID" : 83,
      "context" : "loaded HA and HB onto the surface of GO nanosheets (GO-HA and GO-HB) through hydrogen bonding and – interactions and observed improved stability of HA and HB as compared to their free forms in aqueous solutions.(90,91) Further, in vitro studies using these GO-HA and GO-HB nanocomposites demonstrated excellent photodynamic damage to cancer cells in response to light.",
      "startOffset" : 211,
      "endOffset" : 218
    }, {
      "referenceID" : 84,
      "context" : "developed a GO/TiO2 hybrid and observed signi ̄cantly increased production of intracellular ROS by the GO/TiO2 hybrids when exposed to visible light.(92) The authors explained that this enhanced photodynamic activity of GO/TiO2 hybrids could be attributed to the excellent electrical conductivity of GO, which allowed the transfer of the photoelectrons generated by TiO2 in response to light to the surface of GO that ultimately reacted with oxygen to generate ROS.",
      "startOffset" : 149,
      "endOffset" : 153
    }, {
      "referenceID" : 85,
      "context" : "In another study by the same group, folic acid-conjugated grapheneZnO nanohybrid were synthesized for targeted PDT which showed e±cient generation of ROS in HeLa cells in response to visible light irradiation, that ultimately resulted in apoptosis.(93) Li et al.",
      "startOffset" : 248,
      "endOffset" : 252
    }, {
      "referenceID" : 86,
      "context" : "4(ii)).(94) Methylene blue (MB) loaded GO nanosheets have also been exploited as a PDT agent by Wojtoniszak et al.",
      "startOffset" : 7,
      "endOffset" : 11
    }, {
      "referenceID" : 87,
      "context" : "developed a simple platform consisting of PEGylated NGO sheets loaded with the anti-cancer drug doxorubicin and demonstrated e±cient killing of cancer cells both in vitro and in vivo.(96) The therapeutic e±ciency of the combined treatment strategy was found to be much higher as compared to chemotherapy and PTT alone.",
      "startOffset" : 183,
      "endOffset" : 187
    }, {
      "referenceID" : 88,
      "context" : "destruction of tumors.(97) Another targeted platform was developed by Yang et al.",
      "startOffset" : 22,
      "endOffset" : 26
    }, {
      "referenceID" : 89,
      "context" : "synthesized a highly e±cient chemo-photothermal therapeutic agent consisting of gold nanorods (AuNR) encapsulated in NGO shells and conjugated with hyaluronic acid for targeting.(99) The NGO-HA-AuNR nanocomposites demonstrated 1.",
      "startOffset" : 178,
      "endOffset" : 182
    }, {
      "referenceID" : 90,
      "context" : "synthesized mesoporous silica coated graphene nanosheets conjugated with a targeting peptide (IP) and loaded with DOX as a chemo-photothermal agent for targeted therapy of glioma.(100) The nanocomposites exhibited high drug loading e±ciency along with sustained release pro ̄les in response to both pH and NIR mediated heat.",
      "startOffset" : 179,
      "endOffset" : 184
    }, {
      "referenceID" : 91,
      "context" : "that comprised of amorphous carbon coated mesoporous silica self-assembled on a nanosheet of reduced graphene oxide.(101) These nanocookies were loaded with camptothecin and were used as novel chemo-photothermal agents for tumor treatment.",
      "startOffset" : 116,
      "endOffset" : 121
    }, {
      "referenceID" : 92,
      "context" : "as a chemo-photothermal agent.(102) Anti-cancer drugs could be e±ciently loaded into these nanocapsules and could be used for both in vitro and in vivo chemo-photothermal treatment of cancer with high therapeutic e±ciency.",
      "startOffset" : 30,
      "endOffset" : 35
    }, {
      "referenceID" : 98,
      "context" : "showed a synergistic chemo-PDT of cancer by using GO sheets co-loaded with the anti-cancer drug 7-ethyl-10-hydroxycamptothecin (SN-38) and photosensitizer HA and observed signi ̄cantly enhanced therapeutic e®ects of the combined therapy.(110) Graphene-Based Nanomaterials for Theranostic Applications",
      "startOffset" : 237,
      "endOffset" : 242
    }, {
      "referenceID" : 99,
      "context" : "downregulation of the Bcl-2 protein expression.(111) In addition to this, the PPGA nanocomposites showed enhanced photothermal activity in response to NIR irradiation as compared to PPG nanocomposites lacking the AuNPs, thereby making it also an e±cient photothermal agent.",
      "startOffset" : 47,
      "endOffset" : 52
    }, {
      "referenceID" : 100,
      "context" : "for the delivery of immunostimulatory oligonucleotides like CpG both in in vitro and in vivo.(112) It was observed that GO-PEG-PEI nanocomposites were successful in promoting the production of pro-in°ammatory cytokines as a response to CpGs.",
      "startOffset" : 93,
      "endOffset" : 98
    }, {
      "referenceID" : 101,
      "context" : ", PEGylated GO nanosheets have been used as a gene delivery vector for carrying out co-delivery of two siRNAs targeting the HDAC1 gene and the G12C mutant K-Ras gene in pancreatic cancer cells MIA PaCa-2.(113) The PEGylated GO nanosheets successfully delivered the siRNAs to the cancer cells in vitro which ultimately resulted in induction of apoptosis and cell cycle arrest in the cells.",
      "startOffset" : 204,
      "endOffset" : 209
    }, {
      "referenceID" : 102,
      "context" : "developed a treatment strategy to overcome multi-drug resistance (MDR) in breast cancer tumors through co-delivery of an anti-cancer drug with a MDR reversing agent such as miRNA.(114) PEI and poly (sodium 4-styrenesulfonates) (PSS) dual-polymer-functionalized GO nanocomposites (PPG) were synthesized and sequentially loaded with adriamycin (ADR) and anti-miRNA-21 to form (anti-miR21)-PPGADR nanocomplexes.",
      "startOffset" : 179,
      "endOffset" : 184
    }, {
      "referenceID" : 103,
      "context" : "In a very recent study, Zeng and co-workers developed a multifunctional PEI-PEG-GO delivery system conjugated with folic acid and co-loaded with a siRNA and Dox for carrying out targeted gene silencing combined with chemo-PTT of drug resistant tumors.(115) In the absence of NIR irradiation, the nanocomposites showed gene silencing mediated enhanced chemotherapy of drug resistant cancer cells; while in the presence of NIR irradiation, the overall therapeutic e±ciency was further enhanced due to the NIR responsive photothermal properties of GO (Fig.",
      "startOffset" : 251,
      "endOffset" : 256
    }, {
      "referenceID" : 104,
      "context" : "for the  ̄rst time showed that the photodynamic properties of GO can be signi ̄cantly enhanced by incorporating the NIR responsive photothermal properties of GO into a single multifunctional therapeutic platform.(116) In this study, the authors showed that GOPEG-Ce6 complexes o®ered signi ̄cant photodynamic destruction of cancer cells as compared to free Ce6 molecules.",
      "startOffset" : 212,
      "endOffset" : 217
    }, {
      "referenceID" : 105,
      "context" : "reported the development of a multifunctional phototherapeutic platform based on nano GO sheets non-covalently functionalized with a Pluronic block copolymer and loaded with the photosensitizer MB via electrostatic interactions.(117) In vitro studies showed increased cellular uptake of the nanocomposites by cancer cells as compared to normal cells, and signi ̄cant cell death in response to NIR irradiation.",
      "startOffset" : 228,
      "endOffset" : 233
    }, {
      "referenceID" : 106,
      "context" : "graphene-based nanocomposites was also demonstrated by Chen et al.(118) The group synthesized reduced graphene oxide–ZnO nanoparticles–hyaluronic acid (rGo-ZnOHA)-based multifunctional nanoplatform for a synergistic PTT-PDT of cancer.",
      "startOffset" : 66,
      "endOffset" : 71
    }, {
      "referenceID" : 107,
      "context" : "synthesized a water-soluble graphene–phthalocyanine (GR–TSCuPc) hybrid material by a one-step method involving simple mixing of graphene with tetrasodium salt copper phthalocyanine (TSCuPc) through sonication.(119) In the hybrid, graphene acted as the carrier of the photosensitizer and as a PTT agent, and TSCuPc served the role of a water-soluble PDT agent.",
      "startOffset" : 209,
      "endOffset" : 214
    }, {
      "referenceID" : 108,
      "context" : "Graphene-based bioimaging can be grouped into two major categories: optical and non-optical imaging.(120) Optical imaging includes °uorescence imaging, two-photon °uorescence imaging and Raman imaging, whereas non-optical imaging includes magnetic resonance imaging (MRI), radioactive imaging like PET and SPECT, photoacoustic imaging (PAI) and computed tomography (CT).",
      "startOffset" : 100,
      "endOffset" : 105
    }, {
      "referenceID" : 109,
      "context" : "nano-GO was  ̄rst reported by the Dai group, where they observed that both GO and nGO-PEG exhibited broad °uorescence emission from the visible region to the IR-A region.(121) They exploited this IR responsive intrinsic photoluminescence property of GO and synthesized Rituxan (anti-CD20 mAb) conjugated nGO-PEG nanocomposites for targeted °uorescence imaging of CD20 positive Raji B cells using a 658 nm excitation laser.",
      "startOffset" : 170,
      "endOffset" : 175
    }, {
      "referenceID" : 66,
      "context" : "demonstrated in vivo °uorescence imaging of tumor xenografted mouse models using a NIR dye (Cy7) conjugated nGO-PEG composite.(74) The authors observed that with time the nGO-PEG-Cy7 nanocomposites accumulated in the tumor regions through passive targeting and showed intense °uorescence signals upon NIR irradiation.",
      "startOffset" : 126,
      "endOffset" : 130
    }, {
      "referenceID" : 111,
      "context" : "reported synthesis of IRDye800-conjugated GO loaded with VEGF as a targeted °uorescent probe for imaging of ischemic muscles in a murine model.(123) In addition to GO and rGO, another class of graphene-based nanomaterials have gained a great deal of attention in the recent years especially in the  ̄eld of biomedical imaging.",
      "startOffset" : 143,
      "endOffset" : 148
    }, {
      "referenceID" : 112,
      "context" : "reported the synthesis of biocompatible, water soluble green °uorescent GQDs by a one-step solvothermal process and used it for labeling and imaging of cells in vitro.(125) In addition to this, there are several reports on synthesis and bioimaging applications of di®erent kinds of GQDs.",
      "startOffset" : 167,
      "endOffset" : 172
    }, {
      "referenceID" : 113,
      "context" : "synthesized biocompatible nitrogen-doped graphene quantum dots (N-GQDs) and exploited them as optical probes for TPFI of cells and deep tissues.(126) The authors reported that the N-GQDs could be identi ̄ed even at a depth of 1800 m in the tissue phantom using TPFI as compared to OPFI which could image the N-GQDs only up to a depth of 400 m, thereby demonstrating the advantage and feasibility of graphene-based TPFI for deep tissue imaging.",
      "startOffset" : 144,
      "endOffset" : 149
    }, {
      "referenceID" : 117,
      "context" : "demonstrated targeted Raman imaging of cancer cells using folic acid conjugated Ag/GO hybrids as Raman probes and observed that cells incubated with the hybrids exhibited much stronger Raman signals from the GO sheets as compared to ones incubated with only GO sheets.(130) Huang et al.",
      "startOffset" : 268,
      "endOffset" : 273
    }, {
      "referenceID" : 118,
      "context" : "studied the cellular uptake mechanisms of GO in the Ca Ski cell line by using Raman probes made up of AuNPs attached to the surface of GO sheets through amide linkages between PEG and DMSA.(131) Song et al.",
      "startOffset" : 189,
      "endOffset" : 194
    }, {
      "referenceID" : 119,
      "context" : "reported the synthesis of a new type of graphene-based Raman probe for bioimaging.(132) They synthesized alkyne-PEG functionalized graphitic silver nanoparticles (ACG NPs) using chemical vapor deposition method.",
      "startOffset" : 82,
      "endOffset" : 87
    }, {
      "referenceID" : 120,
      "context" : "developed a new type of MRI contrast agent by using carboxyphenylated graphene nanoribbons as substrates to which Gd3þ ions were chelated (Gd-GNR).(133) It was observed that Gd-GNRs exhibited enhanced MRI contrast and relaxivity as compared to Gd3þ-based agents.",
      "startOffset" : 147,
      "endOffset" : 152
    }, {
      "referenceID" : 121,
      "context" : "6(iii)).(134) Coating of Fe3O4 NPs with dextran allowed formation of aggregates of Fe3O4 NPs on the surface of GO which in turn helped in enhancing the MRI contrast as compared to single Fe3O4 NPs.",
      "startOffset" : 8,
      "endOffset" : 13
    }, {
      "referenceID" : 122,
      "context" : "nanoparticle-based MRI contrast agent was reported for the  ̄rst time by Hu.(135) He developed °uorinated GO sheets by creating dipolar C–F bonds which acted as the paramagnetic centers and demonstrated good T2 contrast.",
      "startOffset" : 76,
      "endOffset" : 81
    }, {
      "referenceID" : 123,
      "context" : "developed a novel PET contrast agent by labeling nGO-PEG with 64Cu via a 1,4,7- triazacyclononane-1,4,7-triacetic acid (NOTA) linkage.(136) They further conjugated this nanocomposite with a CD105 speci ̄c antibody TRC105 and demonstrated targeted PET imaging of tumor vasculatures in 4T1 murine breast tumors (Fig.",
      "startOffset" : 134,
      "endOffset" : 139
    }, {
      "referenceID" : 124,
      "context" : "In another study by the same group, the researchers developed another PET contrast agent by labeling nGO-PEG with 66Ga and demonstrated tumor targeted PET imaging.(137) In addition to PET, graphene-based nanomaterials have also been used for developing SPECT imaging agents.",
      "startOffset" : 163,
      "endOffset" : 168
    }, {
      "referenceID" : 125,
      "context" : "developed a SPECT imaging agent by labeling GO nanosheets with 198;199Au and demonstrated targeted SPECT imaging of tumors.(138) In vivo SPECT imaging of Her2 positive tumors was demonstrated by Cornelissen et al.",
      "startOffset" : 123,
      "endOffset" : 128
    }, {
      "referenceID" : 126,
      "context" : "using 111In-benzyl-diethylenetriaminepentaacetic acid (BnDTPA) labelled anti-Her2 antibody conjugated nGO as the imaging agents.(139) The authors observed that the radiolabeled nanoconstructs showed better pharmacokinetic pro ̄les as compared to radiolabeled antibody alone.",
      "startOffset" : 128,
      "endOffset" : 133
    }, {
      "referenceID" : 127,
      "context" : "utilized the NIR photoluminescence properties of gold nanoclusters (GNC) for bioimaging applications and loaded them onto rGO sheets to form GNCrGO nanotheranostic platforms for carrying out combined drug delivery and °uorescence imaging of cells in vitro.(140) Chen et al.",
      "startOffset" : 256,
      "endOffset" : 261
    }, {
      "referenceID" : 128,
      "context" : "developed an imaging probe consisting of QDs coated with hybrid SiO2 shells conjugated to graphene and functionalized with transferrin.(141) This functionalized nanocomposite was then loaded with doxorubicin and exploited for QD and DOX mediated dual-colored °uorescence imaging-guided tracking and delivery of drug to cancer cells in vitro (Fig.",
      "startOffset" : 135,
      "endOffset" : 140
    }, {
      "referenceID" : 129,
      "context" : "for targeted drug delivery combined with °uorescent imaging of hepatocellular carcinoma cells in vitro.(142) Kim et al.",
      "startOffset" : 103,
      "endOffset" : 108
    }, {
      "referenceID" : 46,
      "context" : "synthesized a graphene-based gene delivery vehicle by conjugating low molecular weight branched polyethylenimine (BPEI) to GO sheets, thereby imparting a positive surface charge to the nanoconstruct that ultimately facilitated complexation with negatively charged plasmid DNA through electrostatic interactions and showed e±cient gene delivery to HeLa and PC3 cells in vitro.(54) In addition to this, the authors exploited the intrinsic °uorescence properties of GO for imaging the cellular uptake of the nanoconstructs.",
      "startOffset" : 375,
      "endOffset" : 379
    }, {
      "referenceID" : 130,
      "context" : "reported the synthesis of nanoGO wrapped AuNPs (Au@NGO) as theranostic tools for Raman imaging and drug delivery to HeLa cells.(143) Similarly, Wang et al.",
      "startOffset" : 127,
      "endOffset" : 132
    }, {
      "referenceID" : 131,
      "context" : "These rGO-NS nanocomposites have the potential to be exploited as a theranostic platform for combined drug delivery and Raman imaging.(144)",
      "startOffset" : 134,
      "endOffset" : 139
    }, {
      "referenceID" : 132,
      "context" : "developed a graphene-based positive T1 MRI contrast agent through conjugation of diethylenetriaminepentaacetic acid (DTPA) to GO followed by complexation with gadolinium ions (GO-DTPA-Gd) and successfully used it as a theranostic platform for carrying out MRI imaging combined with delivery of doxorubicin to HepG2 cancer cells in vitro.(145) The nanocomposite showed improved MRI T1 relaxivity and better cellular MRI contrast as compared to a commercially used contrast agent.",
      "startOffset" : 337,
      "endOffset" : 342
    }, {
      "referenceID" : 133,
      "context" : "magnetic graphene nanocomposites (CMG) loaded with the anti-cancer drug DOX and a plasmid DNA encoding GFP and demonstrated e±cient delivery of both drug and DNA to A549 lung cancer cells and C42b prostate cancer cells in vitro and also to tumor bearing mice in vivo.(146) In addition to this, the CMGs acted as strong T2 contrast-enhancing agent thereby enabling MR imaging of the cells and organs.",
      "startOffset" : 267,
      "endOffset" : 272
    }, {
      "referenceID" : 134,
      "context" : "developed a CdSe/ZnS QD labeled, polypeptide functionalized rGO (QD-rGO) nanotheranostic platform for combined °uorescence imaging and photothermal therapy of cancers.(148) Chen and co-workers demonstrated in vivo PDT of cancer combined with enhanced °uorescence imaging by using PEGylated GO loaded with novel photosensitizer sinoporphyrin sodium (DVDMS) and observed intense °uorescent signals in mice from tumor regions showing enhanced uptake of the nanocomposites by tumors through passive targeting and achieved 100% tumor elimination in mice intravenously injected with GO-PEG-DVDMS without any loss in body weight and reappearance of tumors.",
      "startOffset" : 167,
      "endOffset" : 172
    }, {
      "referenceID" : 135,
      "context" : "Chen and co-workers demonstrated in vivo PDT of cancer combined with enhanced °uorescence imaging by using PEGylated GO loaded with novel photosensitizer sinoporphyrin sodium (DVDMS) and observed intense °uorescent signals in mice from tumor regions showing enhanced uptake of the nanocomposites by tumors through passive targeting and achieved 100% tumor elimination in mice intravenously injected with GO-PEG-DVDMS without any loss in body weight and reappearance of tumors.(149) In another study, Wang et al.",
      "startOffset" : 476,
      "endOffset" : 481
    }, {
      "referenceID" : 136,
      "context" : "reported the synthesis of a novel, multifunctional nanotheranostic platform capable of performing synergistically photothermal and photodynamic therapy combined with imaging.(150) They covalently linked core-shell structured upconversion nanoparticles (UCNP) to the surface of nGO sheets via a PEG spacer, followed by loading a photosensitizer such as phthalocyanine (ZnPc) onto the surface of nGO to form UCNP-nGO/ZnPc nanocomposites.",
      "startOffset" : 174,
      "endOffset" : 179
    }, {
      "referenceID" : 137,
      "context" : "by conjugating Ce6 to GO nanosheets via redox-responsive cleavable disul ̄de linker (GO-SS-Ce6).(151) GO-SS-Ce6 in its native form remains non-°uorescent and non-toxic even in the presence of light irradiation due to quenching by GO.",
      "startOffset" : 96,
      "endOffset" : 101
    }, {
      "referenceID" : 138,
      "context" : "In a follow-up study by the same group, the researchers reported the synthesis of an enzyme activatable theranostic agent by forming a non-covalent complex between GO and Hyaluronic acid-Ce6 (HA-Ce6) through physical adsorption of HA-Ce6 on the surface of GO (GO-HA-Ce6).(152)",
      "startOffset" : 271,
      "endOffset" : 276
    }, {
      "referenceID" : 139,
      "context" : "through the photocatalytic degradation of GO nanoplateletes by using TiO2 nanoparticles.(153) The rGONMs were functionalized with PEG and conjugated with RGD peptide and cyanine 7 for carrying out targeted °uorescence imaging and photothermal ablation of U87MG glioblastoma tumors in mouse models.",
      "startOffset" : 88,
      "endOffset" : 93
    }, {
      "referenceID" : 140,
      "context" : "demonstrated for the  ̄rst time a theranostic strategy based on TPFI coupled with photothermal therapy using graphene-based nanomaterials.(154) They synthesized transferrin conjugated GO-PEG nanocomposites as non-bleaching imaging probes for targeted three-dimensional (3D) TPFI of the gastric cancer cell line AGS, using a low power pulsed laser for excitation.",
      "startOffset" : 138,
      "endOffset" : 143
    }, {
      "referenceID" : 141,
      "context" : "synthesized a novel theranostic platform for a combined photothermalphotodynamic therapy of cancer guided by Raman imaging.(155) They synthesized core-shell nanoparticles comprising of an Au core surrounded by graphene oxide nanocolloid (GON) shell by a one-pot technique, where GONs acted as both reducing agent and stabilizer for the formation of the AuNPs.",
      "startOffset" : 123,
      "endOffset" : 128
    }, {
      "referenceID" : 142,
      "context" : "using iron oxide nanoparticles (IONP) loaded GO nanocomposites (GO/IONP) as a theranostic agent.(156) The IONPs helped in providing the MRI contrast which was enhanced due to the presence of GO as a substrate, thereby making RLNs easily distinguishable from the surrounding tissues.",
      "startOffset" : 96,
      "endOffset" : 101
    }, {
      "referenceID" : 143,
      "context" : "combined photoacoustic imaging with photothermal therapy into a single platform by loading the NIR absorbing dye indocyanine green (ICG) onto GO and demonstrated targeted photothermal ablation of HeLa cells in vitro alongwith PAI through conjugation of folic acid as the targeting ligand with the ICG-GO nanocomposites.(157) In vivo PAI alongwith PTT was demonstrated by Sheng et al.",
      "startOffset" : 319,
      "endOffset" : 324
    }, {
      "referenceID" : 144,
      "context" : "using bovine serum albumin functionalized nano-rGO (BSA-rGO) in a mouse bearing MCF-7 xenograft.(158) Post 2 h intravenous injection of the BSA-rGO Graphene-Based Nanomaterials for Theranostic Applications",
      "startOffset" : 96,
      "endOffset" : 101
    }, {
      "referenceID" : 145,
      "context" : "demonstrated dual modal MRI/CT imaging of tumors in vivo alongwith photothermal ablation using PEGylated GO nanosheets loaded with BaGdF5 nanoparticles (GO/BaGdF5/ PEG).(159) The nanocomposites exhibited enhanced magnetic resonance contrast and better X-ray attenuation property than Iohexol which is a standard contrast agent used in radiographic imaging of arteries, veins, ventricles, joints, etc.",
      "startOffset" : 169,
      "endOffset" : 174
    }, {
      "referenceID" : 146,
      "context" : "developed a multifunctional magnetic and plasmonic graphene-based nanocomposite by loading IONP onto the surface of GO sheets followed by growing a layer of gold on it.(160) This GO-IONP-Au nanocomposite was then functionalized with PEG and used for photothermal ablation of cancer cells and tumors both in vitro and in vivo alongwith dual-modal MRI and X-ray imaging.",
      "startOffset" : 168,
      "endOffset" : 173
    }, {
      "referenceID" : 147,
      "context" : "developed a graphene-based nanotheranostic platform for triple modal °uorescence, photoacoustic, and magnetic resonance imaging of tumors in vivo combined with photothermal therapy and successfully demonstrated multimodal imaging guided photothermal ablation of 4T1-tumors in mice by using C18PMH–PEG functionalized rGO/IONP nanocomposites synthesized via a hydrothermal process.(161) PLA microcapsules encapsulating GO and AuNPs were developed as nanotheranostic agent by Jin et al.",
      "startOffset" : 379,
      "endOffset" : 384
    }, {
      "referenceID" : 148,
      "context" : "for photothermal ablation of tumors under the guidance of bimodal ultrasonic/CT imaging.(162) Rong et al.",
      "startOffset" : 88,
      "endOffset" : 93
    }, {
      "referenceID" : 149,
      "context" : "demonstrated bimodal °uorescence/PET imaging guided photodynamic therapy of tumors using PEGylated GO sheets loaded with a radiolabeled photosensitizer 64Cu -HPPH.(163) Similarly, in a separate study, Yan et al.",
      "startOffset" : 163,
      "endOffset" : 168
    }, {
      "referenceID" : 150,
      "context" : "7(ii)).(164) In another study, Gollavelli et al.",
      "startOffset" : 7,
      "endOffset" : 12
    }, {
      "referenceID" : 151,
      "context" : "developed SiNc4 photosensitizer loaded magnetic °uorescent graphene and demonstrated bimodal °uorescence/MRI imaging guided combined photothermal-photodynamic therapy of HeLa cells in vitro.(165) S.",
      "startOffset" : 190,
      "endOffset" : 195
    }, {
      "referenceID" : 152,
      "context" : "reported the synthesis of graphene-isolated-Au-nanocrystal (GIAN) nanostructures by depositing a thin layer of graphene on the surfaces of Au nanocrystals using CVD method.(166) These nanostructures were used as imaging probes for dual modal Raman and TPFI imaging of cells and also as a substrate for loading of anti-cancer drug doxorubicin and NIR mediated photothermal therapy of cancer (Fig.",
      "startOffset" : 172,
      "endOffset" : 177
    }, {
      "referenceID" : 153,
      "context" : "demonstrated tumor targeted chemo-PTT of cancer combined with X-ray imaging of the tumors using GO@Ag nanocomposites.(167) The GO@Ag nanocomposites were loaded with doxorubicin and conjugated with NGR peptide for active targeting of tumors (GO@Ag-DOX-NGR).",
      "startOffset" : 117,
      "endOffset" : 122
    }, {
      "referenceID" : 154,
      "context" : "developed a theranostic platform based on magnetic graphene-based mesoporous silica for MRI guided targeted chemo-photothermal therapy of gliomas.(168) The MGMS nanocomposites were tagged with a IL-13 targeting peptide and loaded with DOX for targeted delivery of the drugs to U251 glioma cells.",
      "startOffset" : 146,
      "endOffset" : 151
    }, {
      "referenceID" : 155,
      "context" : "reported a new type of theranostic platform by synthesizing ultrasmall FeCo/graphitic carbon shell nanocrystals (FeCo/GC) having size in the range of 3–4 nm in diameter.(169) The FeCo/GC nanocrystals exhibited excellent magnetization, high doxorubicin loading e±ciency and both pH and NIR responsive drug release abilities that resulted in enhanced cytotoxicity towards cancer cells.",
      "startOffset" : 169,
      "endOffset" : 174
    } ],
    "year" : 2018,
    "abstractText" : "Graphene and graphene-based nanomaterials such as graphene oxide (GO), reduced graphene oxide (rGO) and graphene quantum dots (GQDs) have gained a lot of attention from diverse scienti ̄c ̄elds for applications in sensing, catalysis, nanoelectronics, material engineering, energy storage and biomedicine due to its unique structural, optical, electrical and mechanical properties. Graphene-based nanomaterials emerge as a novel class of nanomedicine for cancer therapy for several reasons. Firstly, its structural properties like high surface area and aromaticity enables easy loading of hydrophobic drugs. Secondly, presence of oxygen containing functional groups improve its physiological stability and also act as site for biofunctionalization. Thirdly, its optical absorption in the NIR region enable them to act as photoagents for photothermal and photodynamic therapies of cancer, both in vitro and in vivo. Finally, its intrinsic °uorescence property helps in bioimaging of cancer cells. Overall, graphene-based nanomaterials can act as agents for developing multifunctional theranostic platforms for carrying out more e±cient detection and treatment of cancers. This review provides a detailed summary of the di®erent applications of graphene-based nanomaterials in drug delivery, nucleic acid delivery, phototherapy, bioimaging and theranostics.",
    "creator" : "Arbortext Advanced Print Publisher 10.0.1041/W Unicode"
  }
}